data_2kxy_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kxy _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.4 tp . . . . . 0 N--CA 1.445 -0.681 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 90.3 p -145.06 148.26 33.5 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.476 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -144.52 166.34 25.42 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.466 0.651 . . . . 0.0 109.563 -178.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.4 t -113.45 135.99 53.28 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.572 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.5 m -128.86 100.37 21.29 Favored Pre-proline 0 CA--C 1.549 0.904 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -57.01 144.62 89.09 Favored 'Trans proline' 0 N--CA 1.499 1.842 0 C-N-CA 121.095 1.196 . . . . 0.0 111.704 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 23.0 m -88.86 139.56 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.681 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -119.17 116.41 26.25 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.8 mp -89.98 135.13 33.83 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -122.49 116.66 24.32 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 58.2 mt -66.61 126.06 27.73 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.3 m -127.4 133.96 49.95 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.65 165.06 15.75 Favored Glycine 0 N--CA 1.472 1.043 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -81.32 138.19 35.7 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -68.22 139.49 56.04 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.03 144.09 57.36 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 83.2 p -68.89 -24.08 64.28 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.185 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -91.5 2.89 56.11 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 122.218 0.207 . . . . 0.0 110.99 -179.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 52.8 t -118.91 126.16 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 36.4 t -75.05 -43.32 54.14 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.339 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 37.5 t -163.94 162.11 23.22 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.723 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 80.4 mt -130.4 146.1 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.337 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 40.2 t -132.58 161.83 32.84 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.497 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -146.21 154.67 42.01 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.069 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 50.8 m -144.69 170.89 15.22 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.802 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -146.74 147.69 31.21 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.808 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -74.57 -33.36 62.67 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.067 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.431 ' O ' ' ND1' ' A' ' 36' ' ' HIS . 86.7 mtm180 -133.6 -49.77 0.84 Allowed 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.729 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.38 19.27 57.38 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.431 ' ND1' ' O ' ' A' ' 34' ' ' ARG . 47.9 m80 -142.25 137.5 30.74 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.1 p -133.4 161.88 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 34.1 m -101.53 135.0 43.78 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.335 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 40.5 pt -120.04 149.66 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.8 t -132.79 134.97 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 166.57 -160.3 33.86 Favored Glycine 0 N--CA 1.464 0.531 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.8 m -73.01 151.74 41.63 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 62.1 tp60 -64.96 -34.49 78.54 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.313 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -60.61 -43.81 97.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.736 0.303 . . . . 0.0 110.622 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.72 -40.09 94.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.623 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 67.7 mtt -65.01 -40.67 95.23 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.597 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -65.55 -23.71 66.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.64 0.257 . . . . 0.0 110.53 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -80.61 -34.96 34.68 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.377 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 67.1 mt -91.61 116.35 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -99.1 -24.58 14.84 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.064 0.459 . . . . 0.0 110.221 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 92.9 p -172.36 162.8 5.52 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.044 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 36.7 mm -107.32 120.48 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 33.5 m -85.01 129.93 34.71 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 38.3 t -123.84 90.75 50.37 Favored Pre-proline 0 N--CA 1.471 0.619 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -79.26 146.2 19.62 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 121.485 1.456 . . . . 0.0 111.371 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.7 p -139.57 137.43 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.883 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -79.16 125.29 29.25 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 36.4 pt -103.08 -9.87 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 120.857 0.36 . . . . 0.0 110.294 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 40.3 m -61.81 -39.82 93.09 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.436 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -86.69 -5.0 59.25 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 122.928 0.491 . . . . 0.0 110.679 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 45.4 t -92.43 114.14 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 70.2 p -132.54 -0.13 3.59 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.172 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -144.62 155.7 43.75 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 121.007 0.432 . . . . 0.0 110.435 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -63.9 132.81 51.89 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.04 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.8 t -167.61 -174.9 2.63 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.342 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 96.8 p -151.26 147.25 26.75 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.611 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -140.16 143.93 36.4 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.109 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.8 m -83.13 132.03 35.11 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.168 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 74.8 mt -120.89 129.66 53.58 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 122.907 0.483 . . . . 0.0 109.839 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -96.6 137.68 35.32 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 52.2 mt -110.64 136.93 48.98 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -141.59 147.24 37.34 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -149.89 137.21 19.78 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -86.29 114.6 23.23 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.004 0.431 . . . . 0.0 110.941 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 125.12 -20.56 6.65 Favored Glycine 0 N--CA 1.485 1.937 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.625 178.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 32.8 m -134.13 159.87 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 31.7 m -102.73 111.14 23.32 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.1 t -92.04 129.14 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -156.75 142.0 12.45 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.494 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.92 -10.28 11.73 Favored 'Cis proline' 0 N--CA 1.508 2.33 0 CA-C-N 120.539 1.228 . . . . 0.0 110.58 -0.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.8 p 60.3 23.15 12.6 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.165 177.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 39.7 p -131.93 139.63 48.77 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.5 m -152.36 151.92 11.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -96.19 134.01 39.8 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 44.7 t -126.1 127.08 70.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -104.95 124.38 49.41 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 58.7 mt -108.01 108.68 19.9 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -90.16 129.63 36.41 Favored 'General case' 0 C--O 1.231 0.105 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 38.6 t -104.14 131.36 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 39.9 m -101.18 120.42 40.21 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 91.3 mm-40 . . . . . 0 C--N 1.333 -0.126 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -179.789 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 53.4 mt . . . . . 0 N--CA 1.464 0.268 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 95.8 p -160.58 150.31 17.59 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.8 mtpt -151.11 164.98 35.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.619 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 35.0 m -114.18 137.1 52.2 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.634 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.3 m -126.68 101.67 26.67 Favored Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 123.588 0.755 . . . . 0.0 109.051 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -57.02 144.53 89.42 Favored 'Trans proline' 0 N--CA 1.499 1.803 0 CA-C-N 120.342 1.158 . . . . 0.0 111.939 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 23.3 t -89.41 130.93 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.1 ttmm -117.33 126.95 53.55 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.6 mt -101.82 127.95 48.4 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -115.23 109.95 18.73 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.9 pp -64.19 129.23 39.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.154 -0.476 . . . . 0.0 109.736 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 31.6 m -126.07 135.66 52.0 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 115.23 162.66 13.68 Favored Glycine 0 N--CA 1.476 1.367 0 N-CA-C 110.581 -1.007 . . . . 0.0 110.581 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.0 p-10 -82.64 142.18 31.92 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -66.7 134.34 52.03 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.68 176.63 0.64 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.23 0.538 . . . . 0.0 111.143 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.8 t -85.75 -23.98 27.08 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.099 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -91.32 -13.14 33.12 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -178.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.5 p -98.56 128.25 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 CA-C-O 120.79 0.328 . . . . 0.0 110.875 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 46.7 t -92.09 -37.31 12.85 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.839 0.352 . . . . 0.0 110.122 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 98.3 p -161.21 159.16 28.46 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.151 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 73.9 mt -133.78 142.53 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 65.0 p -135.01 159.12 42.52 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.288 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -145.7 155.85 43.25 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.083 0.468 . . . . 0.0 110.182 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 47.7 t -147.4 163.46 36.41 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.254 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -146.46 143.76 29.2 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.288 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -69.27 -34.36 74.63 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.984 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -135.91 -51.27 0.72 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.014 0.526 . . . . 0.0 109.96 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.84 24.03 61.99 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.439 ' ND1' ' O ' ' A' ' 36' ' ' HIS . 17.8 p80 -148.69 139.68 23.04 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 28.4 m -131.6 164.51 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 61.4 m -99.71 133.55 43.89 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 37.9 pt -118.82 147.5 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 122.854 0.462 . . . . 0.0 110.25 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.2 t -132.13 135.6 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.399 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 170.97 -163.08 36.09 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 30.8 t -72.33 147.4 46.35 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 70.8 tp60 -58.8 -38.19 78.05 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.603 0.24 . . . . 0.0 111.117 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 23.6 mp0 -59.84 -48.02 83.37 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.878 0.37 . . . . 0.0 110.793 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.99 -37.9 86.57 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.738 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 21.2 mmt -65.79 -39.54 91.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.006 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -61.1 -31.98 71.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.609 0.242 . . . . 0.0 110.818 -178.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -71.55 -39.08 70.9 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.776 0.322 . . . . 0.0 110.316 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 57.5 mt -85.54 117.53 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -113.46 -19.52 11.65 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.184 0.593 . . . . 0.0 110.578 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 66.5 p -174.1 161.56 3.63 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.694 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 38.1 mm -111.4 117.85 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 48.2 m -105.51 124.44 49.55 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 36.1 t -127.17 113.44 21.62 Favored Pre-proline 0 N--CA 1.482 1.169 0 CA-C-O 118.446 -0.788 . . . . 0.0 109.792 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -76.81 143.62 23.73 Favored 'Trans proline' 0 N--CA 1.497 1.678 0 CA-C-N 121.254 1.484 . . . . 0.0 110.755 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.8 t -129.31 126.79 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -73.67 126.47 30.4 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.69 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 39.1 pt -102.69 -15.74 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 122.82 0.448 . . . . 0.0 110.912 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.8 t -61.39 -40.32 93.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.594 -178.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -83.3 -5.78 59.25 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 122.374 0.27 . . . . 0.0 110.616 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 47.4 t -91.2 108.45 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 70.6 p -129.88 1.51 4.84 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.636 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -141.95 146.79 36.05 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 21.2 p-10 -63.88 137.12 57.89 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.103 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.431 ' OG1' ' N ' ' A' ' 66' ' ' SER . 5.6 t -168.14 -173.43 2.03 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.265 0.555 . . . . 0.0 110.709 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.431 ' N ' ' OG1' ' A' ' 65' ' ' THR . 90.2 p -147.25 143.35 28.07 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.45 179.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -138.45 142.38 39.47 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.0 0.429 . . . . 0.0 110.238 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 44.6 m -82.1 131.89 35.24 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.5 mt -111.75 111.71 22.88 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 122.659 0.384 . . . . 0.0 110.29 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -83.77 126.37 32.85 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 31.8 mt -103.74 134.74 46.55 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 120.792 0.329 . . . . 0.0 110.597 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -134.94 142.06 46.42 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.084 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -145.41 135.27 23.59 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -85.5 117.73 24.58 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.328 0.585 . . . . 0.0 111.848 -178.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.61 -16.02 16.86 Favored Glycine 0 N--CA 1.482 1.704 0 CA-C-N 114.574 -1.194 . . . . 0.0 112.208 178.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 23.3 m -133.04 159.22 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 56.9 m -107.95 117.73 34.9 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.1 p -105.85 133.52 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 122.938 0.495 . . . . 0.0 109.741 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -158.81 143.67 11.69 Favored Pre-proline 0 CA--C 1.552 1.046 0 CA-C-O 119.078 -0.487 . . . . 0.0 110.654 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.424 ' C ' ' H ' ' A' ' 82' ' ' THR . 87.8 Cg_endo -70.2 -12.13 12.96 Favored 'Cis proline' 0 N--CA 1.516 2.815 0 CA-C-N 120.646 1.266 . . . . 0.0 110.998 0.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 67.6 -6.87 0.62 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.839 177.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.424 ' H ' ' C ' ' A' ' 80' ' ' PRO . 59.0 p -100.31 139.51 35.88 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.8 m -147.92 146.14 18.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -95.23 130.89 41.8 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 44.0 t -126.6 126.04 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -100.09 124.64 45.72 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 59.8 mt -110.41 104.16 12.89 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -92.81 128.88 38.83 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.4 p -107.83 137.08 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.627 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 69.9 m -100.24 121.5 41.56 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 95.4 mm-40 . . . . . 0 N--CA 1.468 0.44 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.985 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 58.6 mt . . . . . 0 N--CA 1.467 0.399 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.0 t -151.67 145.68 25.24 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.567 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -149.64 167.51 26.19 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.565 -178.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 30.5 m -109.48 139.06 44.92 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.059 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.5 m -131.84 95.03 23.48 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 123.625 0.77 . . . . 0.0 109.313 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -58.39 146.19 90.95 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 C-N-CA 121.207 1.272 . . . . 0.0 112.144 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.4 p -98.25 142.1 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.242 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -121.27 133.87 55.15 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 78.3 mt -100.06 128.54 46.13 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -113.47 111.89 22.7 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 56.5 mt -70.28 126.13 28.77 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.1 p -129.31 145.38 51.38 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.956 -0.386 . . . . 0.0 109.956 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.02 168.33 16.39 Favored Glycine 0 N--CA 1.474 1.199 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.6 p-10 -84.75 132.58 34.42 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -64.49 135.93 56.55 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.54 176.06 3.12 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.577 0.703 . . . . 0.0 110.991 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 74.6 m -84.31 -20.75 31.57 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.299 -178.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -90.27 -19.83 23.65 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 122.461 0.304 . . . . 0.0 111.037 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.6 p -97.18 128.31 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-O 120.576 0.227 . . . . 0.0 110.469 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.5 t -103.39 -26.99 12.7 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 120.823 0.345 . . . . 0.0 110.188 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 48.1 t -160.81 154.21 21.9 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.907 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 86.0 mt -129.92 135.79 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.9 p -133.59 154.79 50.6 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -148.42 159.16 44.31 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.409 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.539 ' HG ' ' N ' ' A' ' 32' ' ' PHE . 44.1 t -146.35 168.37 21.29 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.008 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.539 ' N ' ' HG ' ' A' ' 31' ' ' SER . 16.6 p90 -146.41 149.61 34.06 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.952 -179.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -68.12 -33.54 74.69 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.56 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -150.27 -38.96 0.14 Allowed 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.172 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.422 ' O ' ' ND1' ' A' ' 36' ' ' HIS . . . 55.95 25.86 46.69 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 178.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.422 ' ND1' ' O ' ' A' ' 35' ' ' GLY . 15.3 m-70 -138.0 137.32 37.78 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 31.4 m -129.88 160.93 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 35.5 m -102.88 133.78 47.4 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 38.1 pt -117.8 146.44 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 122.758 0.423 . . . . 0.0 110.326 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.7 t -132.86 134.51 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.786 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 168.5 -159.44 32.6 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 95.0 p -72.63 151.62 42.2 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.647 0.26 . . . . 0.0 110.301 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.8 tm0? -63.35 -36.9 85.22 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.763 0.316 . . . . 0.0 110.237 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.44 ' CD ' ' H ' ' A' ' 44' ' ' GLU . 24.9 mp0 -60.55 -53.71 54.24 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.137 -178.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.51 -40.21 96.01 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.909 0.385 . . . . 0.0 110.88 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 88.3 mtp -66.85 -39.61 87.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.702 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -61.79 -34.31 75.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.478 0.18 . . . . 0.0 111.395 -178.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -68.95 -35.26 76.56 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.749 0.309 . . . . 0.0 110.383 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 63.6 mt -85.67 120.1 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -119.42 -16.67 8.92 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 122.968 0.507 . . . . 0.0 110.404 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 68.9 p -172.29 167.5 5.78 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.45 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 81.6 mt -126.73 128.04 70.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.9 t -104.68 132.4 50.97 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 179.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 38.7 t -133.23 90.63 29.83 Favored Pre-proline 0 N--CA 1.473 0.696 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -58.12 142.24 96.92 Favored 'Trans proline' 0 N--CA 1.501 1.955 0 C-N-CA 121.663 1.575 . . . . 0.0 112.026 178.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 60.3 t -128.67 128.7 68.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -77.53 123.18 26.25 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 38.0 pt -99.63 -10.99 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 122.705 0.402 . . . . 0.0 110.697 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 39.4 t -61.66 -40.13 93.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.461 -178.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -85.23 -5.5 59.32 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 122.748 0.419 . . . . 0.0 110.394 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 46.4 t -91.94 106.99 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 71.5 p -131.03 2.66 4.33 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.703 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -147.2 146.07 29.71 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.936 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -52.33 135.21 33.24 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.453 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.417 ' OG1' ' N ' ' A' ' 66' ' ' SER . 7.0 t -167.95 -173.95 2.24 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.095 0.474 . . . . 0.0 110.863 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.417 ' N ' ' OG1' ' A' ' 65' ' ' THR . 61.8 p -150.92 148.73 28.78 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.101 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -143.54 144.15 31.83 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.225 0.536 . . . . 0.0 111.076 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 t -85.85 132.5 34.09 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.509 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 70.7 mt -115.97 120.63 39.79 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.806 0.443 . . . . 0.0 110.592 -179.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -84.87 133.06 34.32 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.265 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.1 mt -113.61 115.29 27.68 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -134.09 151.43 51.39 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -148.43 143.72 26.95 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -85.23 117.4 24.16 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.355 0.598 . . . . 0.0 111.343 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 118.24 -18.33 11.23 Favored Glycine 0 N--CA 1.481 1.658 0 CA-C-N 114.714 -1.13 . . . . 0.0 112.046 178.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.2 m -133.31 160.96 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 56.5 m -103.55 111.66 24.22 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.1 t -91.12 128.6 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -149.81 143.45 16.72 Favored Pre-proline 0 CA--C 1.553 1.085 0 CA-C-O 119.062 -0.494 . . . . 0.0 110.075 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -72.86 -1.23 11.74 Favored 'Cis proline' 0 N--CA 1.511 2.507 0 CA-C-N 120.906 1.359 . . . . 0.0 110.364 0.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.4 t 56.03 22.08 5.58 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.357 -1.292 . . . . 0.0 111.771 178.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 34.9 p -138.0 139.57 39.72 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.4 m -148.79 154.75 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -103.38 132.61 49.5 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 43.0 t -128.93 125.69 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.023 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -102.21 125.71 48.98 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 65.4 mt -107.54 111.2 23.35 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -95.5 126.57 40.88 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.6 m -96.52 137.6 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 44.1 m -100.61 116.41 32.46 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 95.3 mm-40 . . . . . 0 N--CA 1.467 0.408 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 -179.453 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 54.7 mt . . . . . 0 N--CA 1.466 0.354 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.7 t -160.35 143.26 13.4 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.669 ' HZ2' HE22 ' A' ' 43' ' ' GLN . 64.0 mttp -149.75 166.62 28.87 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -178.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.0 m -121.75 137.83 54.6 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.898 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.7 m -123.38 143.88 42.44 Favored Pre-proline 0 N--CA 1.486 1.362 0 C-N-CA 122.691 0.396 . . . . 0.0 110.022 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -74.37 142.24 29.72 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 121.429 1.419 . . . . 0.0 111.6 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.9 t -103.52 134.61 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -127.77 148.02 50.43 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 51.8 mt -112.37 137.88 49.91 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.466 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -119.32 110.27 16.79 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.4 mp -70.52 130.87 43.01 Favored 'General case' 0 C--N 1.334 -0.085 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.8 p -130.03 143.11 50.62 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.7 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.62 170.0 16.48 Favored Glycine 0 N--CA 1.475 1.265 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.8 p-10 -87.06 132.92 33.67 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -65.93 133.65 51.31 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.51 145.47 54.91 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.05 0.452 . . . . 0.0 110.629 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 61.0 m -63.68 -18.33 63.88 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.982 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -84.76 -20.87 30.37 Favored 'General case' 0 C--N 1.343 0.314 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.8 t -107.24 127.48 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-O 121.093 0.473 . . . . 0.0 110.276 -178.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 47.5 t -87.18 -40.7 14.35 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.34 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 47.1 t -155.47 161.31 40.98 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.499 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 82.6 mt -131.4 142.6 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.782 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.3 m -130.41 154.17 47.98 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.283 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -144.68 156.34 44.04 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.134 0.492 . . . . 0.0 110.096 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 45.4 m -148.09 166.52 27.57 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.154 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -146.1 142.49 28.58 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.959 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 33' ' ' ASP . 21.3 p-10 -73.35 -34.23 65.5 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.645 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -126.43 -56.79 1.4 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.111 0.564 . . . . 0.0 110.483 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 59.9 18.64 47.67 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -144.82 136.69 25.75 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.1 m -132.99 163.28 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 44.0 m -102.51 137.37 40.84 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 34.9 pt -117.41 150.44 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.2 p -130.27 134.69 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 123.332 0.395 . . . . 0.0 110.379 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 166.86 -160.75 34.49 Favored Glycine 0 C--N 1.328 0.113 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 44.6 t -77.43 157.04 30.73 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.669 HE22 ' HZ2' ' A' ' 9' ' ' LYS . 9.3 tp-100 -62.81 -35.36 79.64 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -61.75 -44.35 97.07 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.662 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.09 -39.91 95.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.816 0.341 . . . . 0.0 110.754 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 68.6 mtt -66.22 -38.64 88.42 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.418 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -61.08 -31.81 71.48 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.754 -0.203 . . . . 0.0 110.948 -179.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -73.64 -40.37 63.81 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.792 0.329 . . . . 0.0 110.511 179.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 67.0 mt -81.2 116.66 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -112.34 -23.35 10.4 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.248 0.619 . . . . 0.0 109.604 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 98.0 p -170.78 161.67 7.37 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.525 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 77.7 mt -112.53 121.43 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 33.6 m -99.08 130.72 45.42 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.4 t -134.26 93.0 20.07 Favored Pre-proline 0 N--CA 1.475 0.825 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -77.33 145.52 24.06 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 121.118 1.212 . . . . 0.0 111.31 -178.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.1 t -132.21 130.2 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-O 121.113 0.482 . . . . 0.0 110.235 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.9 p-10 -70.43 126.45 29.67 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.921 179.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 34.8 pt -100.02 -13.03 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 120.791 0.329 . . . . 0.0 110.661 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 44.7 m -59.39 -39.12 82.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.332 -178.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -84.65 -6.92 59.39 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 122.744 0.418 . . . . 0.0 110.39 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 42.6 t -93.54 114.48 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 65.4 p -133.48 4.92 3.7 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.158 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -152.66 161.74 42.17 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.846 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -62.36 138.7 58.49 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.953 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.2 t -166.03 170.46 13.55 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.293 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 46.7 m -148.11 140.69 24.5 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.761 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 54.5 pttt -146.63 145.08 29.93 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.488 0.661 . . . . 0.0 110.926 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 33.2 m -81.55 136.76 35.59 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.084 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 70.3 mt -115.89 125.96 53.3 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 122.79 0.436 . . . . 0.0 110.19 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -92.42 132.16 37.0 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 30.8 mt -107.67 129.77 54.98 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -131.15 141.44 50.09 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -139.49 142.14 37.33 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -86.02 133.03 33.93 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 122.21 1.005 . . . . 0.0 112.362 -178.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.05 -15.03 63.83 Favored Glycine 0 N--CA 1.472 1.049 0 CA-C-N 113.564 -1.653 . . . . 0.0 112.149 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 11.1 m -131.55 164.36 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 16.2 m -112.28 112.79 24.62 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.0 t -89.53 132.4 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -155.44 144.38 14.92 Favored Pre-proline 0 CA--C 1.557 1.238 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.858 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.46 -10.79 13.05 Favored 'Cis proline' 0 N--CA 1.514 2.732 0 CA-C-N 120.579 1.242 . . . . 0.0 110.639 0.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 10.4 p 58.21 23.68 10.56 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 114.652 -1.158 . . . . 0.0 112.129 177.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 34.6 p -132.88 139.38 47.38 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.6 m -152.89 154.97 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -94.75 134.74 37.03 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 44.8 t -127.85 130.62 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -111.24 124.23 51.8 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 53.0 mt -108.43 108.86 19.99 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -91.63 128.46 37.47 Favored 'General case' 0 C--O 1.231 0.111 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 43.3 t -102.97 132.61 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 61.8 m -100.31 117.87 35.4 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 . . . . . 0 N--CA 1.462 0.152 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.477 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 34.5 tp . . . . . 0 N--CA 1.467 0.382 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 35.9 m -161.3 140.61 10.24 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.6 ' NZ ' HE22 ' A' ' 43' ' ' GLN . 98.5 mttt -149.25 165.84 30.69 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -178.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 92.5 p -117.16 138.08 51.91 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.903 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.5 m -126.56 143.42 46.23 Favored Pre-proline 0 N--CA 1.482 1.162 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.92 142.4 28.05 Favored 'Trans proline' 0 N--CA 1.501 1.914 0 C-N-CA 121.604 1.536 . . . . 0.0 111.931 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.9 p -95.29 134.51 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.5 mptm? -108.73 133.55 52.65 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.5 tp -104.9 130.42 53.06 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -124.36 111.77 16.17 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.9 pp -69.6 131.11 44.13 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.3 p -125.44 134.95 51.91 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.64 163.88 14.55 Favored Glycine 0 N--CA 1.477 1.417 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.2 p-10 -78.95 136.8 37.35 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -66.81 138.11 57.11 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.42 141.43 58.36 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.206 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.0 t -68.03 -20.87 65.03 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.642 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -94.25 4.71 53.51 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 122.237 0.215 . . . . 0.0 110.914 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 68.6 t -118.42 126.2 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.3 t -73.71 -45.76 50.25 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.069 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 45.6 t -161.1 165.44 29.61 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.175 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 80.1 mt -131.77 144.96 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 99.8 p -135.78 163.37 30.36 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.467 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -144.2 160.13 41.48 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.498 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 61.7 p -148.58 162.87 38.81 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.884 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -146.3 143.9 29.46 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.974 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -72.72 -35.09 67.5 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.682 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -126.61 -54.71 1.43 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 122.95 0.5 . . . . 0.0 110.571 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 62.11 24.23 64.88 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.455 ' ND1' ' O ' ' A' ' 36' ' ' HIS . 15.7 p80 -151.95 138.91 19.04 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 28.9 m -131.29 162.27 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 49.3 m -100.87 134.37 43.95 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 20.4 pt -114.34 145.08 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 49.1 t -127.5 133.54 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 170.47 -162.2 35.28 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.5 m -75.32 160.14 30.66 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.6 HE22 ' NZ ' ' A' ' 9' ' ' LYS . 60.7 tp60 -63.97 -40.14 95.72 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.576 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -65.1 -36.58 84.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.829 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.08 -41.64 90.45 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.783 0.325 . . . . 0.0 111.038 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 68.3 mtt -68.81 -35.96 77.64 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.728 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -60.57 -32.96 72.02 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.519 0.2 . . . . 0.0 110.911 -178.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -73.61 -38.28 65.14 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.839 0.352 . . . . 0.0 110.354 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 68.7 mt -86.27 117.37 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -114.89 -16.7 11.68 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 122.919 0.488 . . . . 0.0 110.108 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 73.4 p -171.49 169.12 6.26 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.809 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 87.9 mt -122.67 124.0 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 33.6 m -89.38 132.15 35.1 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 43.1 t -131.19 91.7 34.96 Favored Pre-proline 0 N--CA 1.476 0.844 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -80.77 140.74 13.14 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 121.597 1.531 . . . . 0.0 111.364 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 49.1 t -131.9 130.87 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.918 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -74.83 124.75 27.42 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 37.6 pt -102.01 -11.86 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 122.795 0.438 . . . . 0.0 110.639 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.7 m -60.53 -38.72 85.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.39 -178.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -86.75 -2.74 58.79 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 45.1 t -97.33 120.72 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.2 t -135.87 6.3 3.15 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.293 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -155.3 171.95 19.0 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.422 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.7 p-10 -65.81 126.45 28.52 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.464 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.0 p -145.58 165.78 27.67 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.899 0.38 . . . . 0.0 110.043 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 90.2 p -150.65 129.36 12.34 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.524 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -140.08 145.97 38.34 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.23 0.538 . . . . 0.0 110.888 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 37.8 m -81.68 134.69 35.49 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.596 178.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.0 mt -118.22 126.24 51.77 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.866 0.467 . . . . 0.0 109.87 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -94.16 135.61 35.35 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.9 mt -106.96 134.84 49.5 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.887 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -134.21 143.77 48.04 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -143.59 137.7 28.55 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -85.77 121.23 28.14 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.256 0.551 . . . . 0.0 112.027 -178.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.71 -13.76 38.56 Favored Glycine 0 N--CA 1.48 1.628 0 CA-C-N 114.571 -1.195 . . . . 0.0 112.305 178.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 18.9 m -133.83 161.43 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 46.7 m -110.77 120.55 42.78 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.6 p -109.52 135.46 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -158.82 144.6 12.21 Favored Pre-proline 0 CA--C 1.551 1.005 0 CA-C-O 119.307 -0.378 . . . . 0.0 110.576 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.43 ' C ' ' H ' ' A' ' 82' ' ' THR . 79.9 Cg_endo -70.57 -12.56 13.82 Favored 'Cis proline' 0 N--CA 1.512 2.571 0 CA-C-N 120.247 1.124 . . . . 0.0 110.82 0.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 p 66.99 -3.51 0.94 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.17 177.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.43 ' H ' ' C ' ' A' ' 80' ' ' PRO . 57.4 p -98.71 140.01 33.56 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.2 m -149.5 144.65 17.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -94.59 132.6 39.12 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 47.4 t -126.35 128.56 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -110.31 123.38 49.71 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 58.3 mt -105.63 120.54 41.93 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm -104.09 126.49 51.25 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 42.4 t -103.77 133.81 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.263 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 70.6 p -96.63 124.04 40.5 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 93.9 mm-40 . . . . . 0 N--CA 1.467 0.397 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 -179.04 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.8 mm? . . . . . 0 CA--C 1.518 -0.258 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 91.1 p -160.52 133.77 6.69 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.45 ' CE ' HE22 ' A' ' 43' ' ' GLN . 67.6 mttm -147.83 166.81 26.47 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 41.2 t -120.85 136.78 54.83 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.073 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.1 m -122.57 126.25 26.2 Favored Pre-proline 0 CA--C 1.561 1.369 0 CA-C-O 119.034 -0.508 . . . . 0.0 109.772 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -59.29 146.85 93.42 Favored 'Trans proline' 0 N--CA 1.506 2.212 0 CA-C-N 121.664 1.63 . . . . 0.0 111.816 178.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.1 t -96.31 132.31 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -125.2 127.96 47.59 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.0 mp -96.26 135.52 37.97 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -116.82 107.4 14.58 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 57.2 mt -67.32 124.6 23.6 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 28.8 m -117.07 128.72 55.43 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.68 -164.3 12.09 Favored Glycine 0 N--CA 1.473 1.138 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -119.58 147.83 44.03 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 115.005 -0.598 . . . . 0.0 109.817 178.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -68.69 139.68 55.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.078 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.49 151.56 44.03 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.48 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.1 t -63.18 -22.08 66.63 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.194 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -83.67 -21.78 32.32 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.7 t -105.02 126.64 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 121.071 0.463 . . . . 0.0 109.964 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.9 m -88.12 -32.48 18.66 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.149 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 94.1 p -155.82 159.65 39.57 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.202 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 81.7 mt -127.52 134.49 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.523 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.6 m -126.1 150.45 48.2 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -139.31 152.25 47.08 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.04 0.448 . . . . 0.0 109.936 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 93.1 p -150.5 152.18 33.81 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.69 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -147.41 147.87 30.71 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.061 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -69.55 -36.09 76.02 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.738 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -139.67 129.38 24.56 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -117.44 27.96 7.39 Favored Glycine 0 N--CA 1.474 1.194 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 40.7 p-80 -145.63 139.41 26.6 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 29.4 m -131.2 161.28 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 49.9 m -103.79 134.29 47.36 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 38.1 pt -116.86 146.38 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 123.12 0.568 . . . . 0.0 109.664 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 52.1 t -132.69 134.21 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 165.49 -158.98 32.05 Favored Glycine 0 N--CA 1.466 0.667 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.4 t -67.4 149.23 50.55 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.45 HE22 ' CE ' ' A' ' 9' ' ' LYS . 71.3 tp60 -64.86 -38.35 90.68 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.379 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -62.01 -39.1 91.13 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.807 0.337 . . . . 0.0 110.6 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.36 -39.55 92.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.675 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 68.6 mtt -66.41 -40.56 89.65 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.579 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -64.3 -24.93 67.83 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.595 0.236 . . . . 0.0 110.547 -179.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -76.26 -37.71 57.22 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 69.7 mt -83.11 117.41 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -99.94 -26.51 13.97 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.328 0.585 . . . . 0.0 109.875 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 96.8 p -171.05 164.11 7.44 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.087 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 41.4 mm -106.26 118.84 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.658 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.4 t -87.85 134.18 33.75 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 38.6 t -132.39 89.0 37.88 Favored Pre-proline 0 N--CA 1.473 0.683 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -81.64 146.41 15.06 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 121.485 1.457 . . . . 0.0 111.54 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.6 p -139.69 136.49 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.857 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -76.47 126.21 30.58 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 20.8 pt -109.71 -2.94 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 122.706 0.402 . . . . 0.0 110.39 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 91.3 p -80.66 -15.07 57.5 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.58 -178.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -102.75 -11.35 18.42 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.126 0.571 . . . . 0.0 110.778 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.9 m -101.34 131.2 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 68.7 p -137.19 11.71 3.04 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.635 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -147.6 145.95 29.2 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.764 -178.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -56.82 136.18 55.56 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.519 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.409 ' OG1' ' N ' ' A' ' 66' ' ' SER . 5.1 t -167.31 -177.28 3.58 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.555 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.409 ' N ' ' OG1' ' A' ' 65' ' ' THR . 47.3 t -149.55 145.99 27.11 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.058 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -148.02 143.53 27.3 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.362 0.601 . . . . 0.0 110.967 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 35.0 m -82.03 135.82 35.3 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.818 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 89.3 mt -119.8 129.58 54.51 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.075 0.55 . . . . 0.0 110.25 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -94.68 134.9 36.76 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 47.4 mt -108.24 133.95 51.77 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.034 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -139.14 147.1 41.46 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -147.62 139.91 24.44 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.408 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.3 mp0 -86.72 117.43 25.47 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.454 0.645 . . . . 0.0 112.037 -178.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 116.44 -16.71 14.48 Favored Glycine 0 N--CA 1.48 1.597 0 CA-C-N 114.221 -1.354 . . . . 0.0 111.74 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.1 m -134.73 160.33 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 50.5 m -105.63 112.51 25.62 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.4 t -89.73 132.05 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -156.13 140.43 11.75 Favored Pre-proline 0 CA--C 1.552 1.035 0 CA-C-O 119.07 -0.49 . . . . 0.0 110.882 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -70.16 -10.66 12.4 Favored 'Cis proline' 0 N--CA 1.513 2.671 0 CA-C-N 120.788 1.317 . . . . 0.0 111.042 0.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.0 p 58.22 19.36 6.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.704 -1.135 . . . . 0.0 112.029 177.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.1 p -130.16 140.29 50.78 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.5 m -151.46 154.17 8.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -101.96 132.8 47.57 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.3 p -128.85 132.04 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 121.164 0.506 . . . . 0.0 109.935 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -106.28 125.98 51.67 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.871 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 57.6 mt -109.38 108.99 19.73 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -92.95 128.87 38.97 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 33.7 m -91.49 137.42 21.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.226 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 26.3 m -104.11 109.72 21.63 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 . . . . . 0 N--CA 1.468 0.466 0 N-CA-C 110.559 -0.163 . . . . 0.0 110.559 -178.754 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 50.9 mt . . . . . 0 CA--C 1.518 -0.257 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.3 t -153.46 156.56 38.39 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.932 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.8 tptt -155.5 164.19 39.01 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.746 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 87.8 p -127.9 137.42 52.3 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.186 -0.915 . . . . 0.0 108.668 179.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.1 m -131.19 144.52 53.82 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.595 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -74.39 144.43 32.61 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 121.864 1.709 . . . . 0.0 111.505 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.5 m -96.73 145.72 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -122.15 139.4 53.79 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.6 mp -113.82 135.96 53.39 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -121.88 118.53 29.15 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.74 0.65 . . . . 0.0 109.262 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 51.3 mt -72.56 126.32 29.59 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 79.9 p -119.24 128.59 54.33 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.98 160.31 13.53 Favored Glycine 0 N--CA 1.47 0.929 0 N-CA-C 110.414 -1.075 . . . . 0.0 110.414 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -84.15 145.48 28.37 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 178.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -65.05 137.58 57.79 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.298 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.91 159.57 25.3 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.981 0.419 . . . . 0.0 110.446 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.4 t -71.49 -30.45 65.99 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.559 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -83.62 -11.06 57.77 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 122.156 0.182 . . . . 0.0 111.176 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 64.2 t -108.5 130.06 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 36.1 m -87.19 -41.79 13.47 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.936 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 45.0 t -159.23 160.51 35.41 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.301 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 76.5 mt -132.15 143.57 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.576 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.4 m -130.86 158.1 41.1 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.186 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -142.51 152.47 42.69 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.867 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 45.7 t -151.93 162.82 40.46 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.759 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -143.87 147.38 33.96 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.035 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -72.49 -33.8 67.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.366 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -135.43 -52.38 0.76 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 122.57 0.348 . . . . 0.0 110.251 -179.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.82 28.23 60.19 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 51.5 m-70 -140.96 137.33 32.98 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.6 m -129.66 161.17 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 27.7 m -103.16 138.91 39.35 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 34.3 pt -119.54 147.89 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.484 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 48.6 t -130.4 134.71 61.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.738 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 162.38 -158.47 30.57 Favored Glycine 0 N--CA 1.462 0.413 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 56.4 m -76.11 149.59 37.37 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -62.38 -29.92 70.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.451 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -61.76 -47.96 82.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.47 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.45 -38.45 91.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.631 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 68.1 mtt -65.99 -39.57 90.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.494 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -62.45 -30.74 71.46 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.555 0.216 . . . . 0.0 110.773 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -74.68 -36.98 62.78 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.717 0.294 . . . . 0.0 110.691 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 68.6 mt -89.13 117.5 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -108.24 -21.42 12.78 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.109 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 93.9 p -170.32 159.19 7.04 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.887 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 72.6 mt -109.44 128.04 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.6 m -89.33 131.67 35.3 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.6 t -128.57 90.37 46.69 Favored Pre-proline 0 CA--C 1.542 0.659 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 178.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -81.8 147.84 15.42 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 122.175 1.916 . . . . 0.0 111.297 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.3 p -142.84 136.17 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.077 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -75.62 129.64 37.49 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 35.1 pt -104.69 -11.04 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 O-C-N 123.299 0.374 . . . . 0.0 110.304 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.476 ' HG ' ' N ' ' A' ' 60' ' ' GLN . 80.6 p -61.18 -39.3 89.64 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.143 -178.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.476 ' N ' ' HG ' ' A' ' 59' ' ' SER . 77.7 mt-30 -86.5 -5.01 59.26 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 122.534 0.334 . . . . 0.0 110.402 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 42.6 t -94.65 117.62 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 58.0 p -134.56 2.05 3.17 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.025 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -147.38 156.52 42.97 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.992 0.425 . . . . 0.0 110.253 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -63.73 136.99 57.89 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.006 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.1 t -166.82 177.49 6.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.163 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 44.1 t -144.01 140.37 29.54 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.408 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -139.28 143.3 37.86 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.108 0.48 . . . . 0.0 110.518 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 28.1 m -83.74 132.52 34.84 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.8 mt -119.69 129.85 54.74 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -97.81 137.19 37.05 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 43.3 mt -113.49 136.69 52.52 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -132.82 140.96 48.22 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -135.55 143.48 45.72 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -85.99 135.62 33.58 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.819 0.818 . . . . 0.0 111.907 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.82 -28.25 8.01 Favored Glycine 0 N--CA 1.476 1.345 0 CA-C-N 114.303 -1.317 . . . . 0.0 112.732 178.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.5 m -118.9 163.45 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 34.0 m -109.48 116.22 31.39 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.0 t -93.81 131.66 40.13 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -157.69 141.39 11.33 Favored Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.703 178.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.54 -12.3 11.72 Favored 'Cis proline' 0 N--CA 1.506 2.239 0 CA-C-N 119.814 0.969 . . . . 0.0 110.051 -0.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.2 p 61.99 23.43 13.8 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.637 177.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 39.3 p -131.01 138.72 49.78 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 24.0 m -151.11 149.76 13.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -95.92 133.51 40.02 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.6 p -128.12 133.09 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -107.52 127.37 53.56 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 39.5 mt -111.06 106.51 15.6 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -89.35 129.63 35.85 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 18.6 t -106.55 132.88 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 31.5 m -100.33 121.03 40.84 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 . . . . . 0 N--CA 1.465 0.307 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -179.387 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 57.2 mt . . . . . 0 N--CA 1.469 0.516 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 95.3 p -147.92 151.07 35.22 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.721 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -146.67 165.09 30.61 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.671 0.748 . . . . 0.0 109.6 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 92.6 p -112.04 136.22 51.68 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 114.004 -1.453 . . . . 0.0 109.918 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.4 m -134.33 99.38 13.31 Favored Pre-proline 0 CA--C 1.544 0.749 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -179.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -57.56 148.23 74.31 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 CA-C-N 120.191 1.104 . . . . 0.0 111.591 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 15.9 t -86.14 132.83 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -113.26 123.34 49.94 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.2 mp -96.27 131.71 42.49 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -120.07 107.73 13.41 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 178.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.9 pp -68.46 129.36 39.7 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.27 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.4 p -130.86 141.7 50.33 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 122.984 0.514 . . . . 0.0 109.645 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.85 168.24 16.49 Favored Glycine 0 N--CA 1.474 1.178 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -86.29 134.76 33.73 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -65.4 137.44 57.49 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.91 173.36 1.08 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.501 0.667 . . . . 0.0 111.32 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 35.2 t -84.71 -23.28 29.4 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.116 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -88.46 -13.65 39.84 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.1 p -102.28 126.02 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-O 121.169 0.509 . . . . 0.0 112.039 -177.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 38.3 t -91.01 -31.01 16.48 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.35 179.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.7 t -159.75 158.13 30.68 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.47 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 85.9 mt -127.88 136.38 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.586 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.9 t -130.54 153.22 49.08 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -147.22 155.62 42.24 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.115 0.483 . . . . 0.0 110.562 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 50.4 m -146.6 160.09 42.61 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.879 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -140.81 143.1 34.63 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.812 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -71.87 -34.02 68.85 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.757 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.401 ' O ' ' ND1' ' A' ' 36' ' ' HIS . 99.6 mtt180 -128.13 -55.95 1.26 Allowed 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 121.194 0.521 . . . . 0.0 110.132 -179.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.23 22.64 58.69 Favored Glycine 0 CA--C 1.523 0.555 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.536 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.401 ' ND1' ' O ' ' A' ' 34' ' ' ARG . 12.8 p-80 -149.93 138.73 20.91 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.42 ' CG2' ' N ' ' A' ' 38' ' ' THR . 3.3 p -127.89 163.32 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.42 ' N ' ' CG2' ' A' ' 37' ' ' VAL . 52.0 m -100.22 132.6 45.49 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.905 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.5 pt -114.84 134.4 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 123.363 0.665 . . . . 0.0 109.304 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.6 t -124.47 133.5 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 163.9 -154.47 25.37 Favored Glycine 0 N--CA 1.468 0.826 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.4 m -69.66 145.41 52.42 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 70.6 tp60 -62.96 -34.49 77.61 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.615 0.245 . . . . 0.0 110.367 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -61.55 -41.44 97.37 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.638 0.256 . . . . 0.0 110.791 -179.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.91 -37.9 89.11 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.777 0.322 . . . . 0.0 110.717 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 66.7 mtt -64.77 -39.78 94.17 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.447 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -63.79 -30.78 71.84 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.539 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -73.92 -40.73 62.91 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.776 0.322 . . . . 0.0 110.66 179.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 58.7 mt -84.8 117.63 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -178.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -114.21 -17.67 11.81 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.04 0.536 . . . . 0.0 110.826 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 73.4 p -174.13 132.74 0.41 Allowed 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.941 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 42.4 mm -83.04 124.08 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 32.5 m -91.55 126.26 36.58 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.4 t -133.46 91.35 26.85 Favored Pre-proline 0 N--CA 1.474 0.774 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -82.01 145.13 13.84 Favored 'Trans proline' 0 N--CA 1.5 1.881 0 C-N-CA 121.672 1.581 . . . . 0.0 111.617 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 60.8 t -129.71 129.13 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.021 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -68.58 125.04 25.25 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.7 pt -99.93 -12.83 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-O 120.847 0.356 . . . . 0.0 110.526 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.5 m -60.17 -38.72 84.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.554 -178.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -86.2 -4.1 59.1 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 122.557 0.343 . . . . 0.0 110.335 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 46.9 t -94.22 111.79 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 60.3 p -128.57 2.87 5.55 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.617 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -152.45 163.03 40.34 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.575 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -64.39 136.64 57.31 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.204 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.7 t -166.36 177.95 6.47 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.585 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 99.1 p -149.71 144.25 25.97 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.818 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -143.51 143.36 31.52 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-O 121.228 0.537 . . . . 0.0 110.476 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 51.4 m -81.75 131.85 35.27 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 64.8 mt -117.39 120.42 38.1 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.823 0.449 . . . . 0.0 109.857 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -84.24 133.64 34.57 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 50.8 mt -102.75 133.79 47.21 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 122.598 0.359 . . . . 0.0 110.047 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -136.17 141.06 44.03 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 122.957 0.503 . . . . 0.0 110.215 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -150.98 130.21 12.74 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -86.21 114.32 22.94 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.293 0.568 . . . . 0.0 111.282 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 128.64 -22.05 5.27 Favored Glycine 0 N--CA 1.48 1.589 0 CA-C-N 114.529 -1.214 . . . . 0.0 111.519 178.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.5 m -134.87 160.41 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-O 120.897 0.38 . . . . 0.0 110.271 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 46.4 m -100.82 117.41 34.83 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -95.99 131.92 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -155.29 135.45 8.39 Favored Pre-proline 0 CA--C 1.553 1.07 0 CA-C-O 119.071 -0.49 . . . . 0.0 110.537 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -71.25 -7.53 12.81 Favored 'Cis proline' 0 N--CA 1.52 3.032 0 CA-C-N 121.325 1.509 . . . . 0.0 111.091 0.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.3 p 59.94 17.85 6.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.661 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.4 p -132.92 140.69 47.98 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.6 m -147.73 154.82 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -101.05 134.38 44.14 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.9 p -131.6 138.18 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 121.178 0.514 . . . . 0.0 110.29 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -114.89 126.88 55.31 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.999 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 56.1 mt -109.16 109.15 20.04 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -92.98 127.68 38.58 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.9 t -100.94 132.35 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 46.0 m -100.16 122.09 42.45 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-O 120.689 0.28 . . . . 0.0 110.709 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 . . . . . 0 N--CA 1.47 0.527 0 C-N-CA 123.065 0.546 . . . . 0.0 109.914 179.73 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 71.3 mt . . . . . 0 N--CA 1.466 0.366 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.504 ' HG ' ' N ' ' A' ' 9' ' ' LYS . 42.8 t -159.89 153.41 22.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.515 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.504 ' N ' ' HG ' ' A' ' 8' ' ' SER . 44.0 mmtm -144.89 166.29 25.69 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.561 0.696 . . . . 0.0 109.699 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 95.2 p -114.19 134.87 54.61 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 114.216 -1.356 . . . . 0.0 109.692 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.5 m -129.25 94.99 31.85 Favored Pre-proline 0 CA--C 1.547 0.861 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -57.71 146.02 87.21 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 CA-C-N 119.992 1.033 . . . . 0.0 111.567 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.0 t -93.98 133.94 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.325 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -114.02 130.15 56.57 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.3 tp -96.39 130.61 43.48 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -122.45 108.54 13.3 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 120.976 0.417 . . . . 0.0 109.879 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.0 pp -65.25 130.16 42.33 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.741 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.7 m -127.57 135.38 50.23 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.81 165.19 15.66 Favored Glycine 0 N--CA 1.475 1.273 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -85.72 134.18 33.97 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.7 ptmm? -63.29 136.95 58.01 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.617 0.246 . . . . 0.0 110.459 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.0 170.43 4.38 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.348 0.594 . . . . 0.0 111.133 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 34.6 t -81.0 -23.16 38.87 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.292 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -87.35 -11.34 49.67 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.8 p -110.1 129.28 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-O 120.84 0.352 . . . . 0.0 110.821 -178.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 36.2 t -86.47 -37.6 18.13 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.982 0.42 . . . . 0.0 109.986 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 98.7 p -160.78 160.07 30.79 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.397 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 92.8 mt -131.31 139.73 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 60.2 m -125.75 154.61 42.25 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -141.37 152.84 44.7 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.017 0.437 . . . . 0.0 110.302 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 96.6 p -151.52 162.05 41.62 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.204 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.469 ' CD1' ' N ' ' A' ' 35' ' ' GLY . 25.0 p90 -146.39 147.35 31.2 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.181 -179.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -69.99 -35.11 74.15 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.612 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -158.98 89.07 0.92 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.409 0.623 . . . . 0.0 109.97 -179.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.469 ' N ' ' CD1' ' A' ' 32' ' ' PHE . . . -76.78 38.17 1.48 Allowed Glycine 0 N--CA 1.462 0.429 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.755 -178.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 27.5 p80 -144.85 137.97 26.69 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 117.659 0.73 . . . . 0.0 109.432 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.6 m -129.16 162.45 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 26.4 m -102.61 133.22 47.96 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 37.9 pt -119.31 146.19 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 122.972 0.509 . . . . 0.0 110.325 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 50.0 t -129.37 134.85 62.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.949 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 162.66 -156.96 28.84 Favored Glycine 0 N--CA 1.467 0.753 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 50.9 m -74.85 147.94 40.66 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 110.321 -0.251 . . . . 0.0 110.321 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -63.92 -30.61 71.67 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.371 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -60.47 -45.16 94.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.721 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.42 -39.61 85.48 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.664 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 67.9 mtt -65.54 -40.87 93.37 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.287 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -64.14 -31.71 73.0 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.045 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.1 tppt? -71.94 -38.57 69.81 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.16 0.505 . . . . 0.0 110.551 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 72.4 mt -88.21 117.52 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.604 -178.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -99.92 -24.93 14.5 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.36 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.9 m -169.99 -178.82 3.0 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.616 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 85.8 mt -124.34 123.48 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 42.4 m -96.07 128.38 42.92 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.5 t -128.53 90.6 46.07 Favored Pre-proline 0 N--CA 1.473 0.718 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -83.47 144.08 11.28 Favored 'Trans proline' 0 N--CA 1.5 1.896 0 C-N-CA 121.829 1.686 . . . . 0.0 111.571 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.6 p -137.44 135.35 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 CA-C-O 121.067 0.461 . . . . 0.0 110.935 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -67.07 128.87 38.0 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 36.1 pt -101.67 -11.23 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-O 120.985 0.422 . . . . 0.0 110.547 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.8 t -62.22 -40.6 96.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.57 -178.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -83.26 -6.88 59.62 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.757 0.423 . . . . 0.0 110.218 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 43.4 t -92.56 109.77 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 70.6 p -132.08 1.91 3.92 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.755 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -142.39 151.97 42.37 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -64.28 134.23 54.3 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.249 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.402 ' OG1' ' N ' ' A' ' 66' ' ' SER . 5.5 t -167.13 -178.38 4.12 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.013 0.435 . . . . 0.0 110.907 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.402 ' N ' ' OG1' ' A' ' 65' ' ' THR . 99.2 p -138.62 147.44 42.93 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.196 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -136.03 141.56 44.34 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.268 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 63.8 m -97.36 125.54 42.03 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 177.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 66.1 mt -120.72 135.93 55.0 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.802 0.441 . . . . 0.0 110.09 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.9 mp0 -98.86 138.3 36.19 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 24.7 mt -106.12 132.28 52.39 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 116.296 -0.411 . . . . 0.0 109.995 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -129.98 140.86 50.83 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -146.82 130.9 17.3 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -85.11 115.38 22.88 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.32 0.581 . . . . 0.0 111.203 -178.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 125.78 -21.13 6.32 Favored Glycine 0 N--CA 1.48 1.575 0 CA-C-N 114.577 -1.192 . . . . 0.0 111.761 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.3 m -132.49 159.09 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 80.7 m -102.94 110.64 22.64 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.4 t -91.58 128.93 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -155.69 138.77 10.75 Favored Pre-proline 0 CA--C 1.554 1.115 0 CA-C-O 118.893 -0.575 . . . . 0.0 110.363 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -70.4 -11.21 13.1 Favored 'Cis proline' 0 N--CA 1.517 2.909 0 CA-C-N 121.291 1.497 . . . . 0.0 110.781 0.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 60.1 22.54 11.77 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.744 -1.117 . . . . 0.0 112.343 177.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 37.7 p -127.07 140.57 52.19 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.7 m -147.53 142.83 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -93.86 131.26 39.44 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 43.4 t -123.3 121.5 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -99.83 123.62 44.28 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 65.4 mt -108.45 105.92 15.8 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -87.91 130.46 34.91 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 26.6 t -104.16 131.39 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 49.5 m -100.05 120.07 39.27 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 . . . . . 0 N--CA 1.467 0.381 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -179.375 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 56.9 mt . . . . . 0 CA--C 1.52 -0.197 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.6 t -161.3 141.08 10.55 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -149.85 167.12 27.5 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -178.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 39.8 t -124.11 137.99 54.49 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 114.867 -1.061 . . . . 0.0 109.136 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.3 m -122.76 144.57 43.04 Favored Pre-proline 0 N--CA 1.482 1.139 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -73.05 143.18 35.71 Favored 'Trans proline' 0 N--CA 1.5 1.872 0 C-N-CA 121.345 1.363 . . . . 0.0 111.586 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 43.8 t -103.69 134.0 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -125.91 146.86 49.66 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.2 mt -112.2 132.59 54.82 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -114.22 113.97 25.36 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.317 -0.624 . . . . 0.0 109.317 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 49.5 mt -70.33 124.1 23.33 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 76.4 p -119.76 135.31 54.9 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 115.55 163.14 13.72 Favored Glycine 0 N--CA 1.471 1.024 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.4 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 1.0 OUTLIER -85.13 138.91 32.1 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 179.131 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -65.9 132.09 47.81 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.18 177.02 2.42 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.468 0.651 . . . . 0.0 110.786 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 89.9 p -85.23 -19.16 32.09 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.929 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -88.13 -21.53 24.6 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 122.134 0.174 . . . . 0.0 110.737 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.3 p -97.37 126.33 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-O 120.859 0.361 . . . . 0.0 111.008 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.5 t -92.6 -35.92 13.29 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.7 t -161.21 158.03 26.69 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.095 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 82.3 mt -128.73 136.62 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 60.5 m -128.97 153.49 47.5 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -144.62 155.58 43.69 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.188 0.518 . . . . 0.0 110.346 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 87.8 p -150.95 163.5 38.55 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.16 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -146.4 147.59 31.43 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.017 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -71.59 -34.03 69.56 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.533 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -134.13 -52.09 0.83 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 122.892 0.477 . . . . 0.0 110.167 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.31 23.41 62.22 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.44 ' ND1' ' O ' ' A' ' 36' ' ' HIS . 18.0 p80 -147.6 140.11 24.61 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 28.4 m -133.11 165.97 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 46.1 m -99.8 137.92 37.6 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 38.7 pt -119.63 148.46 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.4 t -130.68 134.13 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-O 120.915 0.388 . . . . 0.0 109.97 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 167.2 -163.09 36.86 Favored Glycine 0 N--CA 1.464 0.536 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.2 t -73.41 155.03 39.74 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 110.375 -0.232 . . . . 0.0 110.375 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 70.4 tp60 -63.36 -37.57 87.8 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.549 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -64.04 -39.01 93.15 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 110.435 -0.209 . . . . 0.0 110.435 -179.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.33 -44.4 83.44 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.868 0.365 . . . . 0.0 111.097 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 77.8 mtm -68.23 -39.27 82.36 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.825 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -60.36 -32.76 71.59 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.578 0.228 . . . . 0.0 110.895 -179.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.5 ttpp -70.69 -33.63 71.11 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.729 0.3 . . . . 0.0 110.49 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 71.1 mt -86.44 119.17 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -107.56 -22.11 12.65 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-O 121.228 0.537 . . . . 0.0 110.194 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 95.2 p -171.96 162.33 5.94 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.877 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 36.5 mm -107.07 119.28 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 38.2 m -96.69 127.77 42.99 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 26.0 t -133.5 93.0 22.47 Favored Pre-proline 0 N--CA 1.474 0.775 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -77.29 145.19 23.88 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 121.032 1.155 . . . . 0.0 111.422 -178.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.9 t -132.48 129.56 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.904 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -71.38 127.06 31.31 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.609 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 36.5 pt -99.09 -12.73 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 122.597 0.359 . . . . 0.0 110.92 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 80.6 p -59.04 -38.57 79.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.568 -178.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -86.79 -4.78 59.22 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 122.565 0.346 . . . . 0.0 110.505 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.1 t -93.72 110.85 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 67.8 p -131.5 4.46 4.29 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.414 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.3 tp10 -152.33 158.13 42.3 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.851 0.358 . . . . 0.0 110.105 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -59.79 137.41 58.06 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.329 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.2 t -165.01 166.99 18.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.13 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 42.5 t -141.79 140.84 33.13 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.655 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -148.81 147.38 28.7 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.892 0.853 . . . . 0.0 111.11 -179.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 39.6 m -81.67 136.08 35.51 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 114.278 -1.328 . . . . 0.0 109.328 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.5 mt -110.9 113.06 25.35 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.061 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 50.2 tp10 -75.73 126.29 30.71 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 44.9 mt -104.63 128.07 52.55 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -133.2 141.56 48.14 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -142.31 141.73 32.43 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -85.06 134.84 34.19 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 122.027 0.918 . . . . 0.0 113.137 -177.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.8 -9.5 76.12 Favored Glycine 0 N--CA 1.474 1.185 0 CA-C-N 114.152 -1.385 . . . . 0.0 112.073 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.0 m -133.89 161.74 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 60.6 m -110.41 113.68 26.52 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.6 t -90.3 132.61 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -156.51 139.73 11.0 Favored Pre-proline 0 CA--C 1.554 1.118 0 CA-C-O 119.013 -0.518 . . . . 0.0 110.867 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.5 -12.94 11.83 Favored 'Cis proline' 0 N--CA 1.515 2.738 0 CA-C-N 120.838 1.335 . . . . 0.0 110.887 0.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.7 p 61.55 22.52 12.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.66 177.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.2 p -131.93 139.97 48.87 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.2 m -151.34 154.27 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -98.44 132.8 43.6 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.3 t -127.64 130.32 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -107.47 124.94 50.62 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 55.0 mt -109.34 109.57 20.5 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -179.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -91.02 128.3 36.79 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 23.9 t -102.78 131.8 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 52.1 m -99.13 118.19 35.3 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 96.0 mm-40 . . . . . 0 N--CA 1.464 0.266 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 -179.542 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt . . . . . 0 N--CA 1.493 1.696 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.9 mm 55.76 95.67 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.781 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 39.6 t -61.16 -41.41 96.71 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.228 0.537 . . . . 0.0 110.768 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.8 mp -66.16 147.62 53.06 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.514 -0.767 . . . . 0.0 109.426 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -128.8 36.84 4.17 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.443 -177.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -134.09 132.22 39.68 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.4 tp -163.63 152.7 14.24 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 90.3 p -145.06 148.26 33.5 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.476 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -144.52 166.34 25.42 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.466 0.651 . . . . 0.0 109.563 -178.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.4 t -113.45 135.99 53.28 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.572 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.5 m -128.86 100.37 21.29 Favored Pre-proline 0 CA--C 1.549 0.904 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -57.01 144.62 89.09 Favored 'Trans proline' 0 N--CA 1.499 1.842 0 C-N-CA 121.095 1.196 . . . . 0.0 111.704 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 23.0 m -88.86 139.56 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.681 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -119.17 116.41 26.25 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.8 mp -89.98 135.13 33.83 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -122.49 116.66 24.32 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 58.2 mt -66.61 126.06 27.73 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.3 m -127.4 133.96 49.95 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.65 165.06 15.75 Favored Glycine 0 N--CA 1.472 1.043 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -81.32 138.19 35.7 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -68.22 139.49 56.04 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.03 144.09 57.36 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 83.2 p -68.89 -24.08 64.28 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.185 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -91.5 2.89 56.11 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 122.218 0.207 . . . . 0.0 110.99 -179.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 52.8 t -118.91 126.16 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 36.4 t -75.05 -43.32 54.14 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.339 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 37.5 t -163.94 162.11 23.22 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.723 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 80.4 mt -130.4 146.1 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.337 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 40.2 t -132.58 161.83 32.84 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.497 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -146.21 154.67 42.01 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.069 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 50.8 m -144.69 170.89 15.22 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.802 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -146.74 147.69 31.21 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.808 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -74.57 -33.36 62.67 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.067 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.431 ' O ' ' ND1' ' A' ' 36' ' ' HIS . 86.7 mtm180 -133.6 -49.77 0.84 Allowed 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.729 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.38 19.27 57.38 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.431 ' ND1' ' O ' ' A' ' 34' ' ' ARG . 47.9 m80 -142.25 137.5 30.74 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.1 p -133.4 161.88 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 34.1 m -101.53 135.0 43.78 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.335 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 40.5 pt -120.04 149.66 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.8 t -132.79 134.97 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 166.57 -160.3 33.86 Favored Glycine 0 N--CA 1.464 0.531 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.8 m -73.01 151.74 41.63 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 62.1 tp60 -64.96 -34.49 78.54 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.313 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -60.61 -43.81 97.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.736 0.303 . . . . 0.0 110.622 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.72 -40.09 94.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.623 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 67.7 mtt -65.01 -40.67 95.23 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.597 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -65.55 -23.71 66.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.64 0.257 . . . . 0.0 110.53 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -80.61 -34.96 34.68 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.377 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 67.1 mt -91.61 116.35 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -99.1 -24.58 14.84 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.064 0.459 . . . . 0.0 110.221 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 92.9 p -172.36 162.8 5.52 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.044 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 36.7 mm -107.32 120.48 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 33.5 m -85.01 129.93 34.71 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 38.3 t -123.84 90.75 50.37 Favored Pre-proline 0 N--CA 1.471 0.619 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -79.26 146.2 19.62 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 121.485 1.456 . . . . 0.0 111.371 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.7 p -139.57 137.43 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.883 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -79.16 125.29 29.25 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 36.4 pt -103.08 -9.87 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 120.857 0.36 . . . . 0.0 110.294 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 40.3 m -61.81 -39.82 93.09 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.436 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -86.69 -5.0 59.25 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 122.928 0.491 . . . . 0.0 110.679 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 45.4 t -92.43 114.14 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 70.2 p -132.54 -0.13 3.59 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.172 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -144.62 155.7 43.75 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 121.007 0.432 . . . . 0.0 110.435 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -63.9 132.81 51.89 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.04 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.8 t -167.61 -174.9 2.63 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.342 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 96.8 p -151.26 147.25 26.75 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.611 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -140.16 143.93 36.4 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.109 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.8 m -83.13 132.03 35.11 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.168 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 74.8 mt -120.89 129.66 53.58 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 122.907 0.483 . . . . 0.0 109.839 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -96.6 137.68 35.32 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 52.2 mt -110.64 136.93 48.98 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -141.59 147.24 37.34 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -149.89 137.21 19.78 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -86.29 114.6 23.23 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.004 0.431 . . . . 0.0 110.941 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 125.12 -20.56 6.65 Favored Glycine 0 N--CA 1.485 1.937 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.625 178.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 32.8 m -134.13 159.87 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 31.7 m -102.73 111.14 23.32 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.1 t -92.04 129.14 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -156.75 142.0 12.45 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.494 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.92 -10.28 11.73 Favored 'Cis proline' 0 N--CA 1.508 2.33 0 CA-C-N 120.539 1.228 . . . . 0.0 110.58 -0.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.8 p 60.3 23.15 12.6 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.165 177.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 39.7 p -131.93 139.63 48.77 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.5 m -152.36 151.92 11.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -96.19 134.01 39.8 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 44.7 t -126.1 127.08 70.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -104.95 124.38 49.41 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 58.7 mt -108.01 108.68 19.9 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -90.16 129.63 36.41 Favored 'General case' 0 C--O 1.231 0.105 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 38.6 t -104.14 131.36 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 39.9 m -101.18 120.42 40.21 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 91.3 mm-40 -79.85 132.34 36.09 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -70.4 137.14 50.21 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.7 tp -152.05 127.88 10.25 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -67.59 159.79 29.12 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -161.3 -170.91 2.81 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.917 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -64.78 134.66 54.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.03 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -67.98 144.32 55.22 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 66.5 m80 -65.23 125.08 23.9 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -65.0 -42.24 94.68 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.799 0.333 . . . . 0.0 110.119 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 118.115 -0.945 . . . . 0.0 110.732 -179.885 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 22.1 pttp . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 71.9 mt -64.61 143.47 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.637 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.3 t 55.05 89.95 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.163 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.406 ' O ' ' N ' ' A' ' 6' ' ' LYS . 61.3 mt 56.48 103.64 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.409 0.623 . . . . 0.0 110.709 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -65.11 74.54 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.048 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.406 ' N ' ' O ' ' A' ' 4' ' ' LEU . 46.7 mtpt -98.41 137.71 36.71 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 53.4 mt -93.95 -178.93 4.81 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 95.8 p -160.58 150.31 17.59 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.8 mtpt -151.11 164.98 35.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.619 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 35.0 m -114.18 137.1 52.2 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.634 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.3 m -126.68 101.67 26.67 Favored Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 123.588 0.755 . . . . 0.0 109.051 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -57.02 144.53 89.42 Favored 'Trans proline' 0 N--CA 1.499 1.803 0 CA-C-N 120.342 1.158 . . . . 0.0 111.939 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 23.3 t -89.41 130.93 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.1 ttmm -117.33 126.95 53.55 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.6 mt -101.82 127.95 48.4 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -115.23 109.95 18.73 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.9 pp -64.19 129.23 39.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.154 -0.476 . . . . 0.0 109.736 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 31.6 m -126.07 135.66 52.0 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 115.23 162.66 13.68 Favored Glycine 0 N--CA 1.476 1.367 0 N-CA-C 110.581 -1.007 . . . . 0.0 110.581 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.0 p-10 -82.64 142.18 31.92 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -66.7 134.34 52.03 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.68 176.63 0.64 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.23 0.538 . . . . 0.0 111.143 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.8 t -85.75 -23.98 27.08 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.099 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -91.32 -13.14 33.12 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -178.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.5 p -98.56 128.25 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 CA-C-O 120.79 0.328 . . . . 0.0 110.875 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 46.7 t -92.09 -37.31 12.85 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.839 0.352 . . . . 0.0 110.122 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 98.3 p -161.21 159.16 28.46 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.151 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 73.9 mt -133.78 142.53 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 65.0 p -135.01 159.12 42.52 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.288 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -145.7 155.85 43.25 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.083 0.468 . . . . 0.0 110.182 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 47.7 t -147.4 163.46 36.41 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.254 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -146.46 143.76 29.2 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.288 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -69.27 -34.36 74.63 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.984 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -135.91 -51.27 0.72 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.014 0.526 . . . . 0.0 109.96 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.84 24.03 61.99 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.439 ' ND1' ' O ' ' A' ' 36' ' ' HIS . 17.8 p80 -148.69 139.68 23.04 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 28.4 m -131.6 164.51 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 61.4 m -99.71 133.55 43.89 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 37.9 pt -118.82 147.5 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 122.854 0.462 . . . . 0.0 110.25 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.2 t -132.13 135.6 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.399 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 170.97 -163.08 36.09 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 30.8 t -72.33 147.4 46.35 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 70.8 tp60 -58.8 -38.19 78.05 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.603 0.24 . . . . 0.0 111.117 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 23.6 mp0 -59.84 -48.02 83.37 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.878 0.37 . . . . 0.0 110.793 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.99 -37.9 86.57 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.738 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 21.2 mmt -65.79 -39.54 91.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.006 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -61.1 -31.98 71.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.609 0.242 . . . . 0.0 110.818 -178.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -71.55 -39.08 70.9 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.776 0.322 . . . . 0.0 110.316 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 57.5 mt -85.54 117.53 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -113.46 -19.52 11.65 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.184 0.593 . . . . 0.0 110.578 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 66.5 p -174.1 161.56 3.63 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.694 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 38.1 mm -111.4 117.85 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 48.2 m -105.51 124.44 49.55 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 36.1 t -127.17 113.44 21.62 Favored Pre-proline 0 N--CA 1.482 1.169 0 CA-C-O 118.446 -0.788 . . . . 0.0 109.792 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -76.81 143.62 23.73 Favored 'Trans proline' 0 N--CA 1.497 1.678 0 CA-C-N 121.254 1.484 . . . . 0.0 110.755 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.8 t -129.31 126.79 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -73.67 126.47 30.4 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.69 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 39.1 pt -102.69 -15.74 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 122.82 0.448 . . . . 0.0 110.912 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.8 t -61.39 -40.32 93.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.594 -178.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -83.3 -5.78 59.25 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 122.374 0.27 . . . . 0.0 110.616 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 47.4 t -91.2 108.45 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 70.6 p -129.88 1.51 4.84 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.636 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -141.95 146.79 36.05 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 21.2 p-10 -63.88 137.12 57.89 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.103 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.431 ' OG1' ' N ' ' A' ' 66' ' ' SER . 5.6 t -168.14 -173.43 2.03 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.265 0.555 . . . . 0.0 110.709 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.431 ' N ' ' OG1' ' A' ' 65' ' ' THR . 90.2 p -147.25 143.35 28.07 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.45 179.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -138.45 142.38 39.47 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.0 0.429 . . . . 0.0 110.238 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 44.6 m -82.1 131.89 35.24 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.5 mt -111.75 111.71 22.88 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 122.659 0.384 . . . . 0.0 110.29 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -83.77 126.37 32.85 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 31.8 mt -103.74 134.74 46.55 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 120.792 0.329 . . . . 0.0 110.597 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -134.94 142.06 46.42 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.084 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -145.41 135.27 23.59 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -85.5 117.73 24.58 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.328 0.585 . . . . 0.0 111.848 -178.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.61 -16.02 16.86 Favored Glycine 0 N--CA 1.482 1.704 0 CA-C-N 114.574 -1.194 . . . . 0.0 112.208 178.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 23.3 m -133.04 159.22 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 56.9 m -107.95 117.73 34.9 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.1 p -105.85 133.52 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 122.938 0.495 . . . . 0.0 109.741 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -158.81 143.67 11.69 Favored Pre-proline 0 CA--C 1.552 1.046 0 CA-C-O 119.078 -0.487 . . . . 0.0 110.654 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.424 ' C ' ' H ' ' A' ' 82' ' ' THR . 87.8 Cg_endo -70.2 -12.13 12.96 Favored 'Cis proline' 0 N--CA 1.516 2.815 0 CA-C-N 120.646 1.266 . . . . 0.0 110.998 0.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 67.6 -6.87 0.62 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.839 177.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.424 ' H ' ' C ' ' A' ' 80' ' ' PRO . 59.0 p -100.31 139.51 35.88 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.8 m -147.92 146.14 18.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -95.23 130.89 41.8 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 44.0 t -126.6 126.04 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -100.09 124.64 45.72 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 59.8 mt -110.41 104.16 12.89 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -92.81 128.88 38.83 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.4 p -107.83 137.08 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.627 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 69.9 m -100.24 121.5 41.56 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 95.4 mm-40 -80.18 133.8 36.07 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.439 ' C ' ' H ' ' A' ' 94' ' ' GLU . 60.1 tttm -61.73 139.41 58.32 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 9.6 mp -72.91 7.47 2.0 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.877 0.37 . . . . 0.0 110.047 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.439 ' H ' ' C ' ' A' ' 92' ' ' LYS . 93.2 mt-10 50.67 -166.36 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.392 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 72.1 m80 51.84 -87.55 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.599 0.237 . . . . 0.0 111.45 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.432 ' N ' ' O ' ' A' ' 94' ' ' GLU . 71.6 m80 -65.04 120.38 12.53 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.472 ' CD2' ' H ' ' A' ' 99' ' ' HIS . 79.3 t60 -69.5 167.22 17.17 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.446 ' N ' ' CG ' ' A' ' 97' ' ' HIS . 85.8 t60 -60.76 -41.83 96.24 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.291 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.472 ' H ' ' CD2' ' A' ' 97' ' ' HIS . 59.4 t-80 53.85 92.14 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.852 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.771 -179.96 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 68.3 mttm . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 40.6 pt -134.33 163.02 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 122.952 0.501 . . . . 0.0 110.571 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.1 m -162.72 -28.71 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.623 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.43 ' O ' ' N ' ' A' ' 6' ' ' LYS . 4.2 tp -67.06 142.29 57.2 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.025 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 53.46 -87.11 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.731 0.301 . . . . 0.0 110.699 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.43 ' N ' ' O ' ' A' ' 4' ' ' LEU . 67.9 mttm -63.63 133.56 53.9 Favored 'General case' 0 C--O 1.231 0.109 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 58.6 mt -110.59 152.76 26.06 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.0 t -151.67 145.68 25.24 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.567 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -149.64 167.51 26.19 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.565 -178.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 30.5 m -109.48 139.06 44.92 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.059 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.5 m -131.84 95.03 23.48 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 123.625 0.77 . . . . 0.0 109.313 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -58.39 146.19 90.95 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 C-N-CA 121.207 1.272 . . . . 0.0 112.144 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.4 p -98.25 142.1 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.242 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -121.27 133.87 55.15 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 78.3 mt -100.06 128.54 46.13 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -113.47 111.89 22.7 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 56.5 mt -70.28 126.13 28.77 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.1 p -129.31 145.38 51.38 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.956 -0.386 . . . . 0.0 109.956 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.02 168.33 16.39 Favored Glycine 0 N--CA 1.474 1.199 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.6 p-10 -84.75 132.58 34.42 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -64.49 135.93 56.55 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.54 176.06 3.12 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.577 0.703 . . . . 0.0 110.991 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 74.6 m -84.31 -20.75 31.57 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.299 -178.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -90.27 -19.83 23.65 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 122.461 0.304 . . . . 0.0 111.037 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.6 p -97.18 128.31 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-O 120.576 0.227 . . . . 0.0 110.469 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.5 t -103.39 -26.99 12.7 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 120.823 0.345 . . . . 0.0 110.188 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 48.1 t -160.81 154.21 21.9 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.907 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 86.0 mt -129.92 135.79 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.9 p -133.59 154.79 50.6 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -148.42 159.16 44.31 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.409 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.539 ' HG ' ' N ' ' A' ' 32' ' ' PHE . 44.1 t -146.35 168.37 21.29 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.008 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.539 ' N ' ' HG ' ' A' ' 31' ' ' SER . 16.6 p90 -146.41 149.61 34.06 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.952 -179.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -68.12 -33.54 74.69 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.56 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -150.27 -38.96 0.14 Allowed 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.172 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.422 ' O ' ' ND1' ' A' ' 36' ' ' HIS . . . 55.95 25.86 46.69 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 178.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.422 ' ND1' ' O ' ' A' ' 35' ' ' GLY . 15.3 m-70 -138.0 137.32 37.78 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 31.4 m -129.88 160.93 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 35.5 m -102.88 133.78 47.4 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 38.1 pt -117.8 146.44 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 122.758 0.423 . . . . 0.0 110.326 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.7 t -132.86 134.51 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.786 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 168.5 -159.44 32.6 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 95.0 p -72.63 151.62 42.2 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.647 0.26 . . . . 0.0 110.301 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.8 tm0? -63.35 -36.9 85.22 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.763 0.316 . . . . 0.0 110.237 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.44 ' CD ' ' H ' ' A' ' 44' ' ' GLU . 24.9 mp0 -60.55 -53.71 54.24 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.137 -178.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.51 -40.21 96.01 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.909 0.385 . . . . 0.0 110.88 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 88.3 mtp -66.85 -39.61 87.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.702 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -61.79 -34.31 75.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.478 0.18 . . . . 0.0 111.395 -178.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -68.95 -35.26 76.56 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.749 0.309 . . . . 0.0 110.383 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 63.6 mt -85.67 120.1 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -119.42 -16.67 8.92 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 122.968 0.507 . . . . 0.0 110.404 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 68.9 p -172.29 167.5 5.78 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.45 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 81.6 mt -126.73 128.04 70.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.9 t -104.68 132.4 50.97 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 179.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 38.7 t -133.23 90.63 29.83 Favored Pre-proline 0 N--CA 1.473 0.696 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -58.12 142.24 96.92 Favored 'Trans proline' 0 N--CA 1.501 1.955 0 C-N-CA 121.663 1.575 . . . . 0.0 112.026 178.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 60.3 t -128.67 128.7 68.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -77.53 123.18 26.25 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 38.0 pt -99.63 -10.99 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 122.705 0.402 . . . . 0.0 110.697 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 39.4 t -61.66 -40.13 93.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.461 -178.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -85.23 -5.5 59.32 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 122.748 0.419 . . . . 0.0 110.394 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 46.4 t -91.94 106.99 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 71.5 p -131.03 2.66 4.33 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.703 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -147.2 146.07 29.71 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.936 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -52.33 135.21 33.24 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.453 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.417 ' OG1' ' N ' ' A' ' 66' ' ' SER . 7.0 t -167.95 -173.95 2.24 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.095 0.474 . . . . 0.0 110.863 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.417 ' N ' ' OG1' ' A' ' 65' ' ' THR . 61.8 p -150.92 148.73 28.78 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.101 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -143.54 144.15 31.83 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.225 0.536 . . . . 0.0 111.076 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 t -85.85 132.5 34.09 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.509 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 70.7 mt -115.97 120.63 39.79 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.806 0.443 . . . . 0.0 110.592 -179.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -84.87 133.06 34.32 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.265 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.1 mt -113.61 115.29 27.68 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -134.09 151.43 51.39 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -148.43 143.72 26.95 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -85.23 117.4 24.16 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.355 0.598 . . . . 0.0 111.343 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 118.24 -18.33 11.23 Favored Glycine 0 N--CA 1.481 1.658 0 CA-C-N 114.714 -1.13 . . . . 0.0 112.046 178.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.2 m -133.31 160.96 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 56.5 m -103.55 111.66 24.22 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.1 t -91.12 128.6 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -149.81 143.45 16.72 Favored Pre-proline 0 CA--C 1.553 1.085 0 CA-C-O 119.062 -0.494 . . . . 0.0 110.075 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -72.86 -1.23 11.74 Favored 'Cis proline' 0 N--CA 1.511 2.507 0 CA-C-N 120.906 1.359 . . . . 0.0 110.364 0.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.4 t 56.03 22.08 5.58 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.357 -1.292 . . . . 0.0 111.771 178.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 34.9 p -138.0 139.57 39.72 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.4 m -148.79 154.75 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -103.38 132.61 49.5 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 43.0 t -128.93 125.69 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.023 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -102.21 125.71 48.98 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 65.4 mt -107.54 111.2 23.35 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -95.5 126.57 40.88 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.6 m -96.52 137.6 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 44.1 m -100.61 116.41 32.46 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 95.3 mm-40 -80.99 129.63 34.63 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.4 ptmm? -54.86 138.43 42.91 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.868 0.366 . . . . 0.0 110.995 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 37.8 mt -95.07 -5.49 44.2 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.838 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -170.05 149.89 3.67 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.891 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -71.16 130.56 41.78 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.247 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -169.14 89.67 0.21 Allowed 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 48.9 p-80 -65.17 145.33 56.4 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.069 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -161.0 139.03 9.55 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 45.3 p-80 -160.31 161.26 33.24 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.107 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 42.9 p-80 . . . . . 0 C--O 1.221 -0.447 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.581 179.965 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.0 mttt . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 21.4 mm -72.77 132.14 33.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.2 m -158.78 -63.68 0.08 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.207 0.527 . . . . 0.0 109.757 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.6 tp 59.17 -134.45 0.9 Allowed 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.211 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -65.01 152.59 43.01 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -65.11 138.95 58.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.629 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 54.7 mt -113.94 151.42 32.31 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.7 t -160.35 143.26 13.4 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.669 ' HZ2' HE22 ' A' ' 43' ' ' GLN . 64.0 mttp -149.75 166.62 28.87 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -178.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.0 m -121.75 137.83 54.6 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.898 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.7 m -123.38 143.88 42.44 Favored Pre-proline 0 N--CA 1.486 1.362 0 C-N-CA 122.691 0.396 . . . . 0.0 110.022 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -74.37 142.24 29.72 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 121.429 1.419 . . . . 0.0 111.6 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.9 t -103.52 134.61 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -127.77 148.02 50.43 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 51.8 mt -112.37 137.88 49.91 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.466 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -119.32 110.27 16.79 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.4 mp -70.52 130.87 43.01 Favored 'General case' 0 C--N 1.334 -0.085 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.8 p -130.03 143.11 50.62 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.7 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.62 170.0 16.48 Favored Glycine 0 N--CA 1.475 1.265 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.8 p-10 -87.06 132.92 33.67 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -65.93 133.65 51.31 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.51 145.47 54.91 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.05 0.452 . . . . 0.0 110.629 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 61.0 m -63.68 -18.33 63.88 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.982 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -84.76 -20.87 30.37 Favored 'General case' 0 C--N 1.343 0.314 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.8 t -107.24 127.48 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-O 121.093 0.473 . . . . 0.0 110.276 -178.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 47.5 t -87.18 -40.7 14.35 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.34 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 47.1 t -155.47 161.31 40.98 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.499 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 82.6 mt -131.4 142.6 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.782 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.3 m -130.41 154.17 47.98 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.283 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -144.68 156.34 44.04 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.134 0.492 . . . . 0.0 110.096 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 45.4 m -148.09 166.52 27.57 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.154 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -146.1 142.49 28.58 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.959 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 33' ' ' ASP . 21.3 p-10 -73.35 -34.23 65.5 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.645 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -126.43 -56.79 1.4 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.111 0.564 . . . . 0.0 110.483 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 59.9 18.64 47.67 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -144.82 136.69 25.75 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.1 m -132.99 163.28 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 44.0 m -102.51 137.37 40.84 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 34.9 pt -117.41 150.44 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.2 p -130.27 134.69 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 123.332 0.395 . . . . 0.0 110.379 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 166.86 -160.75 34.49 Favored Glycine 0 C--N 1.328 0.113 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 44.6 t -77.43 157.04 30.73 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.669 HE22 ' HZ2' ' A' ' 9' ' ' LYS . 9.3 tp-100 -62.81 -35.36 79.64 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -61.75 -44.35 97.07 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.662 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.09 -39.91 95.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.816 0.341 . . . . 0.0 110.754 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 68.6 mtt -66.22 -38.64 88.42 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.418 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -61.08 -31.81 71.48 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.754 -0.203 . . . . 0.0 110.948 -179.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -73.64 -40.37 63.81 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.792 0.329 . . . . 0.0 110.511 179.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 67.0 mt -81.2 116.66 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -112.34 -23.35 10.4 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.248 0.619 . . . . 0.0 109.604 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 98.0 p -170.78 161.67 7.37 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.525 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 77.7 mt -112.53 121.43 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 33.6 m -99.08 130.72 45.42 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.4 t -134.26 93.0 20.07 Favored Pre-proline 0 N--CA 1.475 0.825 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -77.33 145.52 24.06 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 121.118 1.212 . . . . 0.0 111.31 -178.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.1 t -132.21 130.2 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-O 121.113 0.482 . . . . 0.0 110.235 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.9 p-10 -70.43 126.45 29.67 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.921 179.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 34.8 pt -100.02 -13.03 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 120.791 0.329 . . . . 0.0 110.661 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 44.7 m -59.39 -39.12 82.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.332 -178.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -84.65 -6.92 59.39 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 122.744 0.418 . . . . 0.0 110.39 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 42.6 t -93.54 114.48 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 65.4 p -133.48 4.92 3.7 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.158 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -152.66 161.74 42.17 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.846 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -62.36 138.7 58.49 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.953 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.2 t -166.03 170.46 13.55 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.293 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 46.7 m -148.11 140.69 24.5 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.761 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 54.5 pttt -146.63 145.08 29.93 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.488 0.661 . . . . 0.0 110.926 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 33.2 m -81.55 136.76 35.59 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.084 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 70.3 mt -115.89 125.96 53.3 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 122.79 0.436 . . . . 0.0 110.19 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -92.42 132.16 37.0 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 30.8 mt -107.67 129.77 54.98 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -131.15 141.44 50.09 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -139.49 142.14 37.33 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -86.02 133.03 33.93 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 122.21 1.005 . . . . 0.0 112.362 -178.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.05 -15.03 63.83 Favored Glycine 0 N--CA 1.472 1.049 0 CA-C-N 113.564 -1.653 . . . . 0.0 112.149 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 11.1 m -131.55 164.36 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 16.2 m -112.28 112.79 24.62 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.0 t -89.53 132.4 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -155.44 144.38 14.92 Favored Pre-proline 0 CA--C 1.557 1.238 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.858 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.46 -10.79 13.05 Favored 'Cis proline' 0 N--CA 1.514 2.732 0 CA-C-N 120.579 1.242 . . . . 0.0 110.639 0.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 10.4 p 58.21 23.68 10.56 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 114.652 -1.158 . . . . 0.0 112.129 177.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 34.6 p -132.88 139.38 47.38 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.6 m -152.89 154.97 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -94.75 134.74 37.03 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 44.8 t -127.85 130.62 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -111.24 124.23 51.8 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 53.0 mt -108.43 108.86 19.99 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -91.63 128.46 37.47 Favored 'General case' 0 C--O 1.231 0.111 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 43.3 t -102.97 132.61 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 61.8 m -100.31 117.87 35.4 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -78.72 131.51 36.62 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -63.12 138.04 58.42 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -68.91 130.51 42.98 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -86.58 -171.27 3.46 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.752 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 27.2 p80 -62.95 142.48 58.32 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.319 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -61.45 -47.04 87.52 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.441 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -168.6 156.37 7.93 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.437 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 72.5 m80 -70.2 144.96 51.76 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.956 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 79.2 t60 -161.19 4.55 0.06 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.783 0.325 . . . . 0.0 110.277 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 118.004 -0.998 . . . . 0.0 111.173 179.858 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 63.5 tttm . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 39.6 pt -66.97 -25.07 33.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.621 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.2 m -61.69 144.79 54.04 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.105 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 54.7 tp -65.53 147.64 53.07 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -162.36 42.13 0.13 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.159 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -57.39 155.03 9.77 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.81 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 34.5 tp -131.64 144.88 51.36 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 35.9 m -161.3 140.61 10.24 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.6 ' NZ ' HE22 ' A' ' 43' ' ' GLN . 98.5 mttt -149.25 165.84 30.69 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -178.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 92.5 p -117.16 138.08 51.91 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.903 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.5 m -126.56 143.42 46.23 Favored Pre-proline 0 N--CA 1.482 1.162 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.92 142.4 28.05 Favored 'Trans proline' 0 N--CA 1.501 1.914 0 C-N-CA 121.604 1.536 . . . . 0.0 111.931 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.9 p -95.29 134.51 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.5 mptm? -108.73 133.55 52.65 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.5 tp -104.9 130.42 53.06 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -124.36 111.77 16.17 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.9 pp -69.6 131.11 44.13 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.3 p -125.44 134.95 51.91 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.64 163.88 14.55 Favored Glycine 0 N--CA 1.477 1.417 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.2 p-10 -78.95 136.8 37.35 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -66.81 138.11 57.11 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.42 141.43 58.36 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.206 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.0 t -68.03 -20.87 65.03 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.642 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -94.25 4.71 53.51 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 122.237 0.215 . . . . 0.0 110.914 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 68.6 t -118.42 126.2 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.3 t -73.71 -45.76 50.25 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.069 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 45.6 t -161.1 165.44 29.61 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.175 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 80.1 mt -131.77 144.96 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 99.8 p -135.78 163.37 30.36 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.467 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -144.2 160.13 41.48 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.498 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 61.7 p -148.58 162.87 38.81 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.884 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -146.3 143.9 29.46 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.974 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -72.72 -35.09 67.5 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.682 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -126.61 -54.71 1.43 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 122.95 0.5 . . . . 0.0 110.571 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 62.11 24.23 64.88 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.455 ' ND1' ' O ' ' A' ' 36' ' ' HIS . 15.7 p80 -151.95 138.91 19.04 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 28.9 m -131.29 162.27 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 49.3 m -100.87 134.37 43.95 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 20.4 pt -114.34 145.08 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 49.1 t -127.5 133.54 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 170.47 -162.2 35.28 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.5 m -75.32 160.14 30.66 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.6 HE22 ' NZ ' ' A' ' 9' ' ' LYS . 60.7 tp60 -63.97 -40.14 95.72 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.576 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -65.1 -36.58 84.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.829 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.08 -41.64 90.45 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.783 0.325 . . . . 0.0 111.038 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 68.3 mtt -68.81 -35.96 77.64 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.728 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -60.57 -32.96 72.02 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.519 0.2 . . . . 0.0 110.911 -178.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -73.61 -38.28 65.14 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.839 0.352 . . . . 0.0 110.354 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 68.7 mt -86.27 117.37 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -114.89 -16.7 11.68 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 122.919 0.488 . . . . 0.0 110.108 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 73.4 p -171.49 169.12 6.26 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.809 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 87.9 mt -122.67 124.0 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 33.6 m -89.38 132.15 35.1 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 43.1 t -131.19 91.7 34.96 Favored Pre-proline 0 N--CA 1.476 0.844 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -80.77 140.74 13.14 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 121.597 1.531 . . . . 0.0 111.364 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 49.1 t -131.9 130.87 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.918 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -74.83 124.75 27.42 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 37.6 pt -102.01 -11.86 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 122.795 0.438 . . . . 0.0 110.639 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.7 m -60.53 -38.72 85.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.39 -178.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -86.75 -2.74 58.79 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 45.1 t -97.33 120.72 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.2 t -135.87 6.3 3.15 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.293 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -155.3 171.95 19.0 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.422 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.7 p-10 -65.81 126.45 28.52 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.464 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.0 p -145.58 165.78 27.67 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.899 0.38 . . . . 0.0 110.043 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 90.2 p -150.65 129.36 12.34 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.524 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -140.08 145.97 38.34 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.23 0.538 . . . . 0.0 110.888 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 37.8 m -81.68 134.69 35.49 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.596 178.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.0 mt -118.22 126.24 51.77 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.866 0.467 . . . . 0.0 109.87 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -94.16 135.61 35.35 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.9 mt -106.96 134.84 49.5 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.887 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -134.21 143.77 48.04 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -143.59 137.7 28.55 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -85.77 121.23 28.14 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.256 0.551 . . . . 0.0 112.027 -178.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.71 -13.76 38.56 Favored Glycine 0 N--CA 1.48 1.628 0 CA-C-N 114.571 -1.195 . . . . 0.0 112.305 178.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 18.9 m -133.83 161.43 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 46.7 m -110.77 120.55 42.78 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.6 p -109.52 135.46 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -158.82 144.6 12.21 Favored Pre-proline 0 CA--C 1.551 1.005 0 CA-C-O 119.307 -0.378 . . . . 0.0 110.576 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.43 ' C ' ' H ' ' A' ' 82' ' ' THR . 79.9 Cg_endo -70.57 -12.56 13.82 Favored 'Cis proline' 0 N--CA 1.512 2.571 0 CA-C-N 120.247 1.124 . . . . 0.0 110.82 0.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 p 66.99 -3.51 0.94 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.17 177.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.43 ' H ' ' C ' ' A' ' 80' ' ' PRO . 57.4 p -98.71 140.01 33.56 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.2 m -149.5 144.65 17.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -94.59 132.6 39.12 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 47.4 t -126.35 128.56 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -110.31 123.38 49.71 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 58.3 mt -105.63 120.54 41.93 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm -104.09 126.49 51.25 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 42.4 t -103.77 133.81 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.263 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 70.6 p -96.63 124.04 40.5 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 93.9 mm-40 -93.79 127.73 39.67 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 -179.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -144.42 137.13 26.8 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.442 ' CD2' ' N ' ' A' ' 93' ' ' LEU . 1.1 pt? -168.17 169.42 10.99 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.79 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -172.14 159.29 4.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.723 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 66.9 m80 52.84 -178.03 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.983 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 51.57 83.87 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.969 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -167.72 83.3 0.2 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.171 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 69.2 m80 -68.75 144.85 54.24 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.888 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 30.1 p80 -63.3 138.87 58.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.296 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 62.9 m80 . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 118.005 -0.998 . . . . 0.0 111.212 179.861 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 68.1 mttm . . . . . 0 N--CA 1.491 1.625 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 37.2 pt -68.84 -16.47 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.332 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.1 t -56.31 -31.01 63.28 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.892 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 39.4 tp 60.16 145.44 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.106 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -70.3 148.33 48.62 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -68.84 143.04 54.68 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -83.98 150.55 25.57 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 91.1 p -160.52 133.77 6.69 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.45 ' CE ' HE22 ' A' ' 43' ' ' GLN . 67.6 mttm -147.83 166.81 26.47 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 41.2 t -120.85 136.78 54.83 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.073 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.1 m -122.57 126.25 26.2 Favored Pre-proline 0 CA--C 1.561 1.369 0 CA-C-O 119.034 -0.508 . . . . 0.0 109.772 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -59.29 146.85 93.42 Favored 'Trans proline' 0 N--CA 1.506 2.212 0 CA-C-N 121.664 1.63 . . . . 0.0 111.816 178.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.1 t -96.31 132.31 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -125.2 127.96 47.59 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.0 mp -96.26 135.52 37.97 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -116.82 107.4 14.58 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 57.2 mt -67.32 124.6 23.6 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 28.8 m -117.07 128.72 55.43 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.68 -164.3 12.09 Favored Glycine 0 N--CA 1.473 1.138 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -119.58 147.83 44.03 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 115.005 -0.598 . . . . 0.0 109.817 178.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -68.69 139.68 55.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.078 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.49 151.56 44.03 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.48 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.1 t -63.18 -22.08 66.63 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.194 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -83.67 -21.78 32.32 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.7 t -105.02 126.64 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 121.071 0.463 . . . . 0.0 109.964 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.9 m -88.12 -32.48 18.66 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.149 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 94.1 p -155.82 159.65 39.57 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.202 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 81.7 mt -127.52 134.49 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.523 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.6 m -126.1 150.45 48.2 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -139.31 152.25 47.08 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.04 0.448 . . . . 0.0 109.936 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 93.1 p -150.5 152.18 33.81 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.69 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -147.41 147.87 30.71 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.061 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -69.55 -36.09 76.02 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.738 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -139.67 129.38 24.56 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -117.44 27.96 7.39 Favored Glycine 0 N--CA 1.474 1.194 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 40.7 p-80 -145.63 139.41 26.6 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 29.4 m -131.2 161.28 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 49.9 m -103.79 134.29 47.36 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 38.1 pt -116.86 146.38 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 123.12 0.568 . . . . 0.0 109.664 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 52.1 t -132.69 134.21 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 165.49 -158.98 32.05 Favored Glycine 0 N--CA 1.466 0.667 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.4 t -67.4 149.23 50.55 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.45 HE22 ' CE ' ' A' ' 9' ' ' LYS . 71.3 tp60 -64.86 -38.35 90.68 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.379 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -62.01 -39.1 91.13 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.807 0.337 . . . . 0.0 110.6 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.36 -39.55 92.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.675 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 68.6 mtt -66.41 -40.56 89.65 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.579 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -64.3 -24.93 67.83 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.595 0.236 . . . . 0.0 110.547 -179.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -76.26 -37.71 57.22 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 69.7 mt -83.11 117.41 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -99.94 -26.51 13.97 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.328 0.585 . . . . 0.0 109.875 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 96.8 p -171.05 164.11 7.44 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.087 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 41.4 mm -106.26 118.84 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.658 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.4 t -87.85 134.18 33.75 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 38.6 t -132.39 89.0 37.88 Favored Pre-proline 0 N--CA 1.473 0.683 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -81.64 146.41 15.06 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 121.485 1.457 . . . . 0.0 111.54 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.6 p -139.69 136.49 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.857 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -76.47 126.21 30.58 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 20.8 pt -109.71 -2.94 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 122.706 0.402 . . . . 0.0 110.39 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 91.3 p -80.66 -15.07 57.5 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.58 -178.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -102.75 -11.35 18.42 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.126 0.571 . . . . 0.0 110.778 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.9 m -101.34 131.2 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 68.7 p -137.19 11.71 3.04 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.635 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -147.6 145.95 29.2 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.764 -178.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -56.82 136.18 55.56 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.519 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.409 ' OG1' ' N ' ' A' ' 66' ' ' SER . 5.1 t -167.31 -177.28 3.58 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.555 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.409 ' N ' ' OG1' ' A' ' 65' ' ' THR . 47.3 t -149.55 145.99 27.11 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.058 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -148.02 143.53 27.3 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.362 0.601 . . . . 0.0 110.967 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 35.0 m -82.03 135.82 35.3 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.818 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 89.3 mt -119.8 129.58 54.51 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.075 0.55 . . . . 0.0 110.25 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -94.68 134.9 36.76 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 47.4 mt -108.24 133.95 51.77 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.034 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -139.14 147.1 41.46 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -147.62 139.91 24.44 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.408 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.3 mp0 -86.72 117.43 25.47 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.454 0.645 . . . . 0.0 112.037 -178.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 116.44 -16.71 14.48 Favored Glycine 0 N--CA 1.48 1.597 0 CA-C-N 114.221 -1.354 . . . . 0.0 111.74 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.1 m -134.73 160.33 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 50.5 m -105.63 112.51 25.62 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.4 t -89.73 132.05 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -156.13 140.43 11.75 Favored Pre-proline 0 CA--C 1.552 1.035 0 CA-C-O 119.07 -0.49 . . . . 0.0 110.882 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -70.16 -10.66 12.4 Favored 'Cis proline' 0 N--CA 1.513 2.671 0 CA-C-N 120.788 1.317 . . . . 0.0 111.042 0.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.0 p 58.22 19.36 6.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.704 -1.135 . . . . 0.0 112.029 177.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.1 p -130.16 140.29 50.78 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.5 m -151.46 154.17 8.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -101.96 132.8 47.57 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.3 p -128.85 132.04 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 121.164 0.506 . . . . 0.0 109.935 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -106.28 125.98 51.67 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.871 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 57.6 mt -109.38 108.99 19.73 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -92.95 128.87 38.97 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 33.7 m -91.49 137.42 21.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.226 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 26.3 m -104.11 109.72 21.63 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -76.08 129.25 36.53 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 110.559 -0.163 . . . . 0.0 110.559 -178.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -61.13 104.83 0.42 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.058 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 59.7 mt -75.21 140.12 43.06 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 52.42 89.33 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.526 0.203 . . . . 0.0 110.93 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -68.96 111.14 4.8 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.189 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -67.75 95.66 0.52 Allowed 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 120.805 0.336 . . . . 0.0 110.266 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -168.92 115.24 0.61 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.711 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 43.4 p-80 -169.86 -21.29 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 -166.41 136.6 3.29 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.294 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 118.097 -0.954 . . . . 0.0 110.256 179.751 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 63.6 tttm . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.414 ' CD1' ' N ' ' A' ' 2' ' ' ILE . 0.1 OUTLIER -139.96 172.17 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.207 -0.452 . . . . 0.0 109.874 -179.77 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 96.2 p -168.92 162.72 11.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.053 178.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 70.1 mt -68.59 148.73 50.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.714 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 71.4 mtp85 -63.06 -84.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.257 -179.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.0 mtmm -83.07 142.67 31.12 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 50.9 mt -113.89 155.05 26.47 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.3 t -153.46 156.56 38.39 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.932 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.8 tptt -155.5 164.19 39.01 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.746 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 87.8 p -127.9 137.42 52.3 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.186 -0.915 . . . . 0.0 108.668 179.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.1 m -131.19 144.52 53.82 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.595 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -74.39 144.43 32.61 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 121.864 1.709 . . . . 0.0 111.505 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.5 m -96.73 145.72 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -122.15 139.4 53.79 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.6 mp -113.82 135.96 53.39 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -121.88 118.53 29.15 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.74 0.65 . . . . 0.0 109.262 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 51.3 mt -72.56 126.32 29.59 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 79.9 p -119.24 128.59 54.33 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.98 160.31 13.53 Favored Glycine 0 N--CA 1.47 0.929 0 N-CA-C 110.414 -1.075 . . . . 0.0 110.414 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -84.15 145.48 28.37 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 178.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -65.05 137.58 57.79 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.298 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.91 159.57 25.3 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.981 0.419 . . . . 0.0 110.446 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.4 t -71.49 -30.45 65.99 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.559 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -83.62 -11.06 57.77 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 122.156 0.182 . . . . 0.0 111.176 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 64.2 t -108.5 130.06 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 36.1 m -87.19 -41.79 13.47 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.936 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 45.0 t -159.23 160.51 35.41 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.301 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 76.5 mt -132.15 143.57 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.576 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.4 m -130.86 158.1 41.1 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.186 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -142.51 152.47 42.69 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.867 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 45.7 t -151.93 162.82 40.46 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.759 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -143.87 147.38 33.96 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.035 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -72.49 -33.8 67.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.366 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -135.43 -52.38 0.76 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 122.57 0.348 . . . . 0.0 110.251 -179.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.82 28.23 60.19 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 51.5 m-70 -140.96 137.33 32.98 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.6 m -129.66 161.17 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 27.7 m -103.16 138.91 39.35 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 34.3 pt -119.54 147.89 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.484 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 48.6 t -130.4 134.71 61.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.738 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 162.38 -158.47 30.57 Favored Glycine 0 N--CA 1.462 0.413 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 56.4 m -76.11 149.59 37.37 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -62.38 -29.92 70.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.451 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -61.76 -47.96 82.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.47 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.45 -38.45 91.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.631 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 68.1 mtt -65.99 -39.57 90.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.494 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -62.45 -30.74 71.46 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.555 0.216 . . . . 0.0 110.773 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -74.68 -36.98 62.78 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.717 0.294 . . . . 0.0 110.691 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 68.6 mt -89.13 117.5 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -108.24 -21.42 12.78 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.109 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 93.9 p -170.32 159.19 7.04 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.887 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 72.6 mt -109.44 128.04 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.6 m -89.33 131.67 35.3 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.6 t -128.57 90.37 46.69 Favored Pre-proline 0 CA--C 1.542 0.659 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 178.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -81.8 147.84 15.42 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 122.175 1.916 . . . . 0.0 111.297 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.3 p -142.84 136.17 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.077 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -75.62 129.64 37.49 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 35.1 pt -104.69 -11.04 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 O-C-N 123.299 0.374 . . . . 0.0 110.304 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.476 ' HG ' ' N ' ' A' ' 60' ' ' GLN . 80.6 p -61.18 -39.3 89.64 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.143 -178.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.476 ' N ' ' HG ' ' A' ' 59' ' ' SER . 77.7 mt-30 -86.5 -5.01 59.26 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 122.534 0.334 . . . . 0.0 110.402 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 42.6 t -94.65 117.62 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 58.0 p -134.56 2.05 3.17 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.025 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -147.38 156.52 42.97 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.992 0.425 . . . . 0.0 110.253 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -63.73 136.99 57.89 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.006 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.1 t -166.82 177.49 6.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.163 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 44.1 t -144.01 140.37 29.54 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.408 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -139.28 143.3 37.86 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.108 0.48 . . . . 0.0 110.518 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 28.1 m -83.74 132.52 34.84 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.8 mt -119.69 129.85 54.74 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -97.81 137.19 37.05 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 43.3 mt -113.49 136.69 52.52 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -132.82 140.96 48.22 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -135.55 143.48 45.72 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -85.99 135.62 33.58 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.819 0.818 . . . . 0.0 111.907 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.82 -28.25 8.01 Favored Glycine 0 N--CA 1.476 1.345 0 CA-C-N 114.303 -1.317 . . . . 0.0 112.732 178.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.5 m -118.9 163.45 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 34.0 m -109.48 116.22 31.39 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.0 t -93.81 131.66 40.13 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -157.69 141.39 11.33 Favored Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.703 178.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.54 -12.3 11.72 Favored 'Cis proline' 0 N--CA 1.506 2.239 0 CA-C-N 119.814 0.969 . . . . 0.0 110.051 -0.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.2 p 61.99 23.43 13.8 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.637 177.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 39.3 p -131.01 138.72 49.78 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 24.0 m -151.11 149.76 13.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -95.92 133.51 40.02 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.6 p -128.12 133.09 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -107.52 127.37 53.56 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 39.5 mt -111.06 106.51 15.6 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -89.35 129.63 35.85 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 18.6 t -106.55 132.88 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 31.5 m -100.33 121.03 40.84 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -86.7 133.64 33.66 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -67.66 137.55 55.66 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.7 tp -166.03 65.42 0.11 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.067 0.46 . . . . 0.0 110.702 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.437 ' OE1' ' N ' ' A' ' 94' ' ' GLU . 44.6 mp0 -140.62 153.24 45.97 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.3 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 69.1 m80 -65.44 160.14 22.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.771 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 31.7 p-80 -169.04 81.27 0.13 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.994 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -70.56 157.49 37.81 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -162.01 159.76 26.78 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.132 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -67.46 146.55 53.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.862 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 59.9 t-80 . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.012 179.987 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 68.2 mttm . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 38.6 mm -63.65 -43.64 98.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.207 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.1 m -58.96 -42.18 89.29 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.933 0.397 . . . . 0.0 111.05 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 64.7 mt -70.51 146.96 49.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.825 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 54.22 77.68 0.19 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.947 0.403 . . . . 0.0 110.906 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -64.68 136.27 56.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.775 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 57.2 mt -112.88 147.37 37.16 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 95.3 p -147.92 151.07 35.22 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.721 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -146.67 165.09 30.61 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.671 0.748 . . . . 0.0 109.6 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 92.6 p -112.04 136.22 51.68 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 114.004 -1.453 . . . . 0.0 109.918 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.4 m -134.33 99.38 13.31 Favored Pre-proline 0 CA--C 1.544 0.749 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -179.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -57.56 148.23 74.31 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 CA-C-N 120.191 1.104 . . . . 0.0 111.591 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 15.9 t -86.14 132.83 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -113.26 123.34 49.94 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.2 mp -96.27 131.71 42.49 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -120.07 107.73 13.41 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 178.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.9 pp -68.46 129.36 39.7 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.27 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.4 p -130.86 141.7 50.33 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 122.984 0.514 . . . . 0.0 109.645 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.85 168.24 16.49 Favored Glycine 0 N--CA 1.474 1.178 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -86.29 134.76 33.73 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -65.4 137.44 57.49 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.91 173.36 1.08 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.501 0.667 . . . . 0.0 111.32 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 35.2 t -84.71 -23.28 29.4 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.116 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -88.46 -13.65 39.84 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.1 p -102.28 126.02 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-O 121.169 0.509 . . . . 0.0 112.039 -177.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 38.3 t -91.01 -31.01 16.48 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.35 179.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.7 t -159.75 158.13 30.68 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.47 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 85.9 mt -127.88 136.38 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.586 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.9 t -130.54 153.22 49.08 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -147.22 155.62 42.24 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.115 0.483 . . . . 0.0 110.562 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 50.4 m -146.6 160.09 42.61 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.879 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -140.81 143.1 34.63 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.812 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -71.87 -34.02 68.85 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.757 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.401 ' O ' ' ND1' ' A' ' 36' ' ' HIS . 99.6 mtt180 -128.13 -55.95 1.26 Allowed 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 121.194 0.521 . . . . 0.0 110.132 -179.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.23 22.64 58.69 Favored Glycine 0 CA--C 1.523 0.555 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.536 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.401 ' ND1' ' O ' ' A' ' 34' ' ' ARG . 12.8 p-80 -149.93 138.73 20.91 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.42 ' CG2' ' N ' ' A' ' 38' ' ' THR . 3.3 p -127.89 163.32 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.42 ' N ' ' CG2' ' A' ' 37' ' ' VAL . 52.0 m -100.22 132.6 45.49 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.905 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.5 pt -114.84 134.4 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 123.363 0.665 . . . . 0.0 109.304 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.6 t -124.47 133.5 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 163.9 -154.47 25.37 Favored Glycine 0 N--CA 1.468 0.826 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.4 m -69.66 145.41 52.42 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 70.6 tp60 -62.96 -34.49 77.61 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.615 0.245 . . . . 0.0 110.367 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -61.55 -41.44 97.37 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.638 0.256 . . . . 0.0 110.791 -179.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.91 -37.9 89.11 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.777 0.322 . . . . 0.0 110.717 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 66.7 mtt -64.77 -39.78 94.17 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.447 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -63.79 -30.78 71.84 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.539 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -73.92 -40.73 62.91 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.776 0.322 . . . . 0.0 110.66 179.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 58.7 mt -84.8 117.63 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -178.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -114.21 -17.67 11.81 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.04 0.536 . . . . 0.0 110.826 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 73.4 p -174.13 132.74 0.41 Allowed 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.941 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 42.4 mm -83.04 124.08 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 32.5 m -91.55 126.26 36.58 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.4 t -133.46 91.35 26.85 Favored Pre-proline 0 N--CA 1.474 0.774 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -82.01 145.13 13.84 Favored 'Trans proline' 0 N--CA 1.5 1.881 0 C-N-CA 121.672 1.581 . . . . 0.0 111.617 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 60.8 t -129.71 129.13 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.021 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -68.58 125.04 25.25 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.7 pt -99.93 -12.83 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-O 120.847 0.356 . . . . 0.0 110.526 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.5 m -60.17 -38.72 84.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.554 -178.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -86.2 -4.1 59.1 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 122.557 0.343 . . . . 0.0 110.335 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 46.9 t -94.22 111.79 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 60.3 p -128.57 2.87 5.55 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.617 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -152.45 163.03 40.34 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.575 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -64.39 136.64 57.31 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.204 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.7 t -166.36 177.95 6.47 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.585 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 99.1 p -149.71 144.25 25.97 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.818 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -143.51 143.36 31.52 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-O 121.228 0.537 . . . . 0.0 110.476 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 51.4 m -81.75 131.85 35.27 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 64.8 mt -117.39 120.42 38.1 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.823 0.449 . . . . 0.0 109.857 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -84.24 133.64 34.57 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 50.8 mt -102.75 133.79 47.21 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 122.598 0.359 . . . . 0.0 110.047 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -136.17 141.06 44.03 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 122.957 0.503 . . . . 0.0 110.215 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -150.98 130.21 12.74 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -86.21 114.32 22.94 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.293 0.568 . . . . 0.0 111.282 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 128.64 -22.05 5.27 Favored Glycine 0 N--CA 1.48 1.589 0 CA-C-N 114.529 -1.214 . . . . 0.0 111.519 178.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.5 m -134.87 160.41 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-O 120.897 0.38 . . . . 0.0 110.271 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 46.4 m -100.82 117.41 34.83 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -95.99 131.92 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -155.29 135.45 8.39 Favored Pre-proline 0 CA--C 1.553 1.07 0 CA-C-O 119.071 -0.49 . . . . 0.0 110.537 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -71.25 -7.53 12.81 Favored 'Cis proline' 0 N--CA 1.52 3.032 0 CA-C-N 121.325 1.509 . . . . 0.0 111.091 0.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.3 p 59.94 17.85 6.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.661 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.4 p -132.92 140.69 47.98 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.6 m -147.73 154.82 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -101.05 134.38 44.14 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.9 p -131.6 138.18 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 121.178 0.514 . . . . 0.0 110.29 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -114.89 126.88 55.31 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.999 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 56.1 mt -109.16 109.15 20.04 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -92.98 127.68 38.58 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.9 t -100.94 132.35 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 46.0 m -100.16 122.09 42.45 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-O 120.689 0.28 . . . . 0.0 110.709 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -101.54 127.78 48.09 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.065 0.546 . . . . 0.0 109.914 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -127.29 99.16 5.54 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 177.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 9.8 mp -73.62 95.11 2.26 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -61.88 -31.9 72.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.047 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 60.5 t-80 53.03 79.83 0.11 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.928 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 47.6 p-80 -62.2 126.17 26.41 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.417 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -169.44 119.89 0.68 Allowed 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 17.2 p80 -68.09 118.21 10.94 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -69.32 130.31 42.23 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 . . . . . 0 C--O 1.221 -0.437 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.551 -179.88 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 63.0 mttp . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 37.2 pt -64.06 168.28 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.202 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.9 m -157.63 161.62 38.66 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.577 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.8 tt -147.98 118.86 7.6 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 48.5 ptt85 -169.23 157.52 7.67 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.948 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -136.69 144.45 43.94 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 71.3 mt -97.69 177.02 5.62 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.504 ' HG ' ' N ' ' A' ' 9' ' ' LYS . 42.8 t -159.89 153.41 22.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.515 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.504 ' N ' ' HG ' ' A' ' 8' ' ' SER . 44.0 mmtm -144.89 166.29 25.69 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.561 0.696 . . . . 0.0 109.699 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 95.2 p -114.19 134.87 54.61 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 114.216 -1.356 . . . . 0.0 109.692 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.5 m -129.25 94.99 31.85 Favored Pre-proline 0 CA--C 1.547 0.861 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -57.71 146.02 87.21 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 CA-C-N 119.992 1.033 . . . . 0.0 111.567 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.0 t -93.98 133.94 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.325 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -114.02 130.15 56.57 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.3 tp -96.39 130.61 43.48 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -122.45 108.54 13.3 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 120.976 0.417 . . . . 0.0 109.879 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.0 pp -65.25 130.16 42.33 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.741 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.7 m -127.57 135.38 50.23 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.81 165.19 15.66 Favored Glycine 0 N--CA 1.475 1.273 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -85.72 134.18 33.97 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.7 ptmm? -63.29 136.95 58.01 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.617 0.246 . . . . 0.0 110.459 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.0 170.43 4.38 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.348 0.594 . . . . 0.0 111.133 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 34.6 t -81.0 -23.16 38.87 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.292 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -87.35 -11.34 49.67 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.8 p -110.1 129.28 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-O 120.84 0.352 . . . . 0.0 110.821 -178.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 36.2 t -86.47 -37.6 18.13 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.982 0.42 . . . . 0.0 109.986 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 98.7 p -160.78 160.07 30.79 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.397 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 92.8 mt -131.31 139.73 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 60.2 m -125.75 154.61 42.25 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -141.37 152.84 44.7 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.017 0.437 . . . . 0.0 110.302 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 96.6 p -151.52 162.05 41.62 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.204 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.469 ' CD1' ' N ' ' A' ' 35' ' ' GLY . 25.0 p90 -146.39 147.35 31.2 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.181 -179.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -69.99 -35.11 74.15 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.612 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -158.98 89.07 0.92 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.409 0.623 . . . . 0.0 109.97 -179.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.469 ' N ' ' CD1' ' A' ' 32' ' ' PHE . . . -76.78 38.17 1.48 Allowed Glycine 0 N--CA 1.462 0.429 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.755 -178.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 27.5 p80 -144.85 137.97 26.69 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 117.659 0.73 . . . . 0.0 109.432 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.6 m -129.16 162.45 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 26.4 m -102.61 133.22 47.96 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 37.9 pt -119.31 146.19 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 122.972 0.509 . . . . 0.0 110.325 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 50.0 t -129.37 134.85 62.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.949 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 162.66 -156.96 28.84 Favored Glycine 0 N--CA 1.467 0.753 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 50.9 m -74.85 147.94 40.66 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 110.321 -0.251 . . . . 0.0 110.321 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -63.92 -30.61 71.67 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.371 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -60.47 -45.16 94.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.721 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.42 -39.61 85.48 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.664 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 67.9 mtt -65.54 -40.87 93.37 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.287 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -64.14 -31.71 73.0 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.045 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.1 tppt? -71.94 -38.57 69.81 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.16 0.505 . . . . 0.0 110.551 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 72.4 mt -88.21 117.52 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.604 -178.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -99.92 -24.93 14.5 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.36 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.9 m -169.99 -178.82 3.0 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.616 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 85.8 mt -124.34 123.48 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 42.4 m -96.07 128.38 42.92 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.5 t -128.53 90.6 46.07 Favored Pre-proline 0 N--CA 1.473 0.718 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -83.47 144.08 11.28 Favored 'Trans proline' 0 N--CA 1.5 1.896 0 C-N-CA 121.829 1.686 . . . . 0.0 111.571 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.6 p -137.44 135.35 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 CA-C-O 121.067 0.461 . . . . 0.0 110.935 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -67.07 128.87 38.0 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 36.1 pt -101.67 -11.23 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-O 120.985 0.422 . . . . 0.0 110.547 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.8 t -62.22 -40.6 96.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.57 -178.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -83.26 -6.88 59.62 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.757 0.423 . . . . 0.0 110.218 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 43.4 t -92.56 109.77 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 70.6 p -132.08 1.91 3.92 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.755 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -142.39 151.97 42.37 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -64.28 134.23 54.3 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.249 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.402 ' OG1' ' N ' ' A' ' 66' ' ' SER . 5.5 t -167.13 -178.38 4.12 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.013 0.435 . . . . 0.0 110.907 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.402 ' N ' ' OG1' ' A' ' 65' ' ' THR . 99.2 p -138.62 147.44 42.93 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.196 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -136.03 141.56 44.34 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.268 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 63.8 m -97.36 125.54 42.03 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 177.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 66.1 mt -120.72 135.93 55.0 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.802 0.441 . . . . 0.0 110.09 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.9 mp0 -98.86 138.3 36.19 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 24.7 mt -106.12 132.28 52.39 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 116.296 -0.411 . . . . 0.0 109.995 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -129.98 140.86 50.83 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -146.82 130.9 17.3 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -85.11 115.38 22.88 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.32 0.581 . . . . 0.0 111.203 -178.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 125.78 -21.13 6.32 Favored Glycine 0 N--CA 1.48 1.575 0 CA-C-N 114.577 -1.192 . . . . 0.0 111.761 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.3 m -132.49 159.09 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 80.7 m -102.94 110.64 22.64 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.4 t -91.58 128.93 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -155.69 138.77 10.75 Favored Pre-proline 0 CA--C 1.554 1.115 0 CA-C-O 118.893 -0.575 . . . . 0.0 110.363 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -70.4 -11.21 13.1 Favored 'Cis proline' 0 N--CA 1.517 2.909 0 CA-C-N 121.291 1.497 . . . . 0.0 110.781 0.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 60.1 22.54 11.77 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.744 -1.117 . . . . 0.0 112.343 177.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 37.7 p -127.07 140.57 52.19 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.7 m -147.53 142.83 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -93.86 131.26 39.44 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 43.4 t -123.3 121.5 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -99.83 123.62 44.28 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 65.4 mt -108.45 105.92 15.8 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -87.91 130.46 34.91 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 26.6 t -104.16 131.39 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 49.5 m -100.05 120.07 39.27 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 -82.46 132.2 35.21 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -54.54 142.85 26.22 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.645 0.26 . . . . 0.0 110.799 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.424 ' C ' ' H ' ' A' ' 95' ' ' HIS . 3.8 mm? -72.62 147.34 45.9 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -71.14 4.23 2.92 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.137 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.424 ' H ' ' C ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -59.67 141.93 54.05 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.678 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -67.16 127.97 34.63 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.284 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -167.26 149.63 6.05 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -168.62 88.41 0.21 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.881 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 68.5 m80 53.54 -174.96 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.992 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 32.2 p-80 . . . . . 0 C--O 1.221 -0.441 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.56 179.937 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.0 mttt . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 33.7 pt -66.14 -24.63 34.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.234 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.6 p 61.59 148.82 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.241 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.4 tt -71.63 145.72 48.78 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.901 0.381 . . . . 0.0 110.141 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 47.1 ptt85 -170.0 145.21 2.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.429 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -92.83 149.4 21.3 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 56.9 mt -89.74 164.82 14.52 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.6 t -161.3 141.08 10.55 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -149.85 167.12 27.5 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -178.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 39.8 t -124.11 137.99 54.49 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 114.867 -1.061 . . . . 0.0 109.136 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.3 m -122.76 144.57 43.04 Favored Pre-proline 0 N--CA 1.482 1.139 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -73.05 143.18 35.71 Favored 'Trans proline' 0 N--CA 1.5 1.872 0 C-N-CA 121.345 1.363 . . . . 0.0 111.586 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 43.8 t -103.69 134.0 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -125.91 146.86 49.66 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.2 mt -112.2 132.59 54.82 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -114.22 113.97 25.36 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.317 -0.624 . . . . 0.0 109.317 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 49.5 mt -70.33 124.1 23.33 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 76.4 p -119.76 135.31 54.9 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 115.55 163.14 13.72 Favored Glycine 0 N--CA 1.471 1.024 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.4 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 1.0 OUTLIER -85.13 138.91 32.1 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 179.131 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -65.9 132.09 47.81 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.18 177.02 2.42 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.468 0.651 . . . . 0.0 110.786 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 89.9 p -85.23 -19.16 32.09 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.929 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -88.13 -21.53 24.6 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 122.134 0.174 . . . . 0.0 110.737 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.3 p -97.37 126.33 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-O 120.859 0.361 . . . . 0.0 111.008 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.5 t -92.6 -35.92 13.29 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.7 t -161.21 158.03 26.69 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.095 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 82.3 mt -128.73 136.62 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 60.5 m -128.97 153.49 47.5 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -144.62 155.58 43.69 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.188 0.518 . . . . 0.0 110.346 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 87.8 p -150.95 163.5 38.55 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.16 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -146.4 147.59 31.43 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.017 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -71.59 -34.03 69.56 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.533 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -134.13 -52.09 0.83 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 122.892 0.477 . . . . 0.0 110.167 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.31 23.41 62.22 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.44 ' ND1' ' O ' ' A' ' 36' ' ' HIS . 18.0 p80 -147.6 140.11 24.61 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 28.4 m -133.11 165.97 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 46.1 m -99.8 137.92 37.6 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 38.7 pt -119.63 148.46 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.4 t -130.68 134.13 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-O 120.915 0.388 . . . . 0.0 109.97 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 167.2 -163.09 36.86 Favored Glycine 0 N--CA 1.464 0.536 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.2 t -73.41 155.03 39.74 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 110.375 -0.232 . . . . 0.0 110.375 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 70.4 tp60 -63.36 -37.57 87.8 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.549 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -64.04 -39.01 93.15 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 110.435 -0.209 . . . . 0.0 110.435 -179.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.33 -44.4 83.44 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.868 0.365 . . . . 0.0 111.097 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 77.8 mtm -68.23 -39.27 82.36 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.825 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -60.36 -32.76 71.59 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.578 0.228 . . . . 0.0 110.895 -179.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.5 ttpp -70.69 -33.63 71.11 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.729 0.3 . . . . 0.0 110.49 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 71.1 mt -86.44 119.17 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -107.56 -22.11 12.65 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-O 121.228 0.537 . . . . 0.0 110.194 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 95.2 p -171.96 162.33 5.94 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.877 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 36.5 mm -107.07 119.28 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 38.2 m -96.69 127.77 42.99 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 26.0 t -133.5 93.0 22.47 Favored Pre-proline 0 N--CA 1.474 0.775 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -77.29 145.19 23.88 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 121.032 1.155 . . . . 0.0 111.422 -178.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.9 t -132.48 129.56 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.904 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -71.38 127.06 31.31 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.609 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 36.5 pt -99.09 -12.73 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 122.597 0.359 . . . . 0.0 110.92 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 80.6 p -59.04 -38.57 79.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.568 -178.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -86.79 -4.78 59.22 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 122.565 0.346 . . . . 0.0 110.505 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.1 t -93.72 110.85 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 67.8 p -131.5 4.46 4.29 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.414 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.3 tp10 -152.33 158.13 42.3 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.851 0.358 . . . . 0.0 110.105 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -59.79 137.41 58.06 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.329 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.2 t -165.01 166.99 18.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.13 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 42.5 t -141.79 140.84 33.13 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.655 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -148.81 147.38 28.7 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.892 0.853 . . . . 0.0 111.11 -179.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 39.6 m -81.67 136.08 35.51 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 114.278 -1.328 . . . . 0.0 109.328 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.5 mt -110.9 113.06 25.35 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.061 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 50.2 tp10 -75.73 126.29 30.71 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 44.9 mt -104.63 128.07 52.55 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -133.2 141.56 48.14 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -142.31 141.73 32.43 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -85.06 134.84 34.19 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 122.027 0.918 . . . . 0.0 113.137 -177.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.8 -9.5 76.12 Favored Glycine 0 N--CA 1.474 1.185 0 CA-C-N 114.152 -1.385 . . . . 0.0 112.073 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.0 m -133.89 161.74 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 60.6 m -110.41 113.68 26.52 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.6 t -90.3 132.61 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -156.51 139.73 11.0 Favored Pre-proline 0 CA--C 1.554 1.118 0 CA-C-O 119.013 -0.518 . . . . 0.0 110.867 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.5 -12.94 11.83 Favored 'Cis proline' 0 N--CA 1.515 2.738 0 CA-C-N 120.838 1.335 . . . . 0.0 110.887 0.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.7 p 61.55 22.52 12.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.66 177.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.2 p -131.93 139.97 48.87 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.2 m -151.34 154.27 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -98.44 132.8 43.6 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.3 t -127.64 130.32 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -107.47 124.94 50.62 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 55.0 mt -109.34 109.57 20.5 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -179.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -91.02 128.3 36.79 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 23.9 t -102.78 131.8 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 52.1 m -99.13 118.19 35.3 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 96.0 mm-40 -74.79 135.29 41.69 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -89.85 139.85 30.18 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -153.16 47.97 0.7 Allowed 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.311 0.577 . . . . 0.0 109.975 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -150.32 162.93 39.56 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.581 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -152.83 148.72 27.52 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.844 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -74.69 7.0 3.33 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.304 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 21.1 m170 56.92 106.12 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.642 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 15.5 p80 -56.71 -41.39 77.34 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.823 0.344 . . . . 0.0 110.688 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 -61.74 111.69 1.96 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.344 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 . . . . . 0 C--O 1.22 -0.471 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.413 179.947 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.4 tp . . . . . 0 N--CA 1.445 -0.681 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 90.3 p -145.06 148.26 33.5 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.476 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -144.52 166.34 25.42 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.466 0.651 . . . . 0.0 109.563 -178.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.4 t -113.45 135.99 53.28 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.572 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.5 m -128.86 100.37 21.29 Favored Pre-proline 0 CA--C 1.549 0.904 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -57.01 144.62 89.09 Favored 'Trans proline' 0 N--CA 1.499 1.842 0 C-N-CA 121.095 1.196 . . . . 0.0 111.704 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 23.0 m -88.86 139.56 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.681 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -119.17 116.41 26.25 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.421 ' N ' HD12 ' A' ' 15' ' ' LEU . 10.8 mp -89.98 135.13 33.83 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -122.49 116.66 24.32 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 58.2 mt -66.61 126.06 27.73 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.3 m -127.4 133.96 49.95 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.65 165.06 15.75 Favored Glycine 0 N--CA 1.472 1.043 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -81.32 138.19 35.7 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -68.22 139.49 56.04 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.03 144.09 57.36 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 83.2 p -68.89 -24.08 64.28 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.185 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -91.5 2.89 56.11 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 122.218 0.207 . . . . 0.0 110.99 -179.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 52.8 t -118.91 126.16 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 36.4 t -75.05 -43.32 54.14 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.339 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 37.5 t -163.94 162.11 23.22 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.723 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 80.4 mt -130.4 146.1 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.337 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 40.2 t -132.58 161.83 32.84 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.497 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -146.21 154.67 42.01 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.069 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 50.8 m -144.69 170.89 15.22 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.802 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -146.74 147.69 31.21 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.808 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -74.57 -33.36 62.67 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.067 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 86.7 mtm180 -133.6 -49.77 0.84 Allowed 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.729 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.38 19.27 57.38 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 47.9 m80 -142.25 137.5 30.74 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.49 HG22 ' N ' ' A' ' 38' ' ' THR . 4.1 p -133.4 161.88 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.49 ' N ' HG22 ' A' ' 37' ' ' VAL . 34.1 m -101.53 135.0 43.78 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.335 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 40.5 pt -120.04 149.66 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.8 t -132.79 134.97 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 166.57 -160.3 33.86 Favored Glycine 0 N--CA 1.464 0.531 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.8 m -73.01 151.74 41.63 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 62.1 tp60 -64.96 -34.49 78.54 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.313 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -60.61 -43.81 97.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.736 0.303 . . . . 0.0 110.622 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.72 -40.09 94.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.623 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 67.7 mtt -65.01 -40.67 95.23 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.597 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -65.55 -23.71 66.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.64 0.257 . . . . 0.0 110.53 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -80.61 -34.96 34.68 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.377 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 67.1 mt -91.61 116.35 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -99.1 -24.58 14.84 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.064 0.459 . . . . 0.0 110.221 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 92.9 p -172.36 162.8 5.52 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.044 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 36.7 mm -107.32 120.48 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 33.5 m -85.01 129.93 34.71 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 38.3 t -123.84 90.75 50.37 Favored Pre-proline 0 N--CA 1.471 0.619 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -79.26 146.2 19.62 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 121.485 1.456 . . . . 0.0 111.371 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.7 p -139.57 137.43 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.883 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -79.16 125.29 29.25 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 36.4 pt -103.08 -9.87 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 120.857 0.36 . . . . 0.0 110.294 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 40.3 m -61.81 -39.82 93.09 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.436 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -86.69 -5.0 59.25 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 122.928 0.491 . . . . 0.0 110.679 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 45.4 t -92.43 114.14 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 70.2 p -132.54 -0.13 3.59 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.172 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -144.62 155.7 43.75 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 121.007 0.432 . . . . 0.0 110.435 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -63.9 132.81 51.89 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.04 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.8 t -167.61 -174.9 2.63 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.342 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 96.8 p -151.26 147.25 26.75 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.611 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -140.16 143.93 36.4 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.109 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.8 m -83.13 132.03 35.11 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.168 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 74.8 mt -120.89 129.66 53.58 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 122.907 0.483 . . . . 0.0 109.839 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -96.6 137.68 35.32 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 52.2 mt -110.64 136.93 48.98 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -141.59 147.24 37.34 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -149.89 137.21 19.78 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -86.29 114.6 23.23 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.004 0.431 . . . . 0.0 110.941 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 125.12 -20.56 6.65 Favored Glycine 0 N--CA 1.485 1.937 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.625 178.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 32.8 m -134.13 159.87 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 31.7 m -102.73 111.14 23.32 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.1 t -92.04 129.14 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -156.75 142.0 12.45 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.494 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.92 -10.28 11.73 Favored 'Cis proline' 0 N--CA 1.508 2.33 0 CA-C-N 120.539 1.228 . . . . 0.0 110.58 -0.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.8 p 60.3 23.15 12.6 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.165 177.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 39.7 p -131.93 139.63 48.77 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.5 m -152.36 151.92 11.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -96.19 134.01 39.8 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 44.7 t -126.1 127.08 70.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -104.95 124.38 49.41 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 58.7 mt -108.01 108.68 19.9 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -90.16 129.63 36.41 Favored 'General case' 0 C--O 1.231 0.105 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 38.6 t -104.14 131.36 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 39.9 m -101.18 120.42 40.21 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 91.3 mm-40 . . . . . 0 C--N 1.333 -0.126 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -179.789 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 53.4 mt . . . . . 0 N--CA 1.464 0.268 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 95.8 p -160.58 150.31 17.59 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.8 mtpt -151.11 164.98 35.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.619 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 35.0 m -114.18 137.1 52.2 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.634 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.3 m -126.68 101.67 26.67 Favored Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 123.588 0.755 . . . . 0.0 109.051 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -57.02 144.53 89.42 Favored 'Trans proline' 0 N--CA 1.499 1.803 0 CA-C-N 120.342 1.158 . . . . 0.0 111.939 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 23.3 t -89.41 130.93 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.1 ttmm -117.33 126.95 53.55 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.6 mt -101.82 127.95 48.4 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -115.23 109.95 18.73 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.9 pp -64.19 129.23 39.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.154 -0.476 . . . . 0.0 109.736 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 31.6 m -126.07 135.66 52.0 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 115.23 162.66 13.68 Favored Glycine 0 N--CA 1.476 1.367 0 N-CA-C 110.581 -1.007 . . . . 0.0 110.581 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.0 p-10 -82.64 142.18 31.92 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -66.7 134.34 52.03 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.68 176.63 0.64 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.23 0.538 . . . . 0.0 111.143 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.8 t -85.75 -23.98 27.08 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.099 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -91.32 -13.14 33.12 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -178.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.5 p -98.56 128.25 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 CA-C-O 120.79 0.328 . . . . 0.0 110.875 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 46.7 t -92.09 -37.31 12.85 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.839 0.352 . . . . 0.0 110.122 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 98.3 p -161.21 159.16 28.46 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.151 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 73.9 mt -133.78 142.53 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 65.0 p -135.01 159.12 42.52 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.288 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -145.7 155.85 43.25 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.083 0.468 . . . . 0.0 110.182 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 47.7 t -147.4 163.46 36.41 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.254 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -146.46 143.76 29.2 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.288 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -69.27 -34.36 74.63 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.984 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -135.91 -51.27 0.72 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.014 0.526 . . . . 0.0 109.96 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.84 24.03 61.99 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.439 ' ND1' ' O ' ' A' ' 36' ' ' HIS . 17.8 p80 -148.69 139.68 23.04 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.211 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 28.4 m -131.6 164.51 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 61.4 m -99.71 133.55 43.89 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 37.9 pt -118.82 147.5 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 122.854 0.462 . . . . 0.0 110.25 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.2 t -132.13 135.6 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.399 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 170.97 -163.08 36.09 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 30.8 t -72.33 147.4 46.35 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 70.8 tp60 -58.8 -38.19 78.05 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.603 0.24 . . . . 0.0 111.117 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.445 ' CD ' ' H ' ' A' ' 44' ' ' GLU . 23.6 mp0 -59.84 -48.02 83.37 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.878 0.37 . . . . 0.0 110.793 -179.104 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.99 -37.9 86.57 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.738 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 21.2 mmt -65.79 -39.54 91.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.006 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -61.1 -31.98 71.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.609 0.242 . . . . 0.0 110.818 -178.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -71.55 -39.08 70.9 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.776 0.322 . . . . 0.0 110.316 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 57.5 mt -85.54 117.53 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -113.46 -19.52 11.65 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.184 0.593 . . . . 0.0 110.578 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 66.5 p -174.1 161.56 3.63 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.694 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 38.1 mm -111.4 117.85 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 48.2 m -105.51 124.44 49.55 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 36.1 t -127.17 113.44 21.62 Favored Pre-proline 0 N--CA 1.482 1.169 0 CA-C-O 118.446 -0.788 . . . . 0.0 109.792 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -76.81 143.62 23.73 Favored 'Trans proline' 0 N--CA 1.497 1.678 0 CA-C-N 121.254 1.484 . . . . 0.0 110.755 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.8 t -129.31 126.79 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -73.67 126.47 30.4 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.69 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 39.1 pt -102.69 -15.74 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 122.82 0.448 . . . . 0.0 110.912 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.8 t -61.39 -40.32 93.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.594 -178.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -83.3 -5.78 59.25 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 122.374 0.27 . . . . 0.0 110.616 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 47.4 t -91.2 108.45 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 70.6 p -129.88 1.51 4.84 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.636 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -141.95 146.79 36.05 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 21.2 p-10 -63.88 137.12 57.89 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.103 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.431 ' OG1' ' N ' ' A' ' 66' ' ' SER . 5.6 t -168.14 -173.43 2.03 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.265 0.555 . . . . 0.0 110.709 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.431 ' N ' ' OG1' ' A' ' 65' ' ' THR . 90.2 p -147.25 143.35 28.07 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.45 179.228 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -138.45 142.38 39.47 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.0 0.429 . . . . 0.0 110.238 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 44.6 m -82.1 131.89 35.24 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.5 mt -111.75 111.71 22.88 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 122.659 0.384 . . . . 0.0 110.29 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -83.77 126.37 32.85 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 31.8 mt -103.74 134.74 46.55 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 120.792 0.329 . . . . 0.0 110.597 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -134.94 142.06 46.42 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.084 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -145.41 135.27 23.59 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -85.5 117.73 24.58 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.328 0.585 . . . . 0.0 111.848 -178.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.61 -16.02 16.86 Favored Glycine 0 N--CA 1.482 1.704 0 CA-C-N 114.574 -1.194 . . . . 0.0 112.208 178.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 23.3 m -133.04 159.22 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 56.9 m -107.95 117.73 34.9 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.1 p -105.85 133.52 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 122.938 0.495 . . . . 0.0 109.741 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -158.81 143.67 11.69 Favored Pre-proline 0 CA--C 1.552 1.046 0 CA-C-O 119.078 -0.487 . . . . 0.0 110.654 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.413 ' C ' ' H ' ' A' ' 82' ' ' THR . 87.8 Cg_endo -70.2 -12.13 12.96 Favored 'Cis proline' 0 N--CA 1.516 2.815 0 CA-C-N 120.646 1.266 . . . . 0.0 110.998 0.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 67.6 -6.87 0.62 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.839 177.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.413 ' H ' ' C ' ' A' ' 80' ' ' PRO . 59.0 p -100.31 139.51 35.88 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.8 m -147.92 146.14 18.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -95.23 130.89 41.8 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 44.0 t -126.6 126.04 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -100.09 124.64 45.72 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 59.8 mt -110.41 104.16 12.89 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -92.81 128.88 38.83 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.4 p -107.83 137.08 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.627 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 69.9 m -100.24 121.5 41.56 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 95.4 mm-40 . . . . . 0 N--CA 1.468 0.44 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.985 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 58.6 mt . . . . . 0 N--CA 1.467 0.399 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.0 t -151.67 145.68 25.24 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.567 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -149.64 167.51 26.19 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.565 -178.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 30.5 m -109.48 139.06 44.92 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.059 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.5 m -131.84 95.03 23.48 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 123.625 0.77 . . . . 0.0 109.313 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -58.39 146.19 90.95 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 C-N-CA 121.207 1.272 . . . . 0.0 112.144 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.4 p -98.25 142.1 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.242 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -121.27 133.87 55.15 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 78.3 mt -100.06 128.54 46.13 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -113.47 111.89 22.7 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 56.5 mt -70.28 126.13 28.77 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.1 p -129.31 145.38 51.38 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.956 -0.386 . . . . 0.0 109.956 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.02 168.33 16.39 Favored Glycine 0 N--CA 1.474 1.199 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.6 p-10 -84.75 132.58 34.42 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -64.49 135.93 56.55 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.54 176.06 3.12 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.577 0.703 . . . . 0.0 110.991 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 74.6 m -84.31 -20.75 31.57 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.299 -178.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -90.27 -19.83 23.65 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 122.461 0.304 . . . . 0.0 111.037 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.6 p -97.18 128.31 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-O 120.576 0.227 . . . . 0.0 110.469 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.5 t -103.39 -26.99 12.7 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 120.823 0.345 . . . . 0.0 110.188 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 48.1 t -160.81 154.21 21.9 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.907 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 86.0 mt -129.92 135.79 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.9 p -133.59 154.79 50.6 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -148.42 159.16 44.31 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.409 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.1 t -146.35 168.37 21.29 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.008 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -146.41 149.61 34.06 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.952 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -68.12 -33.54 74.69 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.56 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -150.27 -38.96 0.14 Allowed 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.172 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.422 ' O ' ' ND1' ' A' ' 36' ' ' HIS . . . 55.95 25.86 46.69 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 178.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.422 ' ND1' ' O ' ' A' ' 35' ' ' GLY . 15.3 m-70 -138.0 137.32 37.78 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 31.4 m -129.88 160.93 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 35.5 m -102.88 133.78 47.4 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 38.1 pt -117.8 146.44 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 122.758 0.423 . . . . 0.0 110.326 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.7 t -132.86 134.51 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.786 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 168.5 -159.44 32.6 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 95.0 p -72.63 151.62 42.2 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.647 0.26 . . . . 0.0 110.301 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.8 tm0? -63.35 -36.9 85.22 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.763 0.316 . . . . 0.0 110.237 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.477 ' CD ' ' H ' ' A' ' 44' ' ' GLU . 24.9 mp0 -60.55 -53.71 54.24 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.137 -178.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.51 -40.21 96.01 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.909 0.385 . . . . 0.0 110.88 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 88.3 mtp -66.85 -39.61 87.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.702 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -61.79 -34.31 75.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.478 0.18 . . . . 0.0 111.395 -178.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -68.95 -35.26 76.56 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.749 0.309 . . . . 0.0 110.383 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 63.6 mt -85.67 120.1 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -119.42 -16.67 8.92 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 122.968 0.507 . . . . 0.0 110.404 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 68.9 p -172.29 167.5 5.78 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.45 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 81.6 mt -126.73 128.04 70.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.9 t -104.68 132.4 50.97 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 179.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 38.7 t -133.23 90.63 29.83 Favored Pre-proline 0 N--CA 1.473 0.696 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -58.12 142.24 96.92 Favored 'Trans proline' 0 N--CA 1.501 1.955 0 C-N-CA 121.663 1.575 . . . . 0.0 112.026 178.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 60.3 t -128.67 128.7 68.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -77.53 123.18 26.25 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 38.0 pt -99.63 -10.99 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 122.705 0.402 . . . . 0.0 110.697 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 39.4 t -61.66 -40.13 93.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.461 -178.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -85.23 -5.5 59.32 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 122.748 0.419 . . . . 0.0 110.394 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 46.4 t -91.94 106.99 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 71.5 p -131.03 2.66 4.33 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.703 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -147.2 146.07 29.71 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.936 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -52.33 135.21 33.24 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.453 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.417 ' OG1' ' N ' ' A' ' 66' ' ' SER . 7.0 t -167.95 -173.95 2.24 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.095 0.474 . . . . 0.0 110.863 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.417 ' N ' ' OG1' ' A' ' 65' ' ' THR . 61.8 p -150.92 148.73 28.78 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.101 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -143.54 144.15 31.83 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.225 0.536 . . . . 0.0 111.076 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 t -85.85 132.5 34.09 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.509 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 70.7 mt -115.97 120.63 39.79 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.806 0.443 . . . . 0.0 110.592 -179.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -84.87 133.06 34.32 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.265 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.1 mt -113.61 115.29 27.68 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -134.09 151.43 51.39 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -148.43 143.72 26.95 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -85.23 117.4 24.16 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.355 0.598 . . . . 0.0 111.343 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 118.24 -18.33 11.23 Favored Glycine 0 N--CA 1.481 1.658 0 CA-C-N 114.714 -1.13 . . . . 0.0 112.046 178.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.2 m -133.31 160.96 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 56.5 m -103.55 111.66 24.22 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.1 t -91.12 128.6 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -149.81 143.45 16.72 Favored Pre-proline 0 CA--C 1.553 1.085 0 CA-C-O 119.062 -0.494 . . . . 0.0 110.075 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -72.86 -1.23 11.74 Favored 'Cis proline' 0 N--CA 1.511 2.507 0 CA-C-N 120.906 1.359 . . . . 0.0 110.364 0.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.4 t 56.03 22.08 5.58 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.357 -1.292 . . . . 0.0 111.771 178.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 34.9 p -138.0 139.57 39.72 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.4 m -148.79 154.75 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -103.38 132.61 49.5 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 43.0 t -128.93 125.69 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.023 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -102.21 125.71 48.98 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 65.4 mt -107.54 111.2 23.35 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -95.5 126.57 40.88 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.6 m -96.52 137.6 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 44.1 m -100.61 116.41 32.46 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.154 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 95.3 mm-40 . . . . . 0 N--CA 1.467 0.408 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 -179.453 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 54.7 mt . . . . . 0 N--CA 1.466 0.354 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.7 t -160.35 143.26 13.4 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.629 ' HE2' HE22 ' A' ' 43' ' ' GLN . 64.0 mttp -149.75 166.62 28.87 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -178.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.0 m -121.75 137.83 54.6 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.898 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.7 m -123.38 143.88 42.44 Favored Pre-proline 0 N--CA 1.486 1.362 0 C-N-CA 122.691 0.396 . . . . 0.0 110.022 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -74.37 142.24 29.72 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 121.429 1.419 . . . . 0.0 111.6 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.9 t -103.52 134.61 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -127.77 148.02 50.43 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 51.8 mt -112.37 137.88 49.91 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.466 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -119.32 110.27 16.79 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.433 ' N ' HD12 ' A' ' 17' ' ' LEU . 9.4 mp -70.52 130.87 43.01 Favored 'General case' 0 C--N 1.334 -0.085 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.8 p -130.03 143.11 50.62 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.7 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.62 170.0 16.48 Favored Glycine 0 N--CA 1.475 1.265 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.8 p-10 -87.06 132.92 33.67 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -65.93 133.65 51.31 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.51 145.47 54.91 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.05 0.452 . . . . 0.0 110.629 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 61.0 m -63.68 -18.33 63.88 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.982 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -84.76 -20.87 30.37 Favored 'General case' 0 C--N 1.343 0.314 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.8 t -107.24 127.48 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-O 121.093 0.473 . . . . 0.0 110.276 -178.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 47.5 t -87.18 -40.7 14.35 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.34 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 47.1 t -155.47 161.31 40.98 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.499 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 82.6 mt -131.4 142.6 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.782 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.3 m -130.41 154.17 47.98 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.283 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -144.68 156.34 44.04 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.134 0.492 . . . . 0.0 110.096 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 45.4 m -148.09 166.52 27.57 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.154 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -146.1 142.49 28.58 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.959 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 33' ' ' ASP . 21.3 p-10 -73.35 -34.23 65.5 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.645 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -126.43 -56.79 1.4 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.111 0.564 . . . . 0.0 110.483 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 59.9 18.64 47.67 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -144.82 136.69 25.75 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.1 m -132.99 163.28 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 44.0 m -102.51 137.37 40.84 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 34.9 pt -117.41 150.44 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.2 p -130.27 134.69 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 123.332 0.395 . . . . 0.0 110.379 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 166.86 -160.75 34.49 Favored Glycine 0 C--N 1.328 0.113 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 44.6 t -77.43 157.04 30.73 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.629 HE22 ' HE2' ' A' ' 9' ' ' LYS . 52.2 tp60 -62.81 -35.36 79.64 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -61.75 -44.35 97.07 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.662 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.09 -39.91 95.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.816 0.341 . . . . 0.0 110.754 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 68.6 mtt -66.22 -38.64 88.42 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.418 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -61.08 -31.81 71.48 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.754 -0.203 . . . . 0.0 110.948 -179.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -73.64 -40.37 63.81 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.792 0.329 . . . . 0.0 110.511 179.168 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 67.0 mt -81.2 116.66 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -112.34 -23.35 10.4 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.248 0.619 . . . . 0.0 109.604 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 98.0 p -170.78 161.67 7.37 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.525 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 77.7 mt -112.53 121.43 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 33.6 m -99.08 130.72 45.42 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.4 t -134.26 93.0 20.07 Favored Pre-proline 0 N--CA 1.475 0.825 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -77.33 145.52 24.06 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 121.118 1.212 . . . . 0.0 111.31 -178.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.1 t -132.21 130.2 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-O 121.113 0.482 . . . . 0.0 110.235 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.9 p-10 -70.43 126.45 29.67 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.921 179.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 34.8 pt -100.02 -13.03 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 120.791 0.329 . . . . 0.0 110.661 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 44.7 m -59.39 -39.12 82.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.332 -178.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -84.65 -6.92 59.39 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 122.744 0.418 . . . . 0.0 110.39 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 42.6 t -93.54 114.48 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 65.4 p -133.48 4.92 3.7 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.158 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -152.66 161.74 42.17 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.846 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -62.36 138.7 58.49 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.953 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.2 t -166.03 170.46 13.55 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.293 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 46.7 m -148.11 140.69 24.5 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.761 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 54.5 pttt -146.63 145.08 29.93 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.488 0.661 . . . . 0.0 110.926 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 33.2 m -81.55 136.76 35.59 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.084 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 70.3 mt -115.89 125.96 53.3 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 122.79 0.436 . . . . 0.0 110.19 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.514 ' CD ' ' HZ3' ' A' ' 72' ' ' LYS . 16.1 pt-20 -92.42 132.16 37.0 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 30.8 mt -107.67 129.77 54.98 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.514 ' HZ3' ' CD ' ' A' ' 70' ' ' GLU . 63.3 mttp -131.15 141.44 50.09 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -139.49 142.14 37.33 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -86.02 133.03 33.93 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 122.21 1.005 . . . . 0.0 112.362 -178.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.05 -15.03 63.83 Favored Glycine 0 N--CA 1.472 1.049 0 CA-C-N 113.564 -1.653 . . . . 0.0 112.149 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 11.1 m -131.55 164.36 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 16.2 m -112.28 112.79 24.62 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.0 t -89.53 132.4 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -155.44 144.38 14.92 Favored Pre-proline 0 CA--C 1.557 1.238 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.858 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.46 -10.79 13.05 Favored 'Cis proline' 0 N--CA 1.514 2.732 0 CA-C-N 120.579 1.242 . . . . 0.0 110.639 0.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 10.4 p 58.21 23.68 10.56 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 114.652 -1.158 . . . . 0.0 112.129 177.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 34.6 p -132.88 139.38 47.38 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.6 m -152.89 154.97 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -94.75 134.74 37.03 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 44.8 t -127.85 130.62 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -111.24 124.23 51.8 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 53.0 mt -108.43 108.86 19.99 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -91.63 128.46 37.47 Favored 'General case' 0 C--O 1.231 0.111 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 43.3 t -102.97 132.61 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 61.8 m -100.31 117.87 35.4 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 . . . . . 0 N--CA 1.462 0.152 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.477 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 34.5 tp . . . . . 0 N--CA 1.467 0.382 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 35.9 m -161.3 140.61 10.24 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -149.25 165.84 30.69 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -178.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 92.5 p -117.16 138.08 51.91 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.903 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.5 m -126.56 143.42 46.23 Favored Pre-proline 0 N--CA 1.482 1.162 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.92 142.4 28.05 Favored 'Trans proline' 0 N--CA 1.501 1.914 0 C-N-CA 121.604 1.536 . . . . 0.0 111.931 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.9 p -95.29 134.51 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.5 mptm? -108.73 133.55 52.65 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.107 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.5 tp -104.9 130.42 53.06 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -124.36 111.77 16.17 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.9 pp -69.6 131.11 44.13 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.3 p -125.44 134.95 51.91 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.64 163.88 14.55 Favored Glycine 0 N--CA 1.477 1.417 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.2 p-10 -78.95 136.8 37.35 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -66.81 138.11 57.11 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.42 141.43 58.36 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.206 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.0 t -68.03 -20.87 65.03 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.642 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -94.25 4.71 53.51 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 122.237 0.215 . . . . 0.0 110.914 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 68.6 t -118.42 126.2 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.3 t -73.71 -45.76 50.25 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.069 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 45.6 t -161.1 165.44 29.61 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.175 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 80.1 mt -131.77 144.96 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 99.8 p -135.78 163.37 30.36 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.467 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -144.2 160.13 41.48 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.498 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 61.7 p -148.58 162.87 38.81 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.884 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -146.3 143.9 29.46 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.974 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -72.72 -35.09 67.5 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.682 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -126.61 -54.71 1.43 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 122.95 0.5 . . . . 0.0 110.571 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 62.11 24.23 64.88 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.455 ' ND1' ' O ' ' A' ' 36' ' ' HIS . 15.7 p80 -151.95 138.91 19.04 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 28.9 m -131.29 162.27 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 49.3 m -100.87 134.37 43.95 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 20.4 pt -114.34 145.08 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 49.1 t -127.5 133.54 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 170.47 -162.2 35.28 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.5 m -75.32 160.14 30.66 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.9 tp-100 -63.97 -40.14 95.72 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.576 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -65.1 -36.58 84.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.829 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.08 -41.64 90.45 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.783 0.325 . . . . 0.0 111.038 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 68.3 mtt -68.81 -35.96 77.64 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.728 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -60.57 -32.96 72.02 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.519 0.2 . . . . 0.0 110.911 -178.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -73.61 -38.28 65.14 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.839 0.352 . . . . 0.0 110.354 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 68.7 mt -86.27 117.37 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -114.89 -16.7 11.68 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 122.919 0.488 . . . . 0.0 110.108 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 73.4 p -171.49 169.12 6.26 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.809 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 87.9 mt -122.67 124.0 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 33.6 m -89.38 132.15 35.1 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 43.1 t -131.19 91.7 34.96 Favored Pre-proline 0 N--CA 1.476 0.844 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -80.77 140.74 13.14 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 121.597 1.531 . . . . 0.0 111.364 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 49.1 t -131.9 130.87 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.918 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -74.83 124.75 27.42 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 37.6 pt -102.01 -11.86 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 122.795 0.438 . . . . 0.0 110.639 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.7 m -60.53 -38.72 85.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.39 -178.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -86.75 -2.74 58.79 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 45.1 t -97.33 120.72 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.2 t -135.87 6.3 3.15 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.293 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -155.3 171.95 19.0 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.422 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.7 p-10 -65.81 126.45 28.52 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.464 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.0 p -145.58 165.78 27.67 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.899 0.38 . . . . 0.0 110.043 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 90.2 p -150.65 129.36 12.34 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.524 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -140.08 145.97 38.34 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.23 0.538 . . . . 0.0 110.888 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 37.8 m -81.68 134.69 35.49 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.596 178.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.0 mt -118.22 126.24 51.77 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.866 0.467 . . . . 0.0 109.87 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -94.16 135.61 35.35 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.9 mt -106.96 134.84 49.5 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.887 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -134.21 143.77 48.04 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -143.59 137.7 28.55 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -85.77 121.23 28.14 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.256 0.551 . . . . 0.0 112.027 -178.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.71 -13.76 38.56 Favored Glycine 0 N--CA 1.48 1.628 0 CA-C-N 114.571 -1.195 . . . . 0.0 112.305 178.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 18.9 m -133.83 161.43 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 46.7 m -110.77 120.55 42.78 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.6 p -109.52 135.46 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -158.82 144.6 12.21 Favored Pre-proline 0 CA--C 1.551 1.005 0 CA-C-O 119.307 -0.378 . . . . 0.0 110.576 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.407 ' C ' ' H ' ' A' ' 82' ' ' THR . 79.9 Cg_endo -70.57 -12.56 13.82 Favored 'Cis proline' 0 N--CA 1.512 2.571 0 CA-C-N 120.247 1.124 . . . . 0.0 110.82 0.202 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 p 66.99 -3.51 0.94 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.17 177.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.407 ' H ' ' C ' ' A' ' 80' ' ' PRO . 57.4 p -98.71 140.01 33.56 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.2 m -149.5 144.65 17.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -94.59 132.6 39.12 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 47.4 t -126.35 128.56 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -110.31 123.38 49.71 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 58.3 mt -105.63 120.54 41.93 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm -104.09 126.49 51.25 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 42.4 t -103.77 133.81 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.263 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 70.6 p -96.63 124.04 40.5 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 93.9 mm-40 . . . . . 0 N--CA 1.467 0.397 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 -179.04 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.509 HD12 ' OE1' ' A' ' 43' ' ' GLN . 3.8 mm? . . . . . 0 CA--C 1.518 -0.258 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 91.1 p -160.52 133.77 6.69 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.488 ' CE ' HE22 ' A' ' 43' ' ' GLN . 67.6 mttm -147.83 166.81 26.47 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.355 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 41.2 t -120.85 136.78 54.83 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.073 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.1 m -122.57 126.25 26.2 Favored Pre-proline 0 CA--C 1.561 1.369 0 CA-C-O 119.034 -0.508 . . . . 0.0 109.772 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -59.29 146.85 93.42 Favored 'Trans proline' 0 N--CA 1.506 2.212 0 CA-C-N 121.664 1.63 . . . . 0.0 111.816 178.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.1 t -96.31 132.31 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -125.2 127.96 47.59 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.0 mp -96.26 135.52 37.97 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -116.82 107.4 14.58 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 57.2 mt -67.32 124.6 23.6 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 28.8 m -117.07 128.72 55.43 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.68 -164.3 12.09 Favored Glycine 0 N--CA 1.473 1.138 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -119.58 147.83 44.03 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 115.005 -0.598 . . . . 0.0 109.817 178.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -68.69 139.68 55.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.078 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.49 151.56 44.03 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.48 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.1 t -63.18 -22.08 66.63 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.194 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -83.67 -21.78 32.32 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.7 t -105.02 126.64 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 121.071 0.463 . . . . 0.0 109.964 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.9 m -88.12 -32.48 18.66 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.149 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 94.1 p -155.82 159.65 39.57 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.202 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 81.7 mt -127.52 134.49 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.523 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.6 m -126.1 150.45 48.2 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -139.31 152.25 47.08 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.04 0.448 . . . . 0.0 109.936 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 93.1 p -150.5 152.18 33.81 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.69 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -147.41 147.87 30.71 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.061 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -69.55 -36.09 76.02 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.738 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -139.67 129.38 24.56 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -117.44 27.96 7.39 Favored Glycine 0 N--CA 1.474 1.194 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 40.7 p-80 -145.63 139.41 26.6 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 29.4 m -131.2 161.28 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 49.9 m -103.79 134.29 47.36 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 38.1 pt -116.86 146.38 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 123.12 0.568 . . . . 0.0 109.664 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 52.1 t -132.69 134.21 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 165.49 -158.98 32.05 Favored Glycine 0 N--CA 1.466 0.667 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.4 t -67.4 149.23 50.55 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.509 ' OE1' HD12 ' A' ' 7' ' ' LEU . 71.3 tp60 -64.86 -38.35 90.68 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.379 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -62.01 -39.1 91.13 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.807 0.337 . . . . 0.0 110.6 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.36 -39.55 92.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.675 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 68.6 mtt -66.41 -40.56 89.65 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.579 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -64.3 -24.93 67.83 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.595 0.236 . . . . 0.0 110.547 -179.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -76.26 -37.71 57.22 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 69.7 mt -83.11 117.41 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -99.94 -26.51 13.97 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.328 0.585 . . . . 0.0 109.875 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 96.8 p -171.05 164.11 7.44 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.087 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 41.4 mm -106.26 118.84 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.658 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.4 t -87.85 134.18 33.75 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 38.6 t -132.39 89.0 37.88 Favored Pre-proline 0 N--CA 1.473 0.683 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -81.64 146.41 15.06 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 121.485 1.457 . . . . 0.0 111.54 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.6 p -139.69 136.49 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.857 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -76.47 126.21 30.58 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 20.8 pt -109.71 -2.94 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 122.706 0.402 . . . . 0.0 110.39 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 91.3 p -80.66 -15.07 57.5 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.58 -178.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -102.75 -11.35 18.42 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.126 0.571 . . . . 0.0 110.778 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.9 m -101.34 131.2 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 68.7 p -137.19 11.71 3.04 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.635 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -147.6 145.95 29.2 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.764 -178.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -56.82 136.18 55.56 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.519 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.409 ' OG1' ' N ' ' A' ' 66' ' ' SER . 5.1 t -167.31 -177.28 3.58 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.555 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.409 ' N ' ' OG1' ' A' ' 65' ' ' THR . 47.3 t -149.55 145.99 27.11 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.058 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -148.02 143.53 27.3 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.362 0.601 . . . . 0.0 110.967 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 35.0 m -82.03 135.82 35.3 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.818 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 89.3 mt -119.8 129.58 54.51 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.075 0.55 . . . . 0.0 110.25 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -94.68 134.9 36.76 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 47.4 mt -108.24 133.95 51.77 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.034 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -139.14 147.1 41.46 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -147.62 139.91 24.44 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.408 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.3 mp0 -86.72 117.43 25.47 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.454 0.645 . . . . 0.0 112.037 -178.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 116.44 -16.71 14.48 Favored Glycine 0 N--CA 1.48 1.597 0 CA-C-N 114.221 -1.354 . . . . 0.0 111.74 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.1 m -134.73 160.33 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 50.5 m -105.63 112.51 25.62 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.4 t -89.73 132.05 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -156.13 140.43 11.75 Favored Pre-proline 0 CA--C 1.552 1.035 0 CA-C-O 119.07 -0.49 . . . . 0.0 110.882 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -70.16 -10.66 12.4 Favored 'Cis proline' 0 N--CA 1.513 2.671 0 CA-C-N 120.788 1.317 . . . . 0.0 111.042 0.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.0 p 58.22 19.36 6.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.704 -1.135 . . . . 0.0 112.029 177.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.1 p -130.16 140.29 50.78 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.019 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.5 m -151.46 154.17 8.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -101.96 132.8 47.57 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.04 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.3 p -128.85 132.04 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 121.164 0.506 . . . . 0.0 109.935 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -106.28 125.98 51.67 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.871 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 57.6 mt -109.38 108.99 19.73 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -92.95 128.87 38.97 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 33.7 m -91.49 137.42 21.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.226 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 26.3 m -104.11 109.72 21.63 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 . . . . . 0 N--CA 1.468 0.466 0 N-CA-C 110.559 -0.163 . . . . 0.0 110.559 -178.754 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 50.9 mt . . . . . 0 CA--C 1.518 -0.257 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.3 t -153.46 156.56 38.39 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.932 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.8 tptt -155.5 164.19 39.01 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.746 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 87.8 p -127.9 137.42 52.3 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.186 -0.915 . . . . 0.0 108.668 179.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.1 m -131.19 144.52 53.82 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.595 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -74.39 144.43 32.61 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 121.864 1.709 . . . . 0.0 111.505 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.5 m -96.73 145.72 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -122.15 139.4 53.79 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.6 mp -113.82 135.96 53.39 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -121.88 118.53 29.15 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.74 0.65 . . . . 0.0 109.262 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 51.3 mt -72.56 126.32 29.59 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 79.9 p -119.24 128.59 54.33 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.98 160.31 13.53 Favored Glycine 0 N--CA 1.47 0.929 0 N-CA-C 110.414 -1.075 . . . . 0.0 110.414 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -84.15 145.48 28.37 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 178.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -65.05 137.58 57.79 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.298 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.91 159.57 25.3 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.981 0.419 . . . . 0.0 110.446 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.4 t -71.49 -30.45 65.99 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.559 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -83.62 -11.06 57.77 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 122.156 0.182 . . . . 0.0 111.176 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 64.2 t -108.5 130.06 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 36.1 m -87.19 -41.79 13.47 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.936 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 45.0 t -159.23 160.51 35.41 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.301 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 76.5 mt -132.15 143.57 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.576 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.4 m -130.86 158.1 41.1 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.186 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -142.51 152.47 42.69 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.867 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 45.7 t -151.93 162.82 40.46 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.759 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -143.87 147.38 33.96 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.035 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -72.49 -33.8 67.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.366 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -135.43 -52.38 0.76 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 122.57 0.348 . . . . 0.0 110.251 -179.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.82 28.23 60.19 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 51.5 m-70 -140.96 137.33 32.98 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.6 m -129.66 161.17 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 27.7 m -103.16 138.91 39.35 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 34.3 pt -119.54 147.89 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.484 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 48.6 t -130.4 134.71 61.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.738 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 162.38 -158.47 30.57 Favored Glycine 0 N--CA 1.462 0.413 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 56.4 m -76.11 149.59 37.37 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 29.2 mm100 -62.38 -29.92 70.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.451 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -61.76 -47.96 82.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.47 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.45 -38.45 91.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.631 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 68.1 mtt -65.99 -39.57 90.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.494 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -62.45 -30.74 71.46 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.555 0.216 . . . . 0.0 110.773 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -74.68 -36.98 62.78 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.717 0.294 . . . . 0.0 110.691 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 68.6 mt -89.13 117.5 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -108.24 -21.42 12.78 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.109 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 93.9 p -170.32 159.19 7.04 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.887 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 72.6 mt -109.44 128.04 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.6 m -89.33 131.67 35.3 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.6 t -128.57 90.37 46.69 Favored Pre-proline 0 CA--C 1.542 0.659 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 178.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -81.8 147.84 15.42 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 122.175 1.916 . . . . 0.0 111.297 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.3 p -142.84 136.17 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.077 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -75.62 129.64 37.49 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 35.1 pt -104.69 -11.04 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 O-C-N 123.299 0.374 . . . . 0.0 110.304 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 80.6 p -61.18 -39.3 89.64 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.143 -178.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -86.5 -5.01 59.26 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 122.534 0.334 . . . . 0.0 110.402 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 42.6 t -94.65 117.62 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 58.0 p -134.56 2.05 3.17 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.025 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -147.38 156.52 42.97 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.992 0.425 . . . . 0.0 110.253 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -63.73 136.99 57.89 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.006 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.1 t -166.82 177.49 6.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.163 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 44.1 t -144.01 140.37 29.54 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.408 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -139.28 143.3 37.86 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.108 0.48 . . . . 0.0 110.518 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 28.1 m -83.74 132.52 34.84 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.8 mt -119.69 129.85 54.74 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.451 ' CD ' ' HZ1' ' A' ' 72' ' ' LYS . 19.5 pt-20 -97.81 137.19 37.05 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 43.3 mt -113.49 136.69 52.52 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.451 ' HZ1' ' CD ' ' A' ' 70' ' ' GLU . 63.0 mttp -132.82 140.96 48.22 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -135.55 143.48 45.72 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -85.99 135.62 33.58 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.819 0.818 . . . . 0.0 111.907 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.82 -28.25 8.01 Favored Glycine 0 N--CA 1.476 1.345 0 CA-C-N 114.303 -1.317 . . . . 0.0 112.732 178.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.5 m -118.9 163.45 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 34.0 m -109.48 116.22 31.39 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.0 t -93.81 131.66 40.13 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -157.69 141.39 11.33 Favored Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.703 178.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.54 -12.3 11.72 Favored 'Cis proline' 0 N--CA 1.506 2.239 0 CA-C-N 119.814 0.969 . . . . 0.0 110.051 -0.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.2 p 61.99 23.43 13.8 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.637 177.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 39.3 p -131.01 138.72 49.78 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 24.0 m -151.11 149.76 13.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -95.92 133.51 40.02 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.062 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.6 p -128.12 133.09 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -107.52 127.37 53.56 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 39.5 mt -111.06 106.51 15.6 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -89.35 129.63 35.85 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 18.6 t -106.55 132.88 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 31.5 m -100.33 121.03 40.84 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 . . . . . 0 N--CA 1.465 0.307 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -179.387 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 57.2 mt . . . . . 0 N--CA 1.469 0.516 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 95.3 p -147.92 151.07 35.22 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.721 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -146.67 165.09 30.61 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.671 0.748 . . . . 0.0 109.6 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 92.6 p -112.04 136.22 51.68 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 114.004 -1.453 . . . . 0.0 109.918 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.4 m -134.33 99.38 13.31 Favored Pre-proline 0 CA--C 1.544 0.749 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -179.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -57.56 148.23 74.31 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 CA-C-N 120.191 1.104 . . . . 0.0 111.591 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 15.9 t -86.14 132.83 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -113.26 123.34 49.94 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.2 mp -96.27 131.71 42.49 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -120.07 107.73 13.41 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 178.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.9 pp -68.46 129.36 39.7 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.27 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.4 p -130.86 141.7 50.33 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 122.984 0.514 . . . . 0.0 109.645 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.85 168.24 16.49 Favored Glycine 0 N--CA 1.474 1.178 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -86.29 134.76 33.73 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -65.4 137.44 57.49 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.91 173.36 1.08 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.501 0.667 . . . . 0.0 111.32 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 35.2 t -84.71 -23.28 29.4 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.116 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -88.46 -13.65 39.84 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.406 HG13 ' O ' ' A' ' 25' ' ' VAL . 7.1 p -102.28 126.02 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-O 121.169 0.509 . . . . 0.0 112.039 -177.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 38.3 t -91.01 -31.01 16.48 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.35 179.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.7 t -159.75 158.13 30.68 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.47 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 85.9 mt -127.88 136.38 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.586 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.9 t -130.54 153.22 49.08 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -147.22 155.62 42.24 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.115 0.483 . . . . 0.0 110.562 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 50.4 m -146.6 160.09 42.61 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.879 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -140.81 143.1 34.63 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.812 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -71.87 -34.02 68.85 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.757 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.401 ' O ' ' ND1' ' A' ' 36' ' ' HIS . 99.6 mtt180 -128.13 -55.95 1.26 Allowed 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 121.194 0.521 . . . . 0.0 110.132 -179.104 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.23 22.64 58.69 Favored Glycine 0 CA--C 1.523 0.555 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.536 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.401 ' ND1' ' O ' ' A' ' 34' ' ' ARG . 12.8 p-80 -149.93 138.73 20.91 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.481 HG22 ' N ' ' A' ' 38' ' ' THR . 3.3 p -127.89 163.32 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.481 ' N ' HG22 ' A' ' 37' ' ' VAL . 52.0 m -100.22 132.6 45.49 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.905 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.5 pt -114.84 134.4 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 123.363 0.665 . . . . 0.0 109.304 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.6 t -124.47 133.5 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 163.9 -154.47 25.37 Favored Glycine 0 N--CA 1.468 0.826 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.4 m -69.66 145.41 52.42 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 70.6 tp60 -62.96 -34.49 77.61 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.615 0.245 . . . . 0.0 110.367 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -61.55 -41.44 97.37 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.638 0.256 . . . . 0.0 110.791 -179.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.91 -37.9 89.11 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.777 0.322 . . . . 0.0 110.717 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 66.7 mtt -64.77 -39.78 94.17 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.447 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -63.79 -30.78 71.84 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.539 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -73.92 -40.73 62.91 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.776 0.322 . . . . 0.0 110.66 179.086 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 58.7 mt -84.8 117.63 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -178.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -114.21 -17.67 11.81 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.04 0.536 . . . . 0.0 110.826 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 73.4 p -174.13 132.74 0.41 Allowed 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.941 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 42.4 mm -83.04 124.08 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 32.5 m -91.55 126.26 36.58 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.4 t -133.46 91.35 26.85 Favored Pre-proline 0 N--CA 1.474 0.774 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -82.01 145.13 13.84 Favored 'Trans proline' 0 N--CA 1.5 1.881 0 C-N-CA 121.672 1.581 . . . . 0.0 111.617 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 60.8 t -129.71 129.13 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.021 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -68.58 125.04 25.25 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.7 pt -99.93 -12.83 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-O 120.847 0.356 . . . . 0.0 110.526 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.5 m -60.17 -38.72 84.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.554 -178.321 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -86.2 -4.1 59.1 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 122.557 0.343 . . . . 0.0 110.335 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 46.9 t -94.22 111.79 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 60.3 p -128.57 2.87 5.55 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.617 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -152.45 163.03 40.34 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.575 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -64.39 136.64 57.31 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.204 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.7 t -166.36 177.95 6.47 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.585 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 99.1 p -149.71 144.25 25.97 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.818 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -143.51 143.36 31.52 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-O 121.228 0.537 . . . . 0.0 110.476 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 51.4 m -81.75 131.85 35.27 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 64.8 mt -117.39 120.42 38.1 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.823 0.449 . . . . 0.0 109.857 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -84.24 133.64 34.57 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 50.8 mt -102.75 133.79 47.21 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 122.598 0.359 . . . . 0.0 110.047 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -136.17 141.06 44.03 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 122.957 0.503 . . . . 0.0 110.215 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -150.98 130.21 12.74 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -86.21 114.32 22.94 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.293 0.568 . . . . 0.0 111.282 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 128.64 -22.05 5.27 Favored Glycine 0 N--CA 1.48 1.589 0 CA-C-N 114.529 -1.214 . . . . 0.0 111.519 178.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.5 m -134.87 160.41 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-O 120.897 0.38 . . . . 0.0 110.271 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 46.4 m -100.82 117.41 34.83 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.405 HG22 ' H ' ' A' ' 78' ' ' VAL . 0.4 OUTLIER -95.99 131.92 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.881 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -155.29 135.45 8.39 Favored Pre-proline 0 CA--C 1.553 1.07 0 CA-C-O 119.071 -0.49 . . . . 0.0 110.537 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -71.25 -7.53 12.81 Favored 'Cis proline' 0 N--CA 1.52 3.032 0 CA-C-N 121.325 1.509 . . . . 0.0 111.091 0.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.3 p 59.94 17.85 6.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.661 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.4 p -132.92 140.69 47.98 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.6 m -147.73 154.82 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -101.05 134.38 44.14 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.9 p -131.6 138.18 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 121.178 0.514 . . . . 0.0 110.29 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -114.89 126.88 55.31 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.999 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 56.1 mt -109.16 109.15 20.04 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -92.98 127.68 38.58 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.9 t -100.94 132.35 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 46.0 m -100.16 122.09 42.45 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-O 120.689 0.28 . . . . 0.0 110.709 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 . . . . . 0 N--CA 1.47 0.527 0 C-N-CA 123.065 0.546 . . . . 0.0 109.914 179.73 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 71.3 mt . . . . . 0 N--CA 1.466 0.366 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.8 t -159.89 153.41 22.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.515 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -144.89 166.29 25.69 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.561 0.696 . . . . 0.0 109.699 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 95.2 p -114.19 134.87 54.61 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 114.216 -1.356 . . . . 0.0 109.692 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.5 m -129.25 94.99 31.85 Favored Pre-proline 0 CA--C 1.547 0.861 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -57.71 146.02 87.21 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 CA-C-N 119.992 1.033 . . . . 0.0 111.567 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.0 t -93.98 133.94 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.325 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -114.02 130.15 56.57 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.3 tp -96.39 130.61 43.48 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -122.45 108.54 13.3 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 120.976 0.417 . . . . 0.0 109.879 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.0 pp -65.25 130.16 42.33 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.741 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.7 m -127.57 135.38 50.23 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.81 165.19 15.66 Favored Glycine 0 N--CA 1.475 1.273 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -85.72 134.18 33.97 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.7 ptmm? -63.29 136.95 58.01 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.617 0.246 . . . . 0.0 110.459 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.0 170.43 4.38 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.348 0.594 . . . . 0.0 111.133 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 34.6 t -81.0 -23.16 38.87 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.292 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -87.35 -11.34 49.67 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.8 p -110.1 129.28 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-O 120.84 0.352 . . . . 0.0 110.821 -178.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 36.2 t -86.47 -37.6 18.13 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.982 0.42 . . . . 0.0 109.986 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 98.7 p -160.78 160.07 30.79 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.397 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 92.8 mt -131.31 139.73 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 60.2 m -125.75 154.61 42.25 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -141.37 152.84 44.7 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.017 0.437 . . . . 0.0 110.302 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 96.6 p -151.52 162.05 41.62 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.204 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.469 ' CD1' ' N ' ' A' ' 35' ' ' GLY . 25.0 p90 -146.39 147.35 31.2 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.181 -179.412 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -69.99 -35.11 74.15 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.612 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -158.98 89.07 0.92 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.409 0.623 . . . . 0.0 109.97 -179.276 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.469 ' N ' ' CD1' ' A' ' 32' ' ' PHE . . . -76.78 38.17 1.48 Allowed Glycine 0 N--CA 1.462 0.429 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.755 -178.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 27.5 p80 -144.85 137.97 26.69 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 117.659 0.73 . . . . 0.0 109.432 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.6 m -129.16 162.45 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 26.4 m -102.61 133.22 47.96 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 37.9 pt -119.31 146.19 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 122.972 0.509 . . . . 0.0 110.325 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 50.0 t -129.37 134.85 62.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.949 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 162.66 -156.96 28.84 Favored Glycine 0 N--CA 1.467 0.753 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 50.9 m -74.85 147.94 40.66 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 110.321 -0.251 . . . . 0.0 110.321 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -63.92 -30.61 71.67 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.371 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -60.47 -45.16 94.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.721 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.42 -39.61 85.48 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.664 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 67.9 mtt -65.54 -40.87 93.37 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.287 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -64.14 -31.71 73.0 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.045 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.1 tppt? -71.94 -38.57 69.81 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.16 0.505 . . . . 0.0 110.551 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 72.4 mt -88.21 117.52 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.604 -178.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -99.92 -24.93 14.5 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.36 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.9 m -169.99 -178.82 3.0 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.616 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 85.8 mt -124.34 123.48 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 42.4 m -96.07 128.38 42.92 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.5 t -128.53 90.6 46.07 Favored Pre-proline 0 N--CA 1.473 0.718 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -83.47 144.08 11.28 Favored 'Trans proline' 0 N--CA 1.5 1.896 0 C-N-CA 121.829 1.686 . . . . 0.0 111.571 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.6 p -137.44 135.35 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 CA-C-O 121.067 0.461 . . . . 0.0 110.935 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -67.07 128.87 38.0 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 36.1 pt -101.67 -11.23 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-O 120.985 0.422 . . . . 0.0 110.547 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.8 t -62.22 -40.6 96.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.57 -178.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -83.26 -6.88 59.62 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.757 0.423 . . . . 0.0 110.218 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 43.4 t -92.56 109.77 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 70.6 p -132.08 1.91 3.92 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.755 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -142.39 151.97 42.37 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -64.28 134.23 54.3 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.249 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.402 ' OG1' ' N ' ' A' ' 66' ' ' SER . 5.5 t -167.13 -178.38 4.12 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.013 0.435 . . . . 0.0 110.907 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.402 ' N ' ' OG1' ' A' ' 65' ' ' THR . 99.2 p -138.62 147.44 42.93 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.196 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -136.03 141.56 44.34 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.268 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 63.8 m -97.36 125.54 42.03 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 177.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 66.1 mt -120.72 135.93 55.0 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.802 0.441 . . . . 0.0 110.09 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.9 mp0 -98.86 138.3 36.19 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 24.7 mt -106.12 132.28 52.39 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 116.296 -0.411 . . . . 0.0 109.995 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -129.98 140.86 50.83 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -146.82 130.9 17.3 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -85.11 115.38 22.88 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.32 0.581 . . . . 0.0 111.203 -178.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 125.78 -21.13 6.32 Favored Glycine 0 N--CA 1.48 1.575 0 CA-C-N 114.577 -1.192 . . . . 0.0 111.761 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.3 m -132.49 159.09 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 80.7 m -102.94 110.64 22.64 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.4 t -91.58 128.93 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -155.69 138.77 10.75 Favored Pre-proline 0 CA--C 1.554 1.115 0 CA-C-O 118.893 -0.575 . . . . 0.0 110.363 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -70.4 -11.21 13.1 Favored 'Cis proline' 0 N--CA 1.517 2.909 0 CA-C-N 121.291 1.497 . . . . 0.0 110.781 0.05 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 60.1 22.54 11.77 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.744 -1.117 . . . . 0.0 112.343 177.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 37.7 p -127.07 140.57 52.19 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.7 m -147.53 142.83 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -93.86 131.26 39.44 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 43.4 t -123.3 121.5 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -99.83 123.62 44.28 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 65.4 mt -108.45 105.92 15.8 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -87.91 130.46 34.91 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 26.6 t -104.16 131.39 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 49.5 m -100.05 120.07 39.27 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 . . . . . 0 N--CA 1.467 0.381 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -179.375 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 56.9 mt . . . . . 0 CA--C 1.52 -0.197 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.6 t -161.3 141.08 10.55 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -149.85 167.12 27.5 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -178.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 39.8 t -124.11 137.99 54.49 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 114.867 -1.061 . . . . 0.0 109.136 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.3 m -122.76 144.57 43.04 Favored Pre-proline 0 N--CA 1.482 1.139 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -73.05 143.18 35.71 Favored 'Trans proline' 0 N--CA 1.5 1.872 0 C-N-CA 121.345 1.363 . . . . 0.0 111.586 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 43.8 t -103.69 134.0 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -125.91 146.86 49.66 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.2 mt -112.2 132.59 54.82 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -114.22 113.97 25.36 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.317 -0.624 . . . . 0.0 109.317 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 49.5 mt -70.33 124.1 23.33 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 76.4 p -119.76 135.31 54.9 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 115.55 163.14 13.72 Favored Glycine 0 N--CA 1.471 1.024 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.4 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 1.0 OUTLIER -85.13 138.91 32.1 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 179.131 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -65.9 132.09 47.81 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.18 177.02 2.42 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.468 0.651 . . . . 0.0 110.786 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 89.9 p -85.23 -19.16 32.09 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.929 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -88.13 -21.53 24.6 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 122.134 0.174 . . . . 0.0 110.737 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.3 p -97.37 126.33 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-O 120.859 0.361 . . . . 0.0 111.008 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.5 t -92.6 -35.92 13.29 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.118 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.7 t -161.21 158.03 26.69 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.095 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 82.3 mt -128.73 136.62 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 60.5 m -128.97 153.49 47.5 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -144.62 155.58 43.69 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.188 0.518 . . . . 0.0 110.346 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 87.8 p -150.95 163.5 38.55 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.16 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -146.4 147.59 31.43 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.017 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -71.59 -34.03 69.56 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.533 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -134.13 -52.09 0.83 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 122.892 0.477 . . . . 0.0 110.167 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.31 23.41 62.22 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.44 ' ND1' ' O ' ' A' ' 36' ' ' HIS . 18.0 p80 -147.6 140.11 24.61 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.159 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 28.4 m -133.11 165.97 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 46.1 m -99.8 137.92 37.6 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 38.7 pt -119.63 148.46 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.4 t -130.68 134.13 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-O 120.915 0.388 . . . . 0.0 109.97 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 167.2 -163.09 36.86 Favored Glycine 0 N--CA 1.464 0.536 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.2 t -73.41 155.03 39.74 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 110.375 -0.232 . . . . 0.0 110.375 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 70.4 tp60 -63.36 -37.57 87.8 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.549 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -64.04 -39.01 93.15 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 110.435 -0.209 . . . . 0.0 110.435 -179.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.33 -44.4 83.44 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.868 0.365 . . . . 0.0 111.097 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 77.8 mtm -68.23 -39.27 82.36 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.825 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -60.36 -32.76 71.59 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.578 0.228 . . . . 0.0 110.895 -179.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.5 ttpp -70.69 -33.63 71.11 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.729 0.3 . . . . 0.0 110.49 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 71.1 mt -86.44 119.17 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -107.56 -22.11 12.65 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-O 121.228 0.537 . . . . 0.0 110.194 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 95.2 p -171.96 162.33 5.94 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.877 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 36.5 mm -107.07 119.28 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 38.2 m -96.69 127.77 42.99 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 26.0 t -133.5 93.0 22.47 Favored Pre-proline 0 N--CA 1.474 0.775 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -77.29 145.19 23.88 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 121.032 1.155 . . . . 0.0 111.422 -178.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.9 t -132.48 129.56 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.904 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -71.38 127.06 31.31 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.609 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 36.5 pt -99.09 -12.73 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 122.597 0.359 . . . . 0.0 110.92 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 80.6 p -59.04 -38.57 79.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.568 -178.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -86.79 -4.78 59.22 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 122.565 0.346 . . . . 0.0 110.505 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.1 t -93.72 110.85 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 67.8 p -131.5 4.46 4.29 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.414 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.3 tp10 -152.33 158.13 42.3 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.851 0.358 . . . . 0.0 110.105 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -59.79 137.41 58.06 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.329 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.2 t -165.01 166.99 18.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.13 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 42.5 t -141.79 140.84 33.13 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.655 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -148.81 147.38 28.7 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.892 0.853 . . . . 0.0 111.11 -179.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 39.6 m -81.67 136.08 35.51 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 114.278 -1.328 . . . . 0.0 109.328 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.5 mt -110.9 113.06 25.35 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.061 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 50.2 tp10 -75.73 126.29 30.71 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 44.9 mt -104.63 128.07 52.55 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -133.2 141.56 48.14 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -142.31 141.73 32.43 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -85.06 134.84 34.19 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 122.027 0.918 . . . . 0.0 113.137 -177.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.8 -9.5 76.12 Favored Glycine 0 N--CA 1.474 1.185 0 CA-C-N 114.152 -1.385 . . . . 0.0 112.073 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.0 m -133.89 161.74 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 60.6 m -110.41 113.68 26.52 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.6 t -90.3 132.61 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -156.51 139.73 11.0 Favored Pre-proline 0 CA--C 1.554 1.118 0 CA-C-O 119.013 -0.518 . . . . 0.0 110.867 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.5 -12.94 11.83 Favored 'Cis proline' 0 N--CA 1.515 2.738 0 CA-C-N 120.838 1.335 . . . . 0.0 110.887 0.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.7 p 61.55 22.52 12.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.66 177.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.2 p -131.93 139.97 48.87 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.2 m -151.34 154.27 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -98.44 132.8 43.6 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.3 t -127.64 130.32 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -107.47 124.94 50.62 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 55.0 mt -109.34 109.57 20.5 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -179.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -91.02 128.3 36.79 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 23.9 t -102.78 131.8 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 52.1 m -99.13 118.19 35.3 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 96.0 mm-40 . . . . . 0 N--CA 1.464 0.266 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 -179.542 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt . . . . . 0 N--CA 1.493 1.696 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.9 mm 55.76 95.67 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.781 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 39.6 t -61.16 -41.41 96.71 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.228 0.537 . . . . 0.0 110.768 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.44 ' N ' HD12 ' A' ' 4' ' ' LEU . 8.8 mp -66.16 147.62 53.06 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.514 -0.767 . . . . 0.0 109.426 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -128.8 36.84 4.17 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.443 -177.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -134.09 132.22 39.68 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.4 tp -163.63 152.7 14.24 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 90.3 p -145.06 148.26 33.5 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.476 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -144.52 166.34 25.42 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.466 0.651 . . . . 0.0 109.563 -178.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.4 t -113.45 135.99 53.28 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.572 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.5 m -128.86 100.37 21.29 Favored Pre-proline 0 CA--C 1.549 0.904 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -57.01 144.62 89.09 Favored 'Trans proline' 0 N--CA 1.499 1.842 0 C-N-CA 121.095 1.196 . . . . 0.0 111.704 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 23.0 m -88.86 139.56 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.681 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -119.17 116.41 26.25 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.421 ' N ' HD12 ' A' ' 15' ' ' LEU . 10.8 mp -89.98 135.13 33.83 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -122.49 116.66 24.32 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 58.2 mt -66.61 126.06 27.73 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.3 m -127.4 133.96 49.95 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.65 165.06 15.75 Favored Glycine 0 N--CA 1.472 1.043 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -81.32 138.19 35.7 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -68.22 139.49 56.04 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.03 144.09 57.36 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 83.2 p -68.89 -24.08 64.28 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.185 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -91.5 2.89 56.11 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 122.218 0.207 . . . . 0.0 110.99 -179.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 52.8 t -118.91 126.16 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 36.4 t -75.05 -43.32 54.14 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.339 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 37.5 t -163.94 162.11 23.22 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.723 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 80.4 mt -130.4 146.1 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.337 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 40.2 t -132.58 161.83 32.84 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.497 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -146.21 154.67 42.01 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.069 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 50.8 m -144.69 170.89 15.22 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.802 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -146.74 147.69 31.21 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.808 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -74.57 -33.36 62.67 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.067 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 86.7 mtm180 -133.6 -49.77 0.84 Allowed 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.729 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.38 19.27 57.38 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 47.9 m80 -142.25 137.5 30.74 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.49 HG22 ' N ' ' A' ' 38' ' ' THR . 4.1 p -133.4 161.88 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.49 ' N ' HG22 ' A' ' 37' ' ' VAL . 34.1 m -101.53 135.0 43.78 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.335 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 40.5 pt -120.04 149.66 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.8 t -132.79 134.97 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 166.57 -160.3 33.86 Favored Glycine 0 N--CA 1.464 0.531 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.8 m -73.01 151.74 41.63 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 62.1 tp60 -64.96 -34.49 78.54 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.313 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -60.61 -43.81 97.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.736 0.303 . . . . 0.0 110.622 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.72 -40.09 94.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.623 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 67.7 mtt -65.01 -40.67 95.23 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.597 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -65.55 -23.71 66.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.64 0.257 . . . . 0.0 110.53 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -80.61 -34.96 34.68 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.377 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 67.1 mt -91.61 116.35 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -99.1 -24.58 14.84 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.064 0.459 . . . . 0.0 110.221 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 92.9 p -172.36 162.8 5.52 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.044 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 36.7 mm -107.32 120.48 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 33.5 m -85.01 129.93 34.71 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 38.3 t -123.84 90.75 50.37 Favored Pre-proline 0 N--CA 1.471 0.619 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -79.26 146.2 19.62 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 121.485 1.456 . . . . 0.0 111.371 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.7 p -139.57 137.43 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.883 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -79.16 125.29 29.25 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 36.4 pt -103.08 -9.87 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 120.857 0.36 . . . . 0.0 110.294 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 40.3 m -61.81 -39.82 93.09 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.436 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -86.69 -5.0 59.25 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 122.928 0.491 . . . . 0.0 110.679 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 45.4 t -92.43 114.14 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 70.2 p -132.54 -0.13 3.59 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.172 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -144.62 155.7 43.75 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 121.007 0.432 . . . . 0.0 110.435 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -63.9 132.81 51.89 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.04 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.8 t -167.61 -174.9 2.63 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.342 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 96.8 p -151.26 147.25 26.75 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.611 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -140.16 143.93 36.4 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.109 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.8 m -83.13 132.03 35.11 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.168 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 74.8 mt -120.89 129.66 53.58 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 122.907 0.483 . . . . 0.0 109.839 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -96.6 137.68 35.32 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 52.2 mt -110.64 136.93 48.98 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -141.59 147.24 37.34 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -149.89 137.21 19.78 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -86.29 114.6 23.23 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.004 0.431 . . . . 0.0 110.941 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 125.12 -20.56 6.65 Favored Glycine 0 N--CA 1.485 1.937 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.625 178.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 32.8 m -134.13 159.87 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 31.7 m -102.73 111.14 23.32 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.1 t -92.04 129.14 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -156.75 142.0 12.45 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.494 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.92 -10.28 11.73 Favored 'Cis proline' 0 N--CA 1.508 2.33 0 CA-C-N 120.539 1.228 . . . . 0.0 110.58 -0.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.8 p 60.3 23.15 12.6 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.165 177.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 39.7 p -131.93 139.63 48.77 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.5 m -152.36 151.92 11.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -96.19 134.01 39.8 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 44.7 t -126.1 127.08 70.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -104.95 124.38 49.41 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 58.7 mt -108.01 108.68 19.9 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -90.16 129.63 36.41 Favored 'General case' 0 C--O 1.231 0.105 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 38.6 t -104.14 131.36 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 39.9 m -101.18 120.42 40.21 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 91.3 mm-40 -79.85 132.34 36.09 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -70.4 137.14 50.21 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.7 tp -152.05 127.88 10.25 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -67.59 159.79 29.12 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -161.3 -170.91 2.81 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.917 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -64.78 134.66 54.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.03 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -67.98 144.32 55.22 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 66.5 m80 -65.23 125.08 23.9 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -65.0 -42.24 94.68 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.799 0.333 . . . . 0.0 110.119 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 118.115 -0.945 . . . . 0.0 110.732 -179.885 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 22.1 pttp . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 71.9 mt -64.61 143.47 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.637 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.3 t 55.05 89.95 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.163 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.406 ' O ' ' N ' ' A' ' 6' ' ' LYS . 61.3 mt 56.48 103.64 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.409 0.623 . . . . 0.0 110.709 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -65.11 74.54 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.048 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.406 ' N ' ' O ' ' A' ' 4' ' ' LEU . 46.7 mtpt -98.41 137.71 36.71 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 53.4 mt -93.95 -178.93 4.81 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 95.8 p -160.58 150.31 17.59 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.8 mtpt -151.11 164.98 35.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.619 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 35.0 m -114.18 137.1 52.2 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.634 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.3 m -126.68 101.67 26.67 Favored Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 123.588 0.755 . . . . 0.0 109.051 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -57.02 144.53 89.42 Favored 'Trans proline' 0 N--CA 1.499 1.803 0 CA-C-N 120.342 1.158 . . . . 0.0 111.939 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 23.3 t -89.41 130.93 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.1 ttmm -117.33 126.95 53.55 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.6 mt -101.82 127.95 48.4 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -115.23 109.95 18.73 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.9 pp -64.19 129.23 39.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.154 -0.476 . . . . 0.0 109.736 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 31.6 m -126.07 135.66 52.0 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 115.23 162.66 13.68 Favored Glycine 0 N--CA 1.476 1.367 0 N-CA-C 110.581 -1.007 . . . . 0.0 110.581 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.0 p-10 -82.64 142.18 31.92 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -66.7 134.34 52.03 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.68 176.63 0.64 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.23 0.538 . . . . 0.0 111.143 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.8 t -85.75 -23.98 27.08 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.099 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -91.32 -13.14 33.12 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -178.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.5 p -98.56 128.25 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 CA-C-O 120.79 0.328 . . . . 0.0 110.875 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 46.7 t -92.09 -37.31 12.85 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.839 0.352 . . . . 0.0 110.122 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 98.3 p -161.21 159.16 28.46 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.151 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 73.9 mt -133.78 142.53 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 65.0 p -135.01 159.12 42.52 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.288 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -145.7 155.85 43.25 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.083 0.468 . . . . 0.0 110.182 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 47.7 t -147.4 163.46 36.41 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.254 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -146.46 143.76 29.2 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.288 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -69.27 -34.36 74.63 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.984 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -135.91 -51.27 0.72 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.014 0.526 . . . . 0.0 109.96 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.84 24.03 61.99 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.439 ' ND1' ' O ' ' A' ' 36' ' ' HIS . 17.8 p80 -148.69 139.68 23.04 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.211 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 28.4 m -131.6 164.51 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 61.4 m -99.71 133.55 43.89 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 37.9 pt -118.82 147.5 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 122.854 0.462 . . . . 0.0 110.25 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.2 t -132.13 135.6 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.399 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 170.97 -163.08 36.09 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 30.8 t -72.33 147.4 46.35 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 70.8 tp60 -58.8 -38.19 78.05 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.603 0.24 . . . . 0.0 111.117 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.445 ' CD ' ' H ' ' A' ' 44' ' ' GLU . 23.6 mp0 -59.84 -48.02 83.37 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.878 0.37 . . . . 0.0 110.793 -179.104 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.99 -37.9 86.57 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.738 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 21.2 mmt -65.79 -39.54 91.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.006 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -61.1 -31.98 71.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.609 0.242 . . . . 0.0 110.818 -178.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -71.55 -39.08 70.9 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.776 0.322 . . . . 0.0 110.316 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 57.5 mt -85.54 117.53 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -113.46 -19.52 11.65 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.184 0.593 . . . . 0.0 110.578 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 66.5 p -174.1 161.56 3.63 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.694 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 38.1 mm -111.4 117.85 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 48.2 m -105.51 124.44 49.55 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 36.1 t -127.17 113.44 21.62 Favored Pre-proline 0 N--CA 1.482 1.169 0 CA-C-O 118.446 -0.788 . . . . 0.0 109.792 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -76.81 143.62 23.73 Favored 'Trans proline' 0 N--CA 1.497 1.678 0 CA-C-N 121.254 1.484 . . . . 0.0 110.755 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.8 t -129.31 126.79 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -73.67 126.47 30.4 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.69 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 39.1 pt -102.69 -15.74 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 122.82 0.448 . . . . 0.0 110.912 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.8 t -61.39 -40.32 93.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.594 -178.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -83.3 -5.78 59.25 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 122.374 0.27 . . . . 0.0 110.616 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 47.4 t -91.2 108.45 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 70.6 p -129.88 1.51 4.84 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.636 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -141.95 146.79 36.05 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 21.2 p-10 -63.88 137.12 57.89 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.103 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.431 ' OG1' ' N ' ' A' ' 66' ' ' SER . 5.6 t -168.14 -173.43 2.03 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.265 0.555 . . . . 0.0 110.709 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.431 ' N ' ' OG1' ' A' ' 65' ' ' THR . 90.2 p -147.25 143.35 28.07 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.45 179.228 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -138.45 142.38 39.47 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.0 0.429 . . . . 0.0 110.238 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 44.6 m -82.1 131.89 35.24 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.5 mt -111.75 111.71 22.88 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 122.659 0.384 . . . . 0.0 110.29 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -83.77 126.37 32.85 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 31.8 mt -103.74 134.74 46.55 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 120.792 0.329 . . . . 0.0 110.597 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -134.94 142.06 46.42 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.084 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -145.41 135.27 23.59 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -85.5 117.73 24.58 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.328 0.585 . . . . 0.0 111.848 -178.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.61 -16.02 16.86 Favored Glycine 0 N--CA 1.482 1.704 0 CA-C-N 114.574 -1.194 . . . . 0.0 112.208 178.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 23.3 m -133.04 159.22 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 56.9 m -107.95 117.73 34.9 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.1 p -105.85 133.52 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 122.938 0.495 . . . . 0.0 109.741 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -158.81 143.67 11.69 Favored Pre-proline 0 CA--C 1.552 1.046 0 CA-C-O 119.078 -0.487 . . . . 0.0 110.654 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.413 ' C ' ' H ' ' A' ' 82' ' ' THR . 87.8 Cg_endo -70.2 -12.13 12.96 Favored 'Cis proline' 0 N--CA 1.516 2.815 0 CA-C-N 120.646 1.266 . . . . 0.0 110.998 0.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 67.6 -6.87 0.62 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.839 177.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.413 ' H ' ' C ' ' A' ' 80' ' ' PRO . 59.0 p -100.31 139.51 35.88 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.8 m -147.92 146.14 18.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -95.23 130.89 41.8 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 44.0 t -126.6 126.04 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -100.09 124.64 45.72 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 59.8 mt -110.41 104.16 12.89 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -92.81 128.88 38.83 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.4 p -107.83 137.08 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.627 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 69.9 m -100.24 121.5 41.56 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 95.4 mm-40 -80.18 133.8 36.07 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.41 ' C ' ' H ' ' A' ' 94' ' ' GLU . 60.1 tttm -61.73 139.41 58.32 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.447 ' N ' HD12 ' A' ' 93' ' ' LEU . 9.6 mp -72.91 7.47 2.0 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.877 0.37 . . . . 0.0 110.047 -178.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 96' ' ' HIS . 93.2 mt-10 50.67 -166.36 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.392 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 72.1 m80 51.84 -87.55 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.599 0.237 . . . . 0.0 111.45 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.432 ' N ' ' O ' ' A' ' 94' ' ' GLU . 71.6 m80 -65.04 120.38 12.53 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.446 ' CG ' ' N ' ' A' ' 98' ' ' HIS . 26.7 t-80 -69.5 167.22 17.17 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.446 ' N ' ' CG ' ' A' ' 97' ' ' HIS . 85.8 t60 -60.76 -41.83 96.24 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.291 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 53.85 92.14 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.852 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.771 -179.96 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 68.3 mttm . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 40.6 pt -134.33 163.02 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 122.952 0.501 . . . . 0.0 110.571 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.1 m -162.72 -28.71 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.623 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.43 ' O ' ' N ' ' A' ' 6' ' ' LYS . 4.2 tp -67.06 142.29 57.2 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.025 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 53.46 -87.11 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.731 0.301 . . . . 0.0 110.699 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.43 ' N ' ' O ' ' A' ' 4' ' ' LEU . 67.9 mttm -63.63 133.56 53.9 Favored 'General case' 0 C--O 1.231 0.109 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 58.6 mt -110.59 152.76 26.06 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.0 t -151.67 145.68 25.24 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.567 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -149.64 167.51 26.19 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.565 -178.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 30.5 m -109.48 139.06 44.92 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.059 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.5 m -131.84 95.03 23.48 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 123.625 0.77 . . . . 0.0 109.313 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -58.39 146.19 90.95 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 C-N-CA 121.207 1.272 . . . . 0.0 112.144 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.4 p -98.25 142.1 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.242 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -121.27 133.87 55.15 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 78.3 mt -100.06 128.54 46.13 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -113.47 111.89 22.7 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 56.5 mt -70.28 126.13 28.77 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.1 p -129.31 145.38 51.38 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.956 -0.386 . . . . 0.0 109.956 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.02 168.33 16.39 Favored Glycine 0 N--CA 1.474 1.199 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.6 p-10 -84.75 132.58 34.42 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -64.49 135.93 56.55 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.54 176.06 3.12 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.577 0.703 . . . . 0.0 110.991 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 74.6 m -84.31 -20.75 31.57 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.299 -178.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -90.27 -19.83 23.65 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 122.461 0.304 . . . . 0.0 111.037 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.6 p -97.18 128.31 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-O 120.576 0.227 . . . . 0.0 110.469 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.5 t -103.39 -26.99 12.7 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 120.823 0.345 . . . . 0.0 110.188 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 48.1 t -160.81 154.21 21.9 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.907 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 86.0 mt -129.92 135.79 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.9 p -133.59 154.79 50.6 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -148.42 159.16 44.31 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.409 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.1 t -146.35 168.37 21.29 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.008 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -146.41 149.61 34.06 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.952 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -68.12 -33.54 74.69 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.56 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -150.27 -38.96 0.14 Allowed 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.172 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.422 ' O ' ' ND1' ' A' ' 36' ' ' HIS . . . 55.95 25.86 46.69 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 178.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.422 ' ND1' ' O ' ' A' ' 35' ' ' GLY . 15.3 m-70 -138.0 137.32 37.78 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 31.4 m -129.88 160.93 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 35.5 m -102.88 133.78 47.4 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 38.1 pt -117.8 146.44 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 122.758 0.423 . . . . 0.0 110.326 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.7 t -132.86 134.51 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.786 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 168.5 -159.44 32.6 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 95.0 p -72.63 151.62 42.2 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.647 0.26 . . . . 0.0 110.301 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.8 tm0? -63.35 -36.9 85.22 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.763 0.316 . . . . 0.0 110.237 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.477 ' CD ' ' H ' ' A' ' 44' ' ' GLU . 24.9 mp0 -60.55 -53.71 54.24 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.137 -178.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.51 -40.21 96.01 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.909 0.385 . . . . 0.0 110.88 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 88.3 mtp -66.85 -39.61 87.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.702 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -61.79 -34.31 75.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.478 0.18 . . . . 0.0 111.395 -178.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -68.95 -35.26 76.56 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.749 0.309 . . . . 0.0 110.383 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 63.6 mt -85.67 120.1 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -119.42 -16.67 8.92 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 122.968 0.507 . . . . 0.0 110.404 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 68.9 p -172.29 167.5 5.78 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.45 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 81.6 mt -126.73 128.04 70.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.9 t -104.68 132.4 50.97 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 179.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 38.7 t -133.23 90.63 29.83 Favored Pre-proline 0 N--CA 1.473 0.696 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -58.12 142.24 96.92 Favored 'Trans proline' 0 N--CA 1.501 1.955 0 C-N-CA 121.663 1.575 . . . . 0.0 112.026 178.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 60.3 t -128.67 128.7 68.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -77.53 123.18 26.25 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 38.0 pt -99.63 -10.99 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 122.705 0.402 . . . . 0.0 110.697 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 39.4 t -61.66 -40.13 93.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.461 -178.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -85.23 -5.5 59.32 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 122.748 0.419 . . . . 0.0 110.394 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 46.4 t -91.94 106.99 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 71.5 p -131.03 2.66 4.33 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.703 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -147.2 146.07 29.71 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.936 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -52.33 135.21 33.24 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.453 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.417 ' OG1' ' N ' ' A' ' 66' ' ' SER . 7.0 t -167.95 -173.95 2.24 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.095 0.474 . . . . 0.0 110.863 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.417 ' N ' ' OG1' ' A' ' 65' ' ' THR . 61.8 p -150.92 148.73 28.78 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.101 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -143.54 144.15 31.83 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.225 0.536 . . . . 0.0 111.076 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 t -85.85 132.5 34.09 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.509 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 70.7 mt -115.97 120.63 39.79 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.806 0.443 . . . . 0.0 110.592 -179.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -84.87 133.06 34.32 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.265 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.1 mt -113.61 115.29 27.68 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -134.09 151.43 51.39 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -148.43 143.72 26.95 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -85.23 117.4 24.16 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.355 0.598 . . . . 0.0 111.343 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 118.24 -18.33 11.23 Favored Glycine 0 N--CA 1.481 1.658 0 CA-C-N 114.714 -1.13 . . . . 0.0 112.046 178.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.2 m -133.31 160.96 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 56.5 m -103.55 111.66 24.22 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.1 t -91.12 128.6 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -149.81 143.45 16.72 Favored Pre-proline 0 CA--C 1.553 1.085 0 CA-C-O 119.062 -0.494 . . . . 0.0 110.075 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -72.86 -1.23 11.74 Favored 'Cis proline' 0 N--CA 1.511 2.507 0 CA-C-N 120.906 1.359 . . . . 0.0 110.364 0.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.4 t 56.03 22.08 5.58 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.357 -1.292 . . . . 0.0 111.771 178.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 34.9 p -138.0 139.57 39.72 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.4 m -148.79 154.75 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -103.38 132.61 49.5 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 43.0 t -128.93 125.69 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.023 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -102.21 125.71 48.98 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 65.4 mt -107.54 111.2 23.35 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -95.5 126.57 40.88 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.6 m -96.52 137.6 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 44.1 m -100.61 116.41 32.46 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 95.3 mm-40 -80.99 129.63 34.63 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.4 ptmm? -54.86 138.43 42.91 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.868 0.366 . . . . 0.0 110.995 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 37.8 mt -95.07 -5.49 44.2 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.838 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -170.05 149.89 3.67 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.891 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -71.16 130.56 41.78 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.247 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -169.14 89.67 0.21 Allowed 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 48.9 p-80 -65.17 145.33 56.4 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.069 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -161.0 139.03 9.55 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 45.3 p-80 -160.31 161.26 33.24 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.107 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 42.9 p-80 . . . . . 0 C--O 1.221 -0.447 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.581 179.965 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.0 mttt . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 21.4 mm -72.77 132.14 33.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.2 m -158.78 -63.68 0.08 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.207 0.527 . . . . 0.0 109.757 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.6 tp 59.17 -134.45 0.9 Allowed 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.211 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -65.01 152.59 43.01 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -65.11 138.95 58.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.629 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 54.7 mt -113.94 151.42 32.31 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.7 t -160.35 143.26 13.4 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.629 ' HE2' HE22 ' A' ' 43' ' ' GLN . 64.0 mttp -149.75 166.62 28.87 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -178.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.0 m -121.75 137.83 54.6 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.898 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.7 m -123.38 143.88 42.44 Favored Pre-proline 0 N--CA 1.486 1.362 0 C-N-CA 122.691 0.396 . . . . 0.0 110.022 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -74.37 142.24 29.72 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 121.429 1.419 . . . . 0.0 111.6 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.9 t -103.52 134.61 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -127.77 148.02 50.43 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 51.8 mt -112.37 137.88 49.91 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.466 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -119.32 110.27 16.79 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.433 ' N ' HD12 ' A' ' 17' ' ' LEU . 9.4 mp -70.52 130.87 43.01 Favored 'General case' 0 C--N 1.334 -0.085 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.8 p -130.03 143.11 50.62 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.7 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.62 170.0 16.48 Favored Glycine 0 N--CA 1.475 1.265 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.8 p-10 -87.06 132.92 33.67 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -65.93 133.65 51.31 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.51 145.47 54.91 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.05 0.452 . . . . 0.0 110.629 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 61.0 m -63.68 -18.33 63.88 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.982 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -84.76 -20.87 30.37 Favored 'General case' 0 C--N 1.343 0.314 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.8 t -107.24 127.48 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-O 121.093 0.473 . . . . 0.0 110.276 -178.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 47.5 t -87.18 -40.7 14.35 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.34 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 47.1 t -155.47 161.31 40.98 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.499 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 82.6 mt -131.4 142.6 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.782 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.3 m -130.41 154.17 47.98 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.283 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -144.68 156.34 44.04 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.134 0.492 . . . . 0.0 110.096 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 45.4 m -148.09 166.52 27.57 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.154 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -146.1 142.49 28.58 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.959 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 33' ' ' ASP . 21.3 p-10 -73.35 -34.23 65.5 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.645 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -126.43 -56.79 1.4 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.111 0.564 . . . . 0.0 110.483 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 59.9 18.64 47.67 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -144.82 136.69 25.75 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.1 m -132.99 163.28 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 44.0 m -102.51 137.37 40.84 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 34.9 pt -117.41 150.44 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.2 p -130.27 134.69 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 123.332 0.395 . . . . 0.0 110.379 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 166.86 -160.75 34.49 Favored Glycine 0 C--N 1.328 0.113 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 44.6 t -77.43 157.04 30.73 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.629 HE22 ' HE2' ' A' ' 9' ' ' LYS . 52.2 tp60 -62.81 -35.36 79.64 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -61.75 -44.35 97.07 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.662 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.09 -39.91 95.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.816 0.341 . . . . 0.0 110.754 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 68.6 mtt -66.22 -38.64 88.42 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.418 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -61.08 -31.81 71.48 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.754 -0.203 . . . . 0.0 110.948 -179.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -73.64 -40.37 63.81 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.792 0.329 . . . . 0.0 110.511 179.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 67.0 mt -81.2 116.66 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -112.34 -23.35 10.4 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.248 0.619 . . . . 0.0 109.604 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 98.0 p -170.78 161.67 7.37 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.525 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 77.7 mt -112.53 121.43 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 33.6 m -99.08 130.72 45.42 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.4 t -134.26 93.0 20.07 Favored Pre-proline 0 N--CA 1.475 0.825 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -77.33 145.52 24.06 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 121.118 1.212 . . . . 0.0 111.31 -178.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.1 t -132.21 130.2 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-O 121.113 0.482 . . . . 0.0 110.235 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.9 p-10 -70.43 126.45 29.67 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.921 179.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 34.8 pt -100.02 -13.03 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 120.791 0.329 . . . . 0.0 110.661 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 44.7 m -59.39 -39.12 82.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.332 -178.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -84.65 -6.92 59.39 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 122.744 0.418 . . . . 0.0 110.39 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 42.6 t -93.54 114.48 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 65.4 p -133.48 4.92 3.7 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.158 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -152.66 161.74 42.17 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.846 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -62.36 138.7 58.49 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.953 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.2 t -166.03 170.46 13.55 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.293 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 46.7 m -148.11 140.69 24.5 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.761 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 54.5 pttt -146.63 145.08 29.93 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.488 0.661 . . . . 0.0 110.926 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 33.2 m -81.55 136.76 35.59 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.084 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 70.3 mt -115.89 125.96 53.3 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 122.79 0.436 . . . . 0.0 110.19 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.514 ' CD ' ' HZ3' ' A' ' 72' ' ' LYS . 16.1 pt-20 -92.42 132.16 37.0 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 30.8 mt -107.67 129.77 54.98 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.514 ' HZ3' ' CD ' ' A' ' 70' ' ' GLU . 63.3 mttp -131.15 141.44 50.09 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -139.49 142.14 37.33 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -86.02 133.03 33.93 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 122.21 1.005 . . . . 0.0 112.362 -178.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.05 -15.03 63.83 Favored Glycine 0 N--CA 1.472 1.049 0 CA-C-N 113.564 -1.653 . . . . 0.0 112.149 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 11.1 m -131.55 164.36 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 16.2 m -112.28 112.79 24.62 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.0 t -89.53 132.4 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -155.44 144.38 14.92 Favored Pre-proline 0 CA--C 1.557 1.238 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.858 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.46 -10.79 13.05 Favored 'Cis proline' 0 N--CA 1.514 2.732 0 CA-C-N 120.579 1.242 . . . . 0.0 110.639 0.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 10.4 p 58.21 23.68 10.56 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 114.652 -1.158 . . . . 0.0 112.129 177.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 34.6 p -132.88 139.38 47.38 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.6 m -152.89 154.97 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -94.75 134.74 37.03 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 44.8 t -127.85 130.62 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -111.24 124.23 51.8 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 53.0 mt -108.43 108.86 19.99 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -91.63 128.46 37.47 Favored 'General case' 0 C--O 1.231 0.111 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 43.3 t -102.97 132.61 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 61.8 m -100.31 117.87 35.4 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -78.72 131.51 36.62 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -63.12 138.04 58.42 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.428 ' N ' HD22 ' A' ' 93' ' ' LEU . 4.1 mm? -68.91 130.51 42.98 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -86.58 -171.27 3.46 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.752 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 27.2 p80 -62.95 142.48 58.32 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.319 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -61.45 -47.04 87.52 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.441 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -168.6 156.37 7.93 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.437 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 72.5 m80 -70.2 144.96 51.76 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.956 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 79.2 t60 -161.19 4.55 0.06 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.783 0.325 . . . . 0.0 110.277 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 118.004 -0.998 . . . . 0.0 111.173 179.858 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 63.5 tttm . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 39.6 pt -66.97 -25.07 33.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.621 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.2 m -61.69 144.79 54.04 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.105 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 54.7 tp -65.53 147.64 53.07 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -162.36 42.13 0.13 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.159 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -57.39 155.03 9.77 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.81 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 34.5 tp -131.64 144.88 51.36 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 35.9 m -161.3 140.61 10.24 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -149.25 165.84 30.69 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -178.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 92.5 p -117.16 138.08 51.91 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.903 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.5 m -126.56 143.42 46.23 Favored Pre-proline 0 N--CA 1.482 1.162 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.92 142.4 28.05 Favored 'Trans proline' 0 N--CA 1.501 1.914 0 C-N-CA 121.604 1.536 . . . . 0.0 111.931 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.9 p -95.29 134.51 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.5 mptm? -108.73 133.55 52.65 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.5 tp -104.9 130.42 53.06 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -124.36 111.77 16.17 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.9 pp -69.6 131.11 44.13 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.3 p -125.44 134.95 51.91 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.64 163.88 14.55 Favored Glycine 0 N--CA 1.477 1.417 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.2 p-10 -78.95 136.8 37.35 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -66.81 138.11 57.11 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.42 141.43 58.36 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.206 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.0 t -68.03 -20.87 65.03 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.642 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -94.25 4.71 53.51 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 122.237 0.215 . . . . 0.0 110.914 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 68.6 t -118.42 126.2 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.3 t -73.71 -45.76 50.25 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.069 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 45.6 t -161.1 165.44 29.61 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.175 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 80.1 mt -131.77 144.96 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 99.8 p -135.78 163.37 30.36 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.467 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -144.2 160.13 41.48 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.498 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 61.7 p -148.58 162.87 38.81 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.884 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -146.3 143.9 29.46 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.974 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -72.72 -35.09 67.5 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.682 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -126.61 -54.71 1.43 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 122.95 0.5 . . . . 0.0 110.571 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 62.11 24.23 64.88 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.455 ' ND1' ' O ' ' A' ' 36' ' ' HIS . 15.7 p80 -151.95 138.91 19.04 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 28.9 m -131.29 162.27 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 49.3 m -100.87 134.37 43.95 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 20.4 pt -114.34 145.08 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 49.1 t -127.5 133.54 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 170.47 -162.2 35.28 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.5 m -75.32 160.14 30.66 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.9 tp-100 -63.97 -40.14 95.72 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.576 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -65.1 -36.58 84.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.829 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.08 -41.64 90.45 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.783 0.325 . . . . 0.0 111.038 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 68.3 mtt -68.81 -35.96 77.64 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.728 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -60.57 -32.96 72.02 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.519 0.2 . . . . 0.0 110.911 -178.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -73.61 -38.28 65.14 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.839 0.352 . . . . 0.0 110.354 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 68.7 mt -86.27 117.37 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -114.89 -16.7 11.68 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 122.919 0.488 . . . . 0.0 110.108 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 73.4 p -171.49 169.12 6.26 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.809 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 87.9 mt -122.67 124.0 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 33.6 m -89.38 132.15 35.1 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 43.1 t -131.19 91.7 34.96 Favored Pre-proline 0 N--CA 1.476 0.844 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -80.77 140.74 13.14 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 121.597 1.531 . . . . 0.0 111.364 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 49.1 t -131.9 130.87 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.918 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -74.83 124.75 27.42 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 37.6 pt -102.01 -11.86 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 122.795 0.438 . . . . 0.0 110.639 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.7 m -60.53 -38.72 85.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.39 -178.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -86.75 -2.74 58.79 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 45.1 t -97.33 120.72 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.2 t -135.87 6.3 3.15 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.293 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -155.3 171.95 19.0 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.422 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.7 p-10 -65.81 126.45 28.52 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.464 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.0 p -145.58 165.78 27.67 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.899 0.38 . . . . 0.0 110.043 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 90.2 p -150.65 129.36 12.34 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.524 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -140.08 145.97 38.34 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.23 0.538 . . . . 0.0 110.888 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 37.8 m -81.68 134.69 35.49 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.596 178.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.0 mt -118.22 126.24 51.77 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.866 0.467 . . . . 0.0 109.87 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -94.16 135.61 35.35 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.9 mt -106.96 134.84 49.5 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.887 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -134.21 143.77 48.04 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -143.59 137.7 28.55 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -85.77 121.23 28.14 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.256 0.551 . . . . 0.0 112.027 -178.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.71 -13.76 38.56 Favored Glycine 0 N--CA 1.48 1.628 0 CA-C-N 114.571 -1.195 . . . . 0.0 112.305 178.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 18.9 m -133.83 161.43 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 46.7 m -110.77 120.55 42.78 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.6 p -109.52 135.46 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -158.82 144.6 12.21 Favored Pre-proline 0 CA--C 1.551 1.005 0 CA-C-O 119.307 -0.378 . . . . 0.0 110.576 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.407 ' C ' ' H ' ' A' ' 82' ' ' THR . 79.9 Cg_endo -70.57 -12.56 13.82 Favored 'Cis proline' 0 N--CA 1.512 2.571 0 CA-C-N 120.247 1.124 . . . . 0.0 110.82 0.202 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 p 66.99 -3.51 0.94 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.17 177.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.407 ' H ' ' C ' ' A' ' 80' ' ' PRO . 57.4 p -98.71 140.01 33.56 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.2 m -149.5 144.65 17.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -94.59 132.6 39.12 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 47.4 t -126.35 128.56 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -110.31 123.38 49.71 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 58.3 mt -105.63 120.54 41.93 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm -104.09 126.49 51.25 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 42.4 t -103.77 133.81 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.263 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 70.6 p -96.63 124.04 40.5 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 93.9 mm-40 -93.79 127.73 39.67 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 -179.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -144.42 137.13 26.8 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.546 ' N ' HD23 ' A' ' 93' ' ' LEU . 1.1 pt? -168.17 169.42 10.99 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.79 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -172.14 159.29 4.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.723 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 66.9 m80 52.84 -178.03 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.983 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 51.57 83.87 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.969 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -167.72 83.3 0.2 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.171 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 69.2 m80 -68.75 144.85 54.24 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.888 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 30.1 p80 -63.3 138.87 58.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.296 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 62.9 m80 . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 118.005 -0.998 . . . . 0.0 111.212 179.861 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 68.1 mttm . . . . . 0 N--CA 1.491 1.625 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 37.2 pt -68.84 -16.47 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.332 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.1 t -56.31 -31.01 63.28 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.892 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 39.4 tp 60.16 145.44 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.106 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -70.3 148.33 48.62 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -68.84 143.04 54.68 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.509 HD12 ' OE1' ' A' ' 43' ' ' GLN . 3.8 mm? -83.98 150.55 25.57 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 91.1 p -160.52 133.77 6.69 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.488 ' CE ' HE22 ' A' ' 43' ' ' GLN . 67.6 mttm -147.83 166.81 26.47 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.355 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 41.2 t -120.85 136.78 54.83 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.073 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.1 m -122.57 126.25 26.2 Favored Pre-proline 0 CA--C 1.561 1.369 0 CA-C-O 119.034 -0.508 . . . . 0.0 109.772 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -59.29 146.85 93.42 Favored 'Trans proline' 0 N--CA 1.506 2.212 0 CA-C-N 121.664 1.63 . . . . 0.0 111.816 178.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.1 t -96.31 132.31 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -125.2 127.96 47.59 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.0 mp -96.26 135.52 37.97 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -116.82 107.4 14.58 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 57.2 mt -67.32 124.6 23.6 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 28.8 m -117.07 128.72 55.43 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.68 -164.3 12.09 Favored Glycine 0 N--CA 1.473 1.138 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -119.58 147.83 44.03 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 115.005 -0.598 . . . . 0.0 109.817 178.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -68.69 139.68 55.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.078 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.49 151.56 44.03 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.48 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.1 t -63.18 -22.08 66.63 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.194 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -83.67 -21.78 32.32 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.7 t -105.02 126.64 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 121.071 0.463 . . . . 0.0 109.964 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.9 m -88.12 -32.48 18.66 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.149 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 94.1 p -155.82 159.65 39.57 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.202 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 81.7 mt -127.52 134.49 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.523 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.6 m -126.1 150.45 48.2 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -139.31 152.25 47.08 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.04 0.448 . . . . 0.0 109.936 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 93.1 p -150.5 152.18 33.81 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.69 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -147.41 147.87 30.71 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.061 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -69.55 -36.09 76.02 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.738 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -139.67 129.38 24.56 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -117.44 27.96 7.39 Favored Glycine 0 N--CA 1.474 1.194 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 40.7 p-80 -145.63 139.41 26.6 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 29.4 m -131.2 161.28 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 49.9 m -103.79 134.29 47.36 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 38.1 pt -116.86 146.38 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 123.12 0.568 . . . . 0.0 109.664 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 52.1 t -132.69 134.21 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 165.49 -158.98 32.05 Favored Glycine 0 N--CA 1.466 0.667 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.4 t -67.4 149.23 50.55 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.509 ' OE1' HD12 ' A' ' 7' ' ' LEU . 71.3 tp60 -64.86 -38.35 90.68 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.379 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -62.01 -39.1 91.13 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.807 0.337 . . . . 0.0 110.6 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.36 -39.55 92.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.675 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 68.6 mtt -66.41 -40.56 89.65 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.579 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -64.3 -24.93 67.83 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.595 0.236 . . . . 0.0 110.547 -179.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -76.26 -37.71 57.22 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 69.7 mt -83.11 117.41 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -99.94 -26.51 13.97 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.328 0.585 . . . . 0.0 109.875 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 96.8 p -171.05 164.11 7.44 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.087 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 41.4 mm -106.26 118.84 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.658 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.4 t -87.85 134.18 33.75 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 38.6 t -132.39 89.0 37.88 Favored Pre-proline 0 N--CA 1.473 0.683 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -81.64 146.41 15.06 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 121.485 1.457 . . . . 0.0 111.54 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.6 p -139.69 136.49 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.857 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -76.47 126.21 30.58 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 20.8 pt -109.71 -2.94 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 122.706 0.402 . . . . 0.0 110.39 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 91.3 p -80.66 -15.07 57.5 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.58 -178.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -102.75 -11.35 18.42 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.126 0.571 . . . . 0.0 110.778 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.9 m -101.34 131.2 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 68.7 p -137.19 11.71 3.04 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.635 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -147.6 145.95 29.2 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.764 -178.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -56.82 136.18 55.56 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.519 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.409 ' OG1' ' N ' ' A' ' 66' ' ' SER . 5.1 t -167.31 -177.28 3.58 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.555 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.409 ' N ' ' OG1' ' A' ' 65' ' ' THR . 47.3 t -149.55 145.99 27.11 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.058 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -148.02 143.53 27.3 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.362 0.601 . . . . 0.0 110.967 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 35.0 m -82.03 135.82 35.3 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.818 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 89.3 mt -119.8 129.58 54.51 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.075 0.55 . . . . 0.0 110.25 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -94.68 134.9 36.76 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 47.4 mt -108.24 133.95 51.77 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.034 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -139.14 147.1 41.46 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -147.62 139.91 24.44 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.408 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.3 mp0 -86.72 117.43 25.47 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.454 0.645 . . . . 0.0 112.037 -178.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 116.44 -16.71 14.48 Favored Glycine 0 N--CA 1.48 1.597 0 CA-C-N 114.221 -1.354 . . . . 0.0 111.74 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.1 m -134.73 160.33 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 50.5 m -105.63 112.51 25.62 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.4 t -89.73 132.05 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -156.13 140.43 11.75 Favored Pre-proline 0 CA--C 1.552 1.035 0 CA-C-O 119.07 -0.49 . . . . 0.0 110.882 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -70.16 -10.66 12.4 Favored 'Cis proline' 0 N--CA 1.513 2.671 0 CA-C-N 120.788 1.317 . . . . 0.0 111.042 0.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.0 p 58.22 19.36 6.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.704 -1.135 . . . . 0.0 112.029 177.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.1 p -130.16 140.29 50.78 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.5 m -151.46 154.17 8.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -101.96 132.8 47.57 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.3 p -128.85 132.04 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 121.164 0.506 . . . . 0.0 109.935 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -106.28 125.98 51.67 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.871 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 57.6 mt -109.38 108.99 19.73 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -92.95 128.87 38.97 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 33.7 m -91.49 137.42 21.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.226 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 26.3 m -104.11 109.72 21.63 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -76.08 129.25 36.53 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 110.559 -0.163 . . . . 0.0 110.559 -178.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -61.13 104.83 0.42 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.058 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 59.7 mt -75.21 140.12 43.06 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 52.42 89.33 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.526 0.203 . . . . 0.0 110.93 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -68.96 111.14 4.8 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.189 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -67.75 95.66 0.52 Allowed 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 120.805 0.336 . . . . 0.0 110.266 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -168.92 115.24 0.61 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.711 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 43.4 p-80 -169.86 -21.29 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 -166.41 136.6 3.29 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.294 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 118.097 -0.954 . . . . 0.0 110.256 179.751 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 63.6 tttm . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.668 HD13 ' H ' ' A' ' 2' ' ' ILE . 0.1 OUTLIER -139.96 172.17 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.207 -0.452 . . . . 0.0 109.874 -179.77 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 96.2 p -168.92 162.72 11.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.053 178.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 70.1 mt -68.59 148.73 50.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.714 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 71.4 mtp85 -63.06 -84.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.257 -179.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.0 mtmm -83.07 142.67 31.12 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 50.9 mt -113.89 155.05 26.47 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.3 t -153.46 156.56 38.39 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.932 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.8 tptt -155.5 164.19 39.01 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.746 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 87.8 p -127.9 137.42 52.3 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.186 -0.915 . . . . 0.0 108.668 179.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.1 m -131.19 144.52 53.82 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.595 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -74.39 144.43 32.61 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 121.864 1.709 . . . . 0.0 111.505 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.5 m -96.73 145.72 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -122.15 139.4 53.79 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.6 mp -113.82 135.96 53.39 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -121.88 118.53 29.15 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.74 0.65 . . . . 0.0 109.262 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 51.3 mt -72.56 126.32 29.59 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 79.9 p -119.24 128.59 54.33 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.98 160.31 13.53 Favored Glycine 0 N--CA 1.47 0.929 0 N-CA-C 110.414 -1.075 . . . . 0.0 110.414 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -84.15 145.48 28.37 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 178.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -65.05 137.58 57.79 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.298 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.91 159.57 25.3 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.981 0.419 . . . . 0.0 110.446 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.4 t -71.49 -30.45 65.99 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.559 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -83.62 -11.06 57.77 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 122.156 0.182 . . . . 0.0 111.176 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 64.2 t -108.5 130.06 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 36.1 m -87.19 -41.79 13.47 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.936 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 45.0 t -159.23 160.51 35.41 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.301 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 76.5 mt -132.15 143.57 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.576 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.4 m -130.86 158.1 41.1 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.186 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -142.51 152.47 42.69 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.867 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 45.7 t -151.93 162.82 40.46 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.759 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -143.87 147.38 33.96 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.035 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -72.49 -33.8 67.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.366 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -135.43 -52.38 0.76 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 122.57 0.348 . . . . 0.0 110.251 -179.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.82 28.23 60.19 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 51.5 m-70 -140.96 137.33 32.98 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.6 m -129.66 161.17 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 27.7 m -103.16 138.91 39.35 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 34.3 pt -119.54 147.89 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.484 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 48.6 t -130.4 134.71 61.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.738 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 162.38 -158.47 30.57 Favored Glycine 0 N--CA 1.462 0.413 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 56.4 m -76.11 149.59 37.37 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 29.2 mm100 -62.38 -29.92 70.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.451 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -61.76 -47.96 82.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.47 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.45 -38.45 91.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.631 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 68.1 mtt -65.99 -39.57 90.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.494 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -62.45 -30.74 71.46 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.555 0.216 . . . . 0.0 110.773 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -74.68 -36.98 62.78 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.717 0.294 . . . . 0.0 110.691 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 68.6 mt -89.13 117.5 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -108.24 -21.42 12.78 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.109 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 93.9 p -170.32 159.19 7.04 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.887 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 72.6 mt -109.44 128.04 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.6 m -89.33 131.67 35.3 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.6 t -128.57 90.37 46.69 Favored Pre-proline 0 CA--C 1.542 0.659 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 178.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -81.8 147.84 15.42 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 122.175 1.916 . . . . 0.0 111.297 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.3 p -142.84 136.17 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.077 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -75.62 129.64 37.49 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 35.1 pt -104.69 -11.04 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 O-C-N 123.299 0.374 . . . . 0.0 110.304 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 80.6 p -61.18 -39.3 89.64 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.143 -178.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -86.5 -5.01 59.26 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 122.534 0.334 . . . . 0.0 110.402 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 42.6 t -94.65 117.62 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 58.0 p -134.56 2.05 3.17 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.025 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -147.38 156.52 42.97 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.992 0.425 . . . . 0.0 110.253 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -63.73 136.99 57.89 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.006 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.1 t -166.82 177.49 6.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.163 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 44.1 t -144.01 140.37 29.54 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.408 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -139.28 143.3 37.86 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.108 0.48 . . . . 0.0 110.518 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 28.1 m -83.74 132.52 34.84 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.8 mt -119.69 129.85 54.74 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.451 ' CD ' ' HZ1' ' A' ' 72' ' ' LYS . 19.5 pt-20 -97.81 137.19 37.05 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 43.3 mt -113.49 136.69 52.52 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.451 ' HZ1' ' CD ' ' A' ' 70' ' ' GLU . 63.0 mttp -132.82 140.96 48.22 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -135.55 143.48 45.72 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -85.99 135.62 33.58 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.819 0.818 . . . . 0.0 111.907 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.82 -28.25 8.01 Favored Glycine 0 N--CA 1.476 1.345 0 CA-C-N 114.303 -1.317 . . . . 0.0 112.732 178.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.5 m -118.9 163.45 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 34.0 m -109.48 116.22 31.39 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.0 t -93.81 131.66 40.13 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -157.69 141.39 11.33 Favored Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.703 178.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.54 -12.3 11.72 Favored 'Cis proline' 0 N--CA 1.506 2.239 0 CA-C-N 119.814 0.969 . . . . 0.0 110.051 -0.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.2 p 61.99 23.43 13.8 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.637 177.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 39.3 p -131.01 138.72 49.78 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 24.0 m -151.11 149.76 13.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -95.92 133.51 40.02 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.6 p -128.12 133.09 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -107.52 127.37 53.56 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 39.5 mt -111.06 106.51 15.6 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -89.35 129.63 35.85 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 18.6 t -106.55 132.88 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 31.5 m -100.33 121.03 40.84 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -86.7 133.64 33.66 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -67.66 137.55 55.66 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.454 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 6.7 tp -166.03 65.42 0.11 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.067 0.46 . . . . 0.0 110.702 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.454 ' CD ' ' H ' ' A' ' 93' ' ' LEU . 44.6 mp0 -140.62 153.24 45.97 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.3 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 69.1 m80 -65.44 160.14 22.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.771 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 31.7 p-80 -169.04 81.27 0.13 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.994 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -70.56 157.49 37.81 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -162.01 159.76 26.78 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.132 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -67.46 146.55 53.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.862 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 59.9 t-80 . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.012 179.987 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 68.2 mttm . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 38.6 mm -63.65 -43.64 98.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.207 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.1 m -58.96 -42.18 89.29 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.933 0.397 . . . . 0.0 111.05 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 64.7 mt -70.51 146.96 49.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.825 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 54.22 77.68 0.19 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.947 0.403 . . . . 0.0 110.906 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -64.68 136.27 56.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.775 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 57.2 mt -112.88 147.37 37.16 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 95.3 p -147.92 151.07 35.22 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.721 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -146.67 165.09 30.61 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.671 0.748 . . . . 0.0 109.6 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 92.6 p -112.04 136.22 51.68 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 114.004 -1.453 . . . . 0.0 109.918 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.4 m -134.33 99.38 13.31 Favored Pre-proline 0 CA--C 1.544 0.749 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -179.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -57.56 148.23 74.31 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 CA-C-N 120.191 1.104 . . . . 0.0 111.591 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 15.9 t -86.14 132.83 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -113.26 123.34 49.94 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.2 mp -96.27 131.71 42.49 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -120.07 107.73 13.41 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 178.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.9 pp -68.46 129.36 39.7 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.27 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.4 p -130.86 141.7 50.33 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 122.984 0.514 . . . . 0.0 109.645 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.85 168.24 16.49 Favored Glycine 0 N--CA 1.474 1.178 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -86.29 134.76 33.73 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -65.4 137.44 57.49 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.91 173.36 1.08 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.501 0.667 . . . . 0.0 111.32 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 35.2 t -84.71 -23.28 29.4 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.116 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -88.46 -13.65 39.84 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.406 HG13 ' O ' ' A' ' 25' ' ' VAL . 7.1 p -102.28 126.02 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-O 121.169 0.509 . . . . 0.0 112.039 -177.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 38.3 t -91.01 -31.01 16.48 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.35 179.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.7 t -159.75 158.13 30.68 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.47 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 85.9 mt -127.88 136.38 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.586 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.9 t -130.54 153.22 49.08 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -147.22 155.62 42.24 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.115 0.483 . . . . 0.0 110.562 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 50.4 m -146.6 160.09 42.61 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.879 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -140.81 143.1 34.63 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.812 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -71.87 -34.02 68.85 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.757 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.401 ' O ' ' ND1' ' A' ' 36' ' ' HIS . 99.6 mtt180 -128.13 -55.95 1.26 Allowed 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 121.194 0.521 . . . . 0.0 110.132 -179.104 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.23 22.64 58.69 Favored Glycine 0 CA--C 1.523 0.555 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.536 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.401 ' ND1' ' O ' ' A' ' 34' ' ' ARG . 12.8 p-80 -149.93 138.73 20.91 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.481 HG22 ' N ' ' A' ' 38' ' ' THR . 3.3 p -127.89 163.32 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.481 ' N ' HG22 ' A' ' 37' ' ' VAL . 52.0 m -100.22 132.6 45.49 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.905 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.5 pt -114.84 134.4 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 123.363 0.665 . . . . 0.0 109.304 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.6 t -124.47 133.5 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 163.9 -154.47 25.37 Favored Glycine 0 N--CA 1.468 0.826 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.4 m -69.66 145.41 52.42 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 70.6 tp60 -62.96 -34.49 77.61 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.615 0.245 . . . . 0.0 110.367 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -61.55 -41.44 97.37 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.638 0.256 . . . . 0.0 110.791 -179.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.91 -37.9 89.11 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.777 0.322 . . . . 0.0 110.717 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 66.7 mtt -64.77 -39.78 94.17 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.447 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -63.79 -30.78 71.84 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.539 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -73.92 -40.73 62.91 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.776 0.322 . . . . 0.0 110.66 179.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 58.7 mt -84.8 117.63 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -178.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -114.21 -17.67 11.81 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.04 0.536 . . . . 0.0 110.826 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 73.4 p -174.13 132.74 0.41 Allowed 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.941 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 42.4 mm -83.04 124.08 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 32.5 m -91.55 126.26 36.58 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.4 t -133.46 91.35 26.85 Favored Pre-proline 0 N--CA 1.474 0.774 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -82.01 145.13 13.84 Favored 'Trans proline' 0 N--CA 1.5 1.881 0 C-N-CA 121.672 1.581 . . . . 0.0 111.617 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 60.8 t -129.71 129.13 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.021 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -68.58 125.04 25.25 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.7 pt -99.93 -12.83 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-O 120.847 0.356 . . . . 0.0 110.526 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.5 m -60.17 -38.72 84.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.554 -178.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -86.2 -4.1 59.1 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 122.557 0.343 . . . . 0.0 110.335 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 46.9 t -94.22 111.79 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 60.3 p -128.57 2.87 5.55 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.617 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -152.45 163.03 40.34 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.575 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -64.39 136.64 57.31 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.204 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.7 t -166.36 177.95 6.47 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.585 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 99.1 p -149.71 144.25 25.97 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.818 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -143.51 143.36 31.52 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-O 121.228 0.537 . . . . 0.0 110.476 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 51.4 m -81.75 131.85 35.27 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 64.8 mt -117.39 120.42 38.1 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.823 0.449 . . . . 0.0 109.857 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -84.24 133.64 34.57 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 50.8 mt -102.75 133.79 47.21 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 122.598 0.359 . . . . 0.0 110.047 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -136.17 141.06 44.03 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 122.957 0.503 . . . . 0.0 110.215 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -150.98 130.21 12.74 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -86.21 114.32 22.94 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.293 0.568 . . . . 0.0 111.282 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 128.64 -22.05 5.27 Favored Glycine 0 N--CA 1.48 1.589 0 CA-C-N 114.529 -1.214 . . . . 0.0 111.519 178.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.5 m -134.87 160.41 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-O 120.897 0.38 . . . . 0.0 110.271 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 46.4 m -100.82 117.41 34.83 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.405 HG22 ' H ' ' A' ' 78' ' ' VAL . 0.4 OUTLIER -95.99 131.92 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.881 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -155.29 135.45 8.39 Favored Pre-proline 0 CA--C 1.553 1.07 0 CA-C-O 119.071 -0.49 . . . . 0.0 110.537 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -71.25 -7.53 12.81 Favored 'Cis proline' 0 N--CA 1.52 3.032 0 CA-C-N 121.325 1.509 . . . . 0.0 111.091 0.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.3 p 59.94 17.85 6.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.661 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.4 p -132.92 140.69 47.98 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.6 m -147.73 154.82 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -101.05 134.38 44.14 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.9 p -131.6 138.18 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 121.178 0.514 . . . . 0.0 110.29 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -114.89 126.88 55.31 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.999 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 56.1 mt -109.16 109.15 20.04 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -92.98 127.68 38.58 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.9 t -100.94 132.35 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 46.0 m -100.16 122.09 42.45 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-O 120.689 0.28 . . . . 0.0 110.709 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -101.54 127.78 48.09 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.065 0.546 . . . . 0.0 109.914 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -127.29 99.16 5.54 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 177.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.431 ' N ' HD12 ' A' ' 93' ' ' LEU . 9.8 mp -73.62 95.11 2.26 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -61.88 -31.9 72.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.047 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 60.5 t-80 53.03 79.83 0.11 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.928 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 47.6 p-80 -62.2 126.17 26.41 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.417 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -169.44 119.89 0.68 Allowed 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.4 ' CD2' ' H ' ' A' ' 98' ' ' HIS . 17.2 p80 -68.09 118.21 10.94 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -69.32 130.31 42.23 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 . . . . . 0 C--O 1.221 -0.437 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.551 -179.88 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 63.0 mttp . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 37.2 pt -64.06 168.28 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.202 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.9 m -157.63 161.62 38.66 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.577 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.488 HD23 ' N ' ' A' ' 5' ' ' ARG . 1.8 tt -147.98 118.86 7.6 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.488 ' N ' HD23 ' A' ' 4' ' ' LEU . 48.5 ptt85 -169.23 157.52 7.67 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.948 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -136.69 144.45 43.94 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 71.3 mt -97.69 177.02 5.62 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.8 t -159.89 153.41 22.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.515 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -144.89 166.29 25.69 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.561 0.696 . . . . 0.0 109.699 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 95.2 p -114.19 134.87 54.61 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 114.216 -1.356 . . . . 0.0 109.692 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.5 m -129.25 94.99 31.85 Favored Pre-proline 0 CA--C 1.547 0.861 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -57.71 146.02 87.21 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 CA-C-N 119.992 1.033 . . . . 0.0 111.567 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.0 t -93.98 133.94 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.325 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -114.02 130.15 56.57 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.3 tp -96.39 130.61 43.48 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -122.45 108.54 13.3 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 120.976 0.417 . . . . 0.0 109.879 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.0 pp -65.25 130.16 42.33 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.741 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.7 m -127.57 135.38 50.23 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.81 165.19 15.66 Favored Glycine 0 N--CA 1.475 1.273 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -85.72 134.18 33.97 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.7 ptmm? -63.29 136.95 58.01 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.617 0.246 . . . . 0.0 110.459 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.0 170.43 4.38 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.348 0.594 . . . . 0.0 111.133 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 34.6 t -81.0 -23.16 38.87 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.292 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -87.35 -11.34 49.67 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.8 p -110.1 129.28 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-O 120.84 0.352 . . . . 0.0 110.821 -178.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 36.2 t -86.47 -37.6 18.13 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.982 0.42 . . . . 0.0 109.986 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 98.7 p -160.78 160.07 30.79 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.397 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 92.8 mt -131.31 139.73 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 60.2 m -125.75 154.61 42.25 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -141.37 152.84 44.7 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.017 0.437 . . . . 0.0 110.302 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 96.6 p -151.52 162.05 41.62 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.204 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.469 ' CD1' ' N ' ' A' ' 35' ' ' GLY . 25.0 p90 -146.39 147.35 31.2 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.181 -179.412 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -69.99 -35.11 74.15 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.612 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -158.98 89.07 0.92 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.409 0.623 . . . . 0.0 109.97 -179.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.469 ' N ' ' CD1' ' A' ' 32' ' ' PHE . . . -76.78 38.17 1.48 Allowed Glycine 0 N--CA 1.462 0.429 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.755 -178.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 27.5 p80 -144.85 137.97 26.69 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 117.659 0.73 . . . . 0.0 109.432 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.6 m -129.16 162.45 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 26.4 m -102.61 133.22 47.96 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 37.9 pt -119.31 146.19 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 122.972 0.509 . . . . 0.0 110.325 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 50.0 t -129.37 134.85 62.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.949 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 162.66 -156.96 28.84 Favored Glycine 0 N--CA 1.467 0.753 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 50.9 m -74.85 147.94 40.66 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 110.321 -0.251 . . . . 0.0 110.321 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -63.92 -30.61 71.67 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.371 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -60.47 -45.16 94.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.721 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.42 -39.61 85.48 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.664 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 67.9 mtt -65.54 -40.87 93.37 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.287 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -64.14 -31.71 73.0 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.045 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.1 tppt? -71.94 -38.57 69.81 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.16 0.505 . . . . 0.0 110.551 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 72.4 mt -88.21 117.52 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.604 -178.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -99.92 -24.93 14.5 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.36 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.9 m -169.99 -178.82 3.0 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.616 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 85.8 mt -124.34 123.48 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 42.4 m -96.07 128.38 42.92 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.5 t -128.53 90.6 46.07 Favored Pre-proline 0 N--CA 1.473 0.718 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -83.47 144.08 11.28 Favored 'Trans proline' 0 N--CA 1.5 1.896 0 C-N-CA 121.829 1.686 . . . . 0.0 111.571 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.6 p -137.44 135.35 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 CA-C-O 121.067 0.461 . . . . 0.0 110.935 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -67.07 128.87 38.0 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 36.1 pt -101.67 -11.23 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-O 120.985 0.422 . . . . 0.0 110.547 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.8 t -62.22 -40.6 96.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.57 -178.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -83.26 -6.88 59.62 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.757 0.423 . . . . 0.0 110.218 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 43.4 t -92.56 109.77 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 70.6 p -132.08 1.91 3.92 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.755 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -142.39 151.97 42.37 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -64.28 134.23 54.3 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.249 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.402 ' OG1' ' N ' ' A' ' 66' ' ' SER . 5.5 t -167.13 -178.38 4.12 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.013 0.435 . . . . 0.0 110.907 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.402 ' N ' ' OG1' ' A' ' 65' ' ' THR . 99.2 p -138.62 147.44 42.93 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.196 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -136.03 141.56 44.34 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.268 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 63.8 m -97.36 125.54 42.03 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 177.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 66.1 mt -120.72 135.93 55.0 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.802 0.441 . . . . 0.0 110.09 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.9 mp0 -98.86 138.3 36.19 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 24.7 mt -106.12 132.28 52.39 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 116.296 -0.411 . . . . 0.0 109.995 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -129.98 140.86 50.83 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -146.82 130.9 17.3 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -85.11 115.38 22.88 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.32 0.581 . . . . 0.0 111.203 -178.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 125.78 -21.13 6.32 Favored Glycine 0 N--CA 1.48 1.575 0 CA-C-N 114.577 -1.192 . . . . 0.0 111.761 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.3 m -132.49 159.09 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 80.7 m -102.94 110.64 22.64 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.4 t -91.58 128.93 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -155.69 138.77 10.75 Favored Pre-proline 0 CA--C 1.554 1.115 0 CA-C-O 118.893 -0.575 . . . . 0.0 110.363 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -70.4 -11.21 13.1 Favored 'Cis proline' 0 N--CA 1.517 2.909 0 CA-C-N 121.291 1.497 . . . . 0.0 110.781 0.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 60.1 22.54 11.77 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.744 -1.117 . . . . 0.0 112.343 177.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 37.7 p -127.07 140.57 52.19 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.7 m -147.53 142.83 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -93.86 131.26 39.44 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 43.4 t -123.3 121.5 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -99.83 123.62 44.28 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 65.4 mt -108.45 105.92 15.8 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -87.91 130.46 34.91 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 26.6 t -104.16 131.39 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 49.5 m -100.05 120.07 39.27 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 -82.46 132.2 35.21 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -54.54 142.85 26.22 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.645 0.26 . . . . 0.0 110.799 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.431 ' N ' HD22 ' A' ' 93' ' ' LEU . 3.8 mm? -72.62 147.34 45.9 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -71.14 4.23 2.92 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.137 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.501 ' N ' ' HD1' ' A' ' 95' ' ' HIS . 0.0 OUTLIER -59.67 141.93 54.05 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.678 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -67.16 127.97 34.63 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.284 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -167.26 149.63 6.05 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -168.62 88.41 0.21 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.881 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 68.5 m80 53.54 -174.96 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.992 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 32.2 p-80 . . . . . 0 C--O 1.221 -0.441 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.56 179.937 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.0 mttt . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 33.7 pt -66.14 -24.63 34.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.234 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.6 p 61.59 148.82 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.241 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.4 tt -71.63 145.72 48.78 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.901 0.381 . . . . 0.0 110.141 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 47.1 ptt85 -170.0 145.21 2.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.429 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -92.83 149.4 21.3 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 56.9 mt -89.74 164.82 14.52 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.6 t -161.3 141.08 10.55 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -149.85 167.12 27.5 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -178.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 39.8 t -124.11 137.99 54.49 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 114.867 -1.061 . . . . 0.0 109.136 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.3 m -122.76 144.57 43.04 Favored Pre-proline 0 N--CA 1.482 1.139 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -73.05 143.18 35.71 Favored 'Trans proline' 0 N--CA 1.5 1.872 0 C-N-CA 121.345 1.363 . . . . 0.0 111.586 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 43.8 t -103.69 134.0 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -125.91 146.86 49.66 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.2 mt -112.2 132.59 54.82 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -114.22 113.97 25.36 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.317 -0.624 . . . . 0.0 109.317 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 49.5 mt -70.33 124.1 23.33 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 76.4 p -119.76 135.31 54.9 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 115.55 163.14 13.72 Favored Glycine 0 N--CA 1.471 1.024 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.4 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 1.0 OUTLIER -85.13 138.91 32.1 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 179.131 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -65.9 132.09 47.81 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.18 177.02 2.42 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.468 0.651 . . . . 0.0 110.786 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 89.9 p -85.23 -19.16 32.09 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.929 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -88.13 -21.53 24.6 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 122.134 0.174 . . . . 0.0 110.737 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.3 p -97.37 126.33 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-O 120.859 0.361 . . . . 0.0 111.008 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.5 t -92.6 -35.92 13.29 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.7 t -161.21 158.03 26.69 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.095 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 82.3 mt -128.73 136.62 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 60.5 m -128.97 153.49 47.5 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -144.62 155.58 43.69 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.188 0.518 . . . . 0.0 110.346 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 87.8 p -150.95 163.5 38.55 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.16 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -146.4 147.59 31.43 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.017 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -71.59 -34.03 69.56 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.533 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -134.13 -52.09 0.83 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 122.892 0.477 . . . . 0.0 110.167 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.31 23.41 62.22 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.44 ' ND1' ' O ' ' A' ' 36' ' ' HIS . 18.0 p80 -147.6 140.11 24.61 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.159 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 28.4 m -133.11 165.97 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 46.1 m -99.8 137.92 37.6 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 38.7 pt -119.63 148.46 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.4 t -130.68 134.13 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-O 120.915 0.388 . . . . 0.0 109.97 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 167.2 -163.09 36.86 Favored Glycine 0 N--CA 1.464 0.536 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.2 t -73.41 155.03 39.74 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 110.375 -0.232 . . . . 0.0 110.375 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 70.4 tp60 -63.36 -37.57 87.8 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.549 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -64.04 -39.01 93.15 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 110.435 -0.209 . . . . 0.0 110.435 -179.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.33 -44.4 83.44 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.868 0.365 . . . . 0.0 111.097 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 77.8 mtm -68.23 -39.27 82.36 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.825 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -60.36 -32.76 71.59 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.578 0.228 . . . . 0.0 110.895 -179.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.5 ttpp -70.69 -33.63 71.11 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.729 0.3 . . . . 0.0 110.49 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 71.1 mt -86.44 119.17 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -107.56 -22.11 12.65 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-O 121.228 0.537 . . . . 0.0 110.194 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 95.2 p -171.96 162.33 5.94 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.877 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 36.5 mm -107.07 119.28 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 38.2 m -96.69 127.77 42.99 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 26.0 t -133.5 93.0 22.47 Favored Pre-proline 0 N--CA 1.474 0.775 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -77.29 145.19 23.88 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 121.032 1.155 . . . . 0.0 111.422 -178.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.9 t -132.48 129.56 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.904 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -71.38 127.06 31.31 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.609 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 36.5 pt -99.09 -12.73 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 122.597 0.359 . . . . 0.0 110.92 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 80.6 p -59.04 -38.57 79.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.568 -178.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -86.79 -4.78 59.22 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 122.565 0.346 . . . . 0.0 110.505 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.1 t -93.72 110.85 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 67.8 p -131.5 4.46 4.29 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.414 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.3 tp10 -152.33 158.13 42.3 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.851 0.358 . . . . 0.0 110.105 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -59.79 137.41 58.06 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.329 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.2 t -165.01 166.99 18.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.13 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 42.5 t -141.79 140.84 33.13 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.655 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -148.81 147.38 28.7 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.892 0.853 . . . . 0.0 111.11 -179.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 39.6 m -81.67 136.08 35.51 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 114.278 -1.328 . . . . 0.0 109.328 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.5 mt -110.9 113.06 25.35 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.061 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 50.2 tp10 -75.73 126.29 30.71 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 44.9 mt -104.63 128.07 52.55 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -133.2 141.56 48.14 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -142.31 141.73 32.43 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -85.06 134.84 34.19 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 122.027 0.918 . . . . 0.0 113.137 -177.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.8 -9.5 76.12 Favored Glycine 0 N--CA 1.474 1.185 0 CA-C-N 114.152 -1.385 . . . . 0.0 112.073 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.0 m -133.89 161.74 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 60.6 m -110.41 113.68 26.52 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.6 t -90.3 132.61 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -156.51 139.73 11.0 Favored Pre-proline 0 CA--C 1.554 1.118 0 CA-C-O 119.013 -0.518 . . . . 0.0 110.867 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.5 -12.94 11.83 Favored 'Cis proline' 0 N--CA 1.515 2.738 0 CA-C-N 120.838 1.335 . . . . 0.0 110.887 0.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.7 p 61.55 22.52 12.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.66 177.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.2 p -131.93 139.97 48.87 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.2 m -151.34 154.27 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -98.44 132.8 43.6 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.3 t -127.64 130.32 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -107.47 124.94 50.62 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 55.0 mt -109.34 109.57 20.5 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -179.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -91.02 128.3 36.79 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 23.9 t -102.78 131.8 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 52.1 m -99.13 118.19 35.3 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 96.0 mm-40 -74.79 135.29 41.69 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -89.85 139.85 30.18 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -153.16 47.97 0.7 Allowed 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.311 0.577 . . . . 0.0 109.975 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -150.32 162.93 39.56 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.581 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -152.83 148.72 27.52 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.844 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -74.69 7.0 3.33 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.304 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 21.1 m170 56.92 106.12 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.642 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 15.5 p80 -56.71 -41.39 77.34 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.823 0.344 . . . . 0.0 110.688 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 -61.74 111.69 1.96 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.344 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 . . . . . 0 C--O 1.22 -0.471 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.413 179.947 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.4 tp . . . . . 0 N--CA 1.445 -0.681 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 90.3 p -145.06 148.26 33.5 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.476 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -144.52 166.34 25.42 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.466 0.651 . . . . 0.0 109.563 -178.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.4 t -113.45 135.99 53.28 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.572 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.5 m -128.86 100.37 21.29 Favored Pre-proline 0 CA--C 1.549 0.904 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -57.01 144.62 89.09 Favored 'Trans proline' 0 N--CA 1.499 1.842 0 C-N-CA 121.095 1.196 . . . . 0.0 111.704 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 23.0 m -88.86 139.56 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.681 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -119.17 116.41 26.25 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.421 ' N ' HD12 ' A' ' 15' ' ' LEU . 10.8 mp -89.98 135.13 33.83 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -122.49 116.66 24.32 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 58.2 mt -66.61 126.06 27.73 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.3 m -127.4 133.96 49.95 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.65 165.06 15.75 Favored Glycine 0 N--CA 1.472 1.043 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -81.32 138.19 35.7 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -68.22 139.49 56.04 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.03 144.09 57.36 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 83.2 p -68.89 -24.08 64.28 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.185 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -91.5 2.89 56.11 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 122.218 0.207 . . . . 0.0 110.99 -179.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 52.8 t -118.91 126.16 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 36.4 t -75.05 -43.32 54.14 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.339 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 37.5 t -163.94 162.11 23.22 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.723 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 80.4 mt -130.4 146.1 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.337 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 40.2 t -132.58 161.83 32.84 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.497 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -146.21 154.67 42.01 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.069 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 50.8 m -144.69 170.89 15.22 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.802 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -146.74 147.69 31.21 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.808 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -74.57 -33.36 62.67 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.067 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 86.7 mtm180 -133.6 -49.77 0.84 Allowed 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.729 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.38 19.27 57.38 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 47.9 m80 -142.25 137.5 30.74 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.49 HG22 ' N ' ' A' ' 38' ' ' THR . 4.1 p -133.4 161.88 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.49 ' N ' HG22 ' A' ' 37' ' ' VAL . 34.1 m -101.53 135.0 43.78 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.335 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 40.5 pt -120.04 149.66 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.8 t -132.79 134.97 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 166.57 -160.3 33.86 Favored Glycine 0 N--CA 1.464 0.531 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.8 m -73.01 151.74 41.63 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 62.1 tp60 -64.96 -34.49 78.54 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.313 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -60.61 -43.81 97.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.736 0.303 . . . . 0.0 110.622 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.72 -40.09 94.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.623 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 67.7 mtt -65.01 -40.67 95.23 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.597 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -65.55 -23.71 66.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.64 0.257 . . . . 0.0 110.53 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -80.61 -34.96 34.68 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.377 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 67.1 mt -91.61 116.35 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -99.1 -24.58 14.84 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.064 0.459 . . . . 0.0 110.221 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 92.9 p -172.36 162.8 5.52 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.044 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 36.7 mm -107.32 120.48 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 33.5 m -85.01 129.93 34.71 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 38.3 t -123.84 90.75 50.37 Favored Pre-proline 0 N--CA 1.471 0.619 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -79.26 146.2 19.62 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 121.485 1.456 . . . . 0.0 111.371 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.7 p -139.57 137.43 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.883 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -79.16 125.29 29.25 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 36.4 pt -103.08 -9.87 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 120.857 0.36 . . . . 0.0 110.294 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 40.3 m -61.81 -39.82 93.09 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.436 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -86.69 -5.0 59.25 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 122.928 0.491 . . . . 0.0 110.679 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 45.4 t -92.43 114.14 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 70.2 p -132.54 -0.13 3.59 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.172 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -144.62 155.7 43.75 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 121.007 0.432 . . . . 0.0 110.435 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -63.9 132.81 51.89 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.04 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.8 t -167.61 -174.9 2.63 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.342 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 96.8 p -151.26 147.25 26.75 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.611 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -140.16 143.93 36.4 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.109 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.8 m -83.13 132.03 35.11 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.168 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 74.8 mt -120.89 129.66 53.58 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 122.907 0.483 . . . . 0.0 109.839 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -96.6 137.68 35.32 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 52.2 mt -110.64 136.93 48.98 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -141.59 147.24 37.34 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -149.89 137.21 19.78 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -86.29 114.6 23.23 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.004 0.431 . . . . 0.0 110.941 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 125.12 -20.56 6.65 Favored Glycine 0 N--CA 1.485 1.937 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.625 178.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 32.8 m -134.13 159.87 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 31.7 m -102.73 111.14 23.32 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.1 t -92.04 129.14 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -156.75 142.0 12.45 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.494 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.92 -10.28 11.73 Favored 'Cis proline' 0 N--CA 1.508 2.33 0 CA-C-N 120.539 1.228 . . . . 0.0 110.58 -0.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.8 p 60.3 23.15 12.6 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.165 177.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 39.7 p -131.93 139.63 48.77 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.5 m -152.36 151.92 11.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -96.19 134.01 39.8 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 44.7 t -126.1 127.08 70.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -104.95 124.38 49.41 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 58.7 mt -108.01 108.68 19.9 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -90.16 129.63 36.41 Favored 'General case' 0 C--O 1.231 0.105 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 38.6 t -104.14 131.36 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 39.9 m -101.18 120.42 40.21 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 91.3 mm-40 . . . . . 0 C--N 1.333 -0.126 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -179.789 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 53.4 mt . . . . . 0 N--CA 1.464 0.268 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 95.8 p -160.58 150.31 17.59 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.8 mtpt -151.11 164.98 35.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.619 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 35.0 m -114.18 137.1 52.2 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.634 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.3 m -126.68 101.67 26.67 Favored Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 123.588 0.755 . . . . 0.0 109.051 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -57.02 144.53 89.42 Favored 'Trans proline' 0 N--CA 1.499 1.803 0 CA-C-N 120.342 1.158 . . . . 0.0 111.939 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 23.3 t -89.41 130.93 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.1 ttmm -117.33 126.95 53.55 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.6 mt -101.82 127.95 48.4 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -115.23 109.95 18.73 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.9 pp -64.19 129.23 39.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.154 -0.476 . . . . 0.0 109.736 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 31.6 m -126.07 135.66 52.0 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 115.23 162.66 13.68 Favored Glycine 0 N--CA 1.476 1.367 0 N-CA-C 110.581 -1.007 . . . . 0.0 110.581 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.0 p-10 -82.64 142.18 31.92 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -66.7 134.34 52.03 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.68 176.63 0.64 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.23 0.538 . . . . 0.0 111.143 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.8 t -85.75 -23.98 27.08 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.099 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -91.32 -13.14 33.12 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -178.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.5 p -98.56 128.25 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 CA-C-O 120.79 0.328 . . . . 0.0 110.875 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 46.7 t -92.09 -37.31 12.85 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.839 0.352 . . . . 0.0 110.122 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 98.3 p -161.21 159.16 28.46 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.151 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 73.9 mt -133.78 142.53 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 65.0 p -135.01 159.12 42.52 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.288 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -145.7 155.85 43.25 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.083 0.468 . . . . 0.0 110.182 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 47.7 t -147.4 163.46 36.41 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.254 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -146.46 143.76 29.2 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.288 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -69.27 -34.36 74.63 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.984 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -135.91 -51.27 0.72 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.014 0.526 . . . . 0.0 109.96 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.84 24.03 61.99 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.439 ' ND1' ' O ' ' A' ' 36' ' ' HIS . 17.8 p80 -148.69 139.68 23.04 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 28.4 m -131.6 164.51 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 61.4 m -99.71 133.55 43.89 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 37.9 pt -118.82 147.5 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 122.854 0.462 . . . . 0.0 110.25 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.2 t -132.13 135.6 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.399 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 170.97 -163.08 36.09 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 30.8 t -72.33 147.4 46.35 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 70.8 tp60 -58.8 -38.19 78.05 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.603 0.24 . . . . 0.0 111.117 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.445 ' CD ' ' H ' ' A' ' 44' ' ' GLU . 23.6 mp0 -59.84 -48.02 83.37 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.878 0.37 . . . . 0.0 110.793 -179.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.99 -37.9 86.57 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.738 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 21.2 mmt -65.79 -39.54 91.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.006 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -61.1 -31.98 71.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.609 0.242 . . . . 0.0 110.818 -178.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -71.55 -39.08 70.9 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.776 0.322 . . . . 0.0 110.316 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 57.5 mt -85.54 117.53 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -113.46 -19.52 11.65 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.184 0.593 . . . . 0.0 110.578 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 66.5 p -174.1 161.56 3.63 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.694 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 38.1 mm -111.4 117.85 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 48.2 m -105.51 124.44 49.55 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 36.1 t -127.17 113.44 21.62 Favored Pre-proline 0 N--CA 1.482 1.169 0 CA-C-O 118.446 -0.788 . . . . 0.0 109.792 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -76.81 143.62 23.73 Favored 'Trans proline' 0 N--CA 1.497 1.678 0 CA-C-N 121.254 1.484 . . . . 0.0 110.755 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.8 t -129.31 126.79 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -73.67 126.47 30.4 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.69 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 39.1 pt -102.69 -15.74 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 122.82 0.448 . . . . 0.0 110.912 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.8 t -61.39 -40.32 93.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.594 -178.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -83.3 -5.78 59.25 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 122.374 0.27 . . . . 0.0 110.616 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 47.4 t -91.2 108.45 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 70.6 p -129.88 1.51 4.84 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.636 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -141.95 146.79 36.05 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 21.2 p-10 -63.88 137.12 57.89 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.103 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.431 ' OG1' ' N ' ' A' ' 66' ' ' SER . 5.6 t -168.14 -173.43 2.03 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.265 0.555 . . . . 0.0 110.709 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.431 ' N ' ' OG1' ' A' ' 65' ' ' THR . 90.2 p -147.25 143.35 28.07 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.45 179.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -138.45 142.38 39.47 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.0 0.429 . . . . 0.0 110.238 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 44.6 m -82.1 131.89 35.24 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.5 mt -111.75 111.71 22.88 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 122.659 0.384 . . . . 0.0 110.29 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -83.77 126.37 32.85 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 31.8 mt -103.74 134.74 46.55 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 120.792 0.329 . . . . 0.0 110.597 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -134.94 142.06 46.42 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.084 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -145.41 135.27 23.59 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -85.5 117.73 24.58 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.328 0.585 . . . . 0.0 111.848 -178.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.61 -16.02 16.86 Favored Glycine 0 N--CA 1.482 1.704 0 CA-C-N 114.574 -1.194 . . . . 0.0 112.208 178.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 23.3 m -133.04 159.22 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 56.9 m -107.95 117.73 34.9 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.1 p -105.85 133.52 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 122.938 0.495 . . . . 0.0 109.741 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -158.81 143.67 11.69 Favored Pre-proline 0 CA--C 1.552 1.046 0 CA-C-O 119.078 -0.487 . . . . 0.0 110.654 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.413 ' C ' ' H ' ' A' ' 82' ' ' THR . 87.8 Cg_endo -70.2 -12.13 12.96 Favored 'Cis proline' 0 N--CA 1.516 2.815 0 CA-C-N 120.646 1.266 . . . . 0.0 110.998 0.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 67.6 -6.87 0.62 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.839 177.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.413 ' H ' ' C ' ' A' ' 80' ' ' PRO . 59.0 p -100.31 139.51 35.88 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.8 m -147.92 146.14 18.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -95.23 130.89 41.8 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 44.0 t -126.6 126.04 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -100.09 124.64 45.72 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 59.8 mt -110.41 104.16 12.89 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -92.81 128.88 38.83 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.4 p -107.83 137.08 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.627 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 69.9 m -100.24 121.5 41.56 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 95.4 mm-40 . . . . . 0 N--CA 1.468 0.44 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.985 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 58.6 mt . . . . . 0 N--CA 1.467 0.399 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.0 t -151.67 145.68 25.24 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.567 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -149.64 167.51 26.19 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.565 -178.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 30.5 m -109.48 139.06 44.92 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.059 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.5 m -131.84 95.03 23.48 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 123.625 0.77 . . . . 0.0 109.313 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -58.39 146.19 90.95 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 C-N-CA 121.207 1.272 . . . . 0.0 112.144 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.4 p -98.25 142.1 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.242 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -121.27 133.87 55.15 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 78.3 mt -100.06 128.54 46.13 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -113.47 111.89 22.7 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 56.5 mt -70.28 126.13 28.77 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.1 p -129.31 145.38 51.38 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.956 -0.386 . . . . 0.0 109.956 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.02 168.33 16.39 Favored Glycine 0 N--CA 1.474 1.199 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.6 p-10 -84.75 132.58 34.42 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -64.49 135.93 56.55 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.54 176.06 3.12 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.577 0.703 . . . . 0.0 110.991 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 74.6 m -84.31 -20.75 31.57 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.299 -178.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -90.27 -19.83 23.65 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 122.461 0.304 . . . . 0.0 111.037 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.6 p -97.18 128.31 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-O 120.576 0.227 . . . . 0.0 110.469 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.5 t -103.39 -26.99 12.7 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 120.823 0.345 . . . . 0.0 110.188 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 48.1 t -160.81 154.21 21.9 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.907 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 86.0 mt -129.92 135.79 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.9 p -133.59 154.79 50.6 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -148.42 159.16 44.31 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.409 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.1 t -146.35 168.37 21.29 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.008 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -146.41 149.61 34.06 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.952 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -68.12 -33.54 74.69 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.56 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -150.27 -38.96 0.14 Allowed 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.172 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.422 ' O ' ' ND1' ' A' ' 36' ' ' HIS . . . 55.95 25.86 46.69 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 178.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.422 ' ND1' ' O ' ' A' ' 35' ' ' GLY . 15.3 m-70 -138.0 137.32 37.78 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 31.4 m -129.88 160.93 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 35.5 m -102.88 133.78 47.4 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 38.1 pt -117.8 146.44 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 122.758 0.423 . . . . 0.0 110.326 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.7 t -132.86 134.51 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.786 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 168.5 -159.44 32.6 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 95.0 p -72.63 151.62 42.2 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.647 0.26 . . . . 0.0 110.301 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.8 tm0? -63.35 -36.9 85.22 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.763 0.316 . . . . 0.0 110.237 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.477 ' CD ' ' H ' ' A' ' 44' ' ' GLU . 24.9 mp0 -60.55 -53.71 54.24 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.137 -178.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.51 -40.21 96.01 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.909 0.385 . . . . 0.0 110.88 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 88.3 mtp -66.85 -39.61 87.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.702 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -61.79 -34.31 75.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.478 0.18 . . . . 0.0 111.395 -178.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -68.95 -35.26 76.56 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.749 0.309 . . . . 0.0 110.383 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 63.6 mt -85.67 120.1 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -119.42 -16.67 8.92 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 122.968 0.507 . . . . 0.0 110.404 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 68.9 p -172.29 167.5 5.78 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.45 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 81.6 mt -126.73 128.04 70.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.9 t -104.68 132.4 50.97 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 179.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 38.7 t -133.23 90.63 29.83 Favored Pre-proline 0 N--CA 1.473 0.696 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -58.12 142.24 96.92 Favored 'Trans proline' 0 N--CA 1.501 1.955 0 C-N-CA 121.663 1.575 . . . . 0.0 112.026 178.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 60.3 t -128.67 128.7 68.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -77.53 123.18 26.25 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 38.0 pt -99.63 -10.99 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 122.705 0.402 . . . . 0.0 110.697 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 39.4 t -61.66 -40.13 93.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.461 -178.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -85.23 -5.5 59.32 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 122.748 0.419 . . . . 0.0 110.394 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 46.4 t -91.94 106.99 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 71.5 p -131.03 2.66 4.33 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.703 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -147.2 146.07 29.71 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.936 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -52.33 135.21 33.24 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.453 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.417 ' OG1' ' N ' ' A' ' 66' ' ' SER . 7.0 t -167.95 -173.95 2.24 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.095 0.474 . . . . 0.0 110.863 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.417 ' N ' ' OG1' ' A' ' 65' ' ' THR . 61.8 p -150.92 148.73 28.78 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.101 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -143.54 144.15 31.83 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.225 0.536 . . . . 0.0 111.076 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 t -85.85 132.5 34.09 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.509 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 70.7 mt -115.97 120.63 39.79 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.806 0.443 . . . . 0.0 110.592 -179.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -84.87 133.06 34.32 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.265 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.1 mt -113.61 115.29 27.68 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -134.09 151.43 51.39 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -148.43 143.72 26.95 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -85.23 117.4 24.16 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.355 0.598 . . . . 0.0 111.343 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 118.24 -18.33 11.23 Favored Glycine 0 N--CA 1.481 1.658 0 CA-C-N 114.714 -1.13 . . . . 0.0 112.046 178.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.2 m -133.31 160.96 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 56.5 m -103.55 111.66 24.22 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.1 t -91.12 128.6 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -149.81 143.45 16.72 Favored Pre-proline 0 CA--C 1.553 1.085 0 CA-C-O 119.062 -0.494 . . . . 0.0 110.075 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -72.86 -1.23 11.74 Favored 'Cis proline' 0 N--CA 1.511 2.507 0 CA-C-N 120.906 1.359 . . . . 0.0 110.364 0.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.4 t 56.03 22.08 5.58 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.357 -1.292 . . . . 0.0 111.771 178.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 34.9 p -138.0 139.57 39.72 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.4 m -148.79 154.75 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -103.38 132.61 49.5 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 43.0 t -128.93 125.69 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.023 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -102.21 125.71 48.98 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 65.4 mt -107.54 111.2 23.35 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -95.5 126.57 40.88 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.6 m -96.52 137.6 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 44.1 m -100.61 116.41 32.46 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 95.3 mm-40 . . . . . 0 N--CA 1.467 0.408 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 -179.453 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 54.7 mt . . . . . 0 N--CA 1.466 0.354 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.7 t -160.35 143.26 13.4 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.593 ' NZ ' HE22 ' A' ' 43' ' ' GLN . 64.0 mttp -149.75 166.62 28.87 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -178.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.0 m -121.75 137.83 54.6 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.898 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.7 m -123.38 143.88 42.44 Favored Pre-proline 0 N--CA 1.486 1.362 0 C-N-CA 122.691 0.396 . . . . 0.0 110.022 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -74.37 142.24 29.72 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 121.429 1.419 . . . . 0.0 111.6 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.9 t -103.52 134.61 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -127.77 148.02 50.43 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 51.8 mt -112.37 137.88 49.91 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.466 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -119.32 110.27 16.79 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.433 ' N ' HD12 ' A' ' 17' ' ' LEU . 9.4 mp -70.52 130.87 43.01 Favored 'General case' 0 C--N 1.334 -0.085 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.8 p -130.03 143.11 50.62 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.7 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.62 170.0 16.48 Favored Glycine 0 N--CA 1.475 1.265 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.8 p-10 -87.06 132.92 33.67 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -65.93 133.65 51.31 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.51 145.47 54.91 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.05 0.452 . . . . 0.0 110.629 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 61.0 m -63.68 -18.33 63.88 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.982 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -84.76 -20.87 30.37 Favored 'General case' 0 C--N 1.343 0.314 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.8 t -107.24 127.48 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-O 121.093 0.473 . . . . 0.0 110.276 -178.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 47.5 t -87.18 -40.7 14.35 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.34 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 47.1 t -155.47 161.31 40.98 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.499 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 82.6 mt -131.4 142.6 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.782 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.3 m -130.41 154.17 47.98 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.283 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -144.68 156.34 44.04 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.134 0.492 . . . . 0.0 110.096 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 45.4 m -148.09 166.52 27.57 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.154 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -146.1 142.49 28.58 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.959 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 33' ' ' ASP . 21.3 p-10 -73.35 -34.23 65.5 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.645 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -126.43 -56.79 1.4 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.111 0.564 . . . . 0.0 110.483 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 59.9 18.64 47.67 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -144.82 136.69 25.75 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.1 m -132.99 163.28 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 44.0 m -102.51 137.37 40.84 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 34.9 pt -117.41 150.44 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.2 p -130.27 134.69 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 123.332 0.395 . . . . 0.0 110.379 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 166.86 -160.75 34.49 Favored Glycine 0 C--N 1.328 0.113 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 44.6 t -77.43 157.04 30.73 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.593 HE22 ' NZ ' ' A' ' 9' ' ' LYS . 9.3 tp-100 -62.81 -35.36 79.64 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -61.75 -44.35 97.07 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.662 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.09 -39.91 95.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.816 0.341 . . . . 0.0 110.754 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 68.6 mtt -66.22 -38.64 88.42 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.418 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -61.08 -31.81 71.48 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.754 -0.203 . . . . 0.0 110.948 -179.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -73.64 -40.37 63.81 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.792 0.329 . . . . 0.0 110.511 179.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 67.0 mt -81.2 116.66 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -112.34 -23.35 10.4 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.248 0.619 . . . . 0.0 109.604 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 98.0 p -170.78 161.67 7.37 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.525 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 77.7 mt -112.53 121.43 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 33.6 m -99.08 130.72 45.42 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.4 t -134.26 93.0 20.07 Favored Pre-proline 0 N--CA 1.475 0.825 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -77.33 145.52 24.06 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 121.118 1.212 . . . . 0.0 111.31 -178.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.1 t -132.21 130.2 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-O 121.113 0.482 . . . . 0.0 110.235 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.9 p-10 -70.43 126.45 29.67 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.921 179.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 34.8 pt -100.02 -13.03 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 120.791 0.329 . . . . 0.0 110.661 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 44.7 m -59.39 -39.12 82.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.332 -178.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -84.65 -6.92 59.39 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 122.744 0.418 . . . . 0.0 110.39 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 42.6 t -93.54 114.48 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 65.4 p -133.48 4.92 3.7 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.158 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -152.66 161.74 42.17 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.846 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -62.36 138.7 58.49 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.953 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.2 t -166.03 170.46 13.55 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.293 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 46.7 m -148.11 140.69 24.5 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.761 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 54.5 pttt -146.63 145.08 29.93 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.488 0.661 . . . . 0.0 110.926 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 33.2 m -81.55 136.76 35.59 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.084 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 70.3 mt -115.89 125.96 53.3 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 122.79 0.436 . . . . 0.0 110.19 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.514 ' CD ' ' HZ3' ' A' ' 72' ' ' LYS . 16.1 pt-20 -92.42 132.16 37.0 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 30.8 mt -107.67 129.77 54.98 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.514 ' HZ3' ' CD ' ' A' ' 70' ' ' GLU . 63.3 mttp -131.15 141.44 50.09 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -139.49 142.14 37.33 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -86.02 133.03 33.93 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 122.21 1.005 . . . . 0.0 112.362 -178.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.05 -15.03 63.83 Favored Glycine 0 N--CA 1.472 1.049 0 CA-C-N 113.564 -1.653 . . . . 0.0 112.149 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 11.1 m -131.55 164.36 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 16.2 m -112.28 112.79 24.62 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.0 t -89.53 132.4 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -155.44 144.38 14.92 Favored Pre-proline 0 CA--C 1.557 1.238 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.858 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.46 -10.79 13.05 Favored 'Cis proline' 0 N--CA 1.514 2.732 0 CA-C-N 120.579 1.242 . . . . 0.0 110.639 0.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 10.4 p 58.21 23.68 10.56 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 114.652 -1.158 . . . . 0.0 112.129 177.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 34.6 p -132.88 139.38 47.38 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.6 m -152.89 154.97 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -94.75 134.74 37.03 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 44.8 t -127.85 130.62 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -111.24 124.23 51.8 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 53.0 mt -108.43 108.86 19.99 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -91.63 128.46 37.47 Favored 'General case' 0 C--O 1.231 0.111 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 43.3 t -102.97 132.61 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 61.8 m -100.31 117.87 35.4 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 . . . . . 0 N--CA 1.462 0.152 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.477 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 34.5 tp . . . . . 0 N--CA 1.467 0.382 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 35.9 m -161.3 140.61 10.24 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.63 ' NZ ' HE22 ' A' ' 43' ' ' GLN . 98.5 mttt -149.25 165.84 30.69 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -178.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 92.5 p -117.16 138.08 51.91 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.903 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.5 m -126.56 143.42 46.23 Favored Pre-proline 0 N--CA 1.482 1.162 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.92 142.4 28.05 Favored 'Trans proline' 0 N--CA 1.501 1.914 0 C-N-CA 121.604 1.536 . . . . 0.0 111.931 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.9 p -95.29 134.51 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.5 mptm? -108.73 133.55 52.65 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.5 tp -104.9 130.42 53.06 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -124.36 111.77 16.17 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.9 pp -69.6 131.11 44.13 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.3 p -125.44 134.95 51.91 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.64 163.88 14.55 Favored Glycine 0 N--CA 1.477 1.417 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.2 p-10 -78.95 136.8 37.35 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -66.81 138.11 57.11 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.42 141.43 58.36 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.206 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.0 t -68.03 -20.87 65.03 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.642 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -94.25 4.71 53.51 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 122.237 0.215 . . . . 0.0 110.914 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 68.6 t -118.42 126.2 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.3 t -73.71 -45.76 50.25 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.069 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 45.6 t -161.1 165.44 29.61 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.175 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 80.1 mt -131.77 144.96 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 99.8 p -135.78 163.37 30.36 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.467 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -144.2 160.13 41.48 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.498 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 61.7 p -148.58 162.87 38.81 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.884 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -146.3 143.9 29.46 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.974 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -72.72 -35.09 67.5 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.682 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -126.61 -54.71 1.43 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 122.95 0.5 . . . . 0.0 110.571 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 62.11 24.23 64.88 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.455 ' ND1' ' O ' ' A' ' 36' ' ' HIS . 15.7 p80 -151.95 138.91 19.04 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 28.9 m -131.29 162.27 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 49.3 m -100.87 134.37 43.95 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 20.4 pt -114.34 145.08 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 49.1 t -127.5 133.54 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 170.47 -162.2 35.28 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.5 m -75.32 160.14 30.66 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.63 HE22 ' NZ ' ' A' ' 9' ' ' LYS . 60.7 tp60 -63.97 -40.14 95.72 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.576 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -65.1 -36.58 84.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.829 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.08 -41.64 90.45 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.783 0.325 . . . . 0.0 111.038 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 68.3 mtt -68.81 -35.96 77.64 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.728 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -60.57 -32.96 72.02 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.519 0.2 . . . . 0.0 110.911 -178.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -73.61 -38.28 65.14 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.839 0.352 . . . . 0.0 110.354 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 68.7 mt -86.27 117.37 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -114.89 -16.7 11.68 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 122.919 0.488 . . . . 0.0 110.108 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 73.4 p -171.49 169.12 6.26 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.809 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 87.9 mt -122.67 124.0 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 33.6 m -89.38 132.15 35.1 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 43.1 t -131.19 91.7 34.96 Favored Pre-proline 0 N--CA 1.476 0.844 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -80.77 140.74 13.14 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 121.597 1.531 . . . . 0.0 111.364 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 49.1 t -131.9 130.87 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.918 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -74.83 124.75 27.42 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 37.6 pt -102.01 -11.86 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 122.795 0.438 . . . . 0.0 110.639 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.7 m -60.53 -38.72 85.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.39 -178.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -86.75 -2.74 58.79 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 45.1 t -97.33 120.72 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.2 t -135.87 6.3 3.15 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.293 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -155.3 171.95 19.0 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.422 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.7 p-10 -65.81 126.45 28.52 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.464 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.0 p -145.58 165.78 27.67 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.899 0.38 . . . . 0.0 110.043 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 90.2 p -150.65 129.36 12.34 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.524 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -140.08 145.97 38.34 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.23 0.538 . . . . 0.0 110.888 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 37.8 m -81.68 134.69 35.49 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.596 178.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.0 mt -118.22 126.24 51.77 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.866 0.467 . . . . 0.0 109.87 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -94.16 135.61 35.35 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.9 mt -106.96 134.84 49.5 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.887 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -134.21 143.77 48.04 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -143.59 137.7 28.55 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -85.77 121.23 28.14 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.256 0.551 . . . . 0.0 112.027 -178.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.71 -13.76 38.56 Favored Glycine 0 N--CA 1.48 1.628 0 CA-C-N 114.571 -1.195 . . . . 0.0 112.305 178.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 18.9 m -133.83 161.43 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 46.7 m -110.77 120.55 42.78 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.6 p -109.52 135.46 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -158.82 144.6 12.21 Favored Pre-proline 0 CA--C 1.551 1.005 0 CA-C-O 119.307 -0.378 . . . . 0.0 110.576 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.407 ' C ' ' H ' ' A' ' 82' ' ' THR . 79.9 Cg_endo -70.57 -12.56 13.82 Favored 'Cis proline' 0 N--CA 1.512 2.571 0 CA-C-N 120.247 1.124 . . . . 0.0 110.82 0.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 p 66.99 -3.51 0.94 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.17 177.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.407 ' H ' ' C ' ' A' ' 80' ' ' PRO . 57.4 p -98.71 140.01 33.56 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.2 m -149.5 144.65 17.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -94.59 132.6 39.12 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 47.4 t -126.35 128.56 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -110.31 123.38 49.71 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 58.3 mt -105.63 120.54 41.93 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm -104.09 126.49 51.25 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 42.4 t -103.77 133.81 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.263 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 70.6 p -96.63 124.04 40.5 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 93.9 mm-40 . . . . . 0 N--CA 1.467 0.397 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 -179.04 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.509 HD12 ' OE1' ' A' ' 43' ' ' GLN . 3.8 mm? . . . . . 0 CA--C 1.518 -0.258 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 91.1 p -160.52 133.77 6.69 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.488 ' CE ' HE22 ' A' ' 43' ' ' GLN . 67.6 mttm -147.83 166.81 26.47 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 41.2 t -120.85 136.78 54.83 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.073 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.1 m -122.57 126.25 26.2 Favored Pre-proline 0 CA--C 1.561 1.369 0 CA-C-O 119.034 -0.508 . . . . 0.0 109.772 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -59.29 146.85 93.42 Favored 'Trans proline' 0 N--CA 1.506 2.212 0 CA-C-N 121.664 1.63 . . . . 0.0 111.816 178.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.1 t -96.31 132.31 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -125.2 127.96 47.59 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.0 mp -96.26 135.52 37.97 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -116.82 107.4 14.58 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 57.2 mt -67.32 124.6 23.6 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 28.8 m -117.07 128.72 55.43 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.68 -164.3 12.09 Favored Glycine 0 N--CA 1.473 1.138 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -119.58 147.83 44.03 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 115.005 -0.598 . . . . 0.0 109.817 178.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -68.69 139.68 55.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.078 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.49 151.56 44.03 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.48 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.1 t -63.18 -22.08 66.63 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.194 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -83.67 -21.78 32.32 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.7 t -105.02 126.64 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 121.071 0.463 . . . . 0.0 109.964 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.9 m -88.12 -32.48 18.66 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.149 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 94.1 p -155.82 159.65 39.57 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.202 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 81.7 mt -127.52 134.49 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.523 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.6 m -126.1 150.45 48.2 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -139.31 152.25 47.08 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.04 0.448 . . . . 0.0 109.936 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 93.1 p -150.5 152.18 33.81 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.69 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -147.41 147.87 30.71 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.061 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -69.55 -36.09 76.02 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.738 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -139.67 129.38 24.56 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -117.44 27.96 7.39 Favored Glycine 0 N--CA 1.474 1.194 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 40.7 p-80 -145.63 139.41 26.6 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 29.4 m -131.2 161.28 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 49.9 m -103.79 134.29 47.36 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 38.1 pt -116.86 146.38 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 123.12 0.568 . . . . 0.0 109.664 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 52.1 t -132.69 134.21 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 165.49 -158.98 32.05 Favored Glycine 0 N--CA 1.466 0.667 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.4 t -67.4 149.23 50.55 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.509 ' OE1' HD12 ' A' ' 7' ' ' LEU . 71.3 tp60 -64.86 -38.35 90.68 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.379 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -62.01 -39.1 91.13 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.807 0.337 . . . . 0.0 110.6 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.36 -39.55 92.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.675 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 68.6 mtt -66.41 -40.56 89.65 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.579 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -64.3 -24.93 67.83 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.595 0.236 . . . . 0.0 110.547 -179.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -76.26 -37.71 57.22 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 69.7 mt -83.11 117.41 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -99.94 -26.51 13.97 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.328 0.585 . . . . 0.0 109.875 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 96.8 p -171.05 164.11 7.44 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.087 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 41.4 mm -106.26 118.84 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.658 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.4 t -87.85 134.18 33.75 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 38.6 t -132.39 89.0 37.88 Favored Pre-proline 0 N--CA 1.473 0.683 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -81.64 146.41 15.06 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 121.485 1.457 . . . . 0.0 111.54 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.6 p -139.69 136.49 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.857 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -76.47 126.21 30.58 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 20.8 pt -109.71 -2.94 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 122.706 0.402 . . . . 0.0 110.39 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 91.3 p -80.66 -15.07 57.5 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.58 -178.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -102.75 -11.35 18.42 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.126 0.571 . . . . 0.0 110.778 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.9 m -101.34 131.2 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 68.7 p -137.19 11.71 3.04 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.635 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -147.6 145.95 29.2 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.764 -178.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -56.82 136.18 55.56 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.519 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.409 ' OG1' ' N ' ' A' ' 66' ' ' SER . 5.1 t -167.31 -177.28 3.58 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.555 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.409 ' N ' ' OG1' ' A' ' 65' ' ' THR . 47.3 t -149.55 145.99 27.11 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.058 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -148.02 143.53 27.3 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.362 0.601 . . . . 0.0 110.967 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 35.0 m -82.03 135.82 35.3 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.818 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 89.3 mt -119.8 129.58 54.51 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.075 0.55 . . . . 0.0 110.25 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -94.68 134.9 36.76 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 47.4 mt -108.24 133.95 51.77 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.034 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -139.14 147.1 41.46 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -147.62 139.91 24.44 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.408 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.3 mp0 -86.72 117.43 25.47 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.454 0.645 . . . . 0.0 112.037 -178.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 116.44 -16.71 14.48 Favored Glycine 0 N--CA 1.48 1.597 0 CA-C-N 114.221 -1.354 . . . . 0.0 111.74 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.1 m -134.73 160.33 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 50.5 m -105.63 112.51 25.62 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.4 t -89.73 132.05 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -156.13 140.43 11.75 Favored Pre-proline 0 CA--C 1.552 1.035 0 CA-C-O 119.07 -0.49 . . . . 0.0 110.882 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -70.16 -10.66 12.4 Favored 'Cis proline' 0 N--CA 1.513 2.671 0 CA-C-N 120.788 1.317 . . . . 0.0 111.042 0.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.0 p 58.22 19.36 6.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.704 -1.135 . . . . 0.0 112.029 177.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.1 p -130.16 140.29 50.78 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.5 m -151.46 154.17 8.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -101.96 132.8 47.57 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.3 p -128.85 132.04 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 121.164 0.506 . . . . 0.0 109.935 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -106.28 125.98 51.67 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.871 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 57.6 mt -109.38 108.99 19.73 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -92.95 128.87 38.97 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 33.7 m -91.49 137.42 21.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.226 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 26.3 m -104.11 109.72 21.63 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 . . . . . 0 N--CA 1.468 0.466 0 N-CA-C 110.559 -0.163 . . . . 0.0 110.559 -178.754 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 50.9 mt . . . . . 0 CA--C 1.518 -0.257 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.3 t -153.46 156.56 38.39 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.932 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.8 tptt -155.5 164.19 39.01 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.746 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 87.8 p -127.9 137.42 52.3 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.186 -0.915 . . . . 0.0 108.668 179.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.1 m -131.19 144.52 53.82 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.595 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -74.39 144.43 32.61 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 121.864 1.709 . . . . 0.0 111.505 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.5 m -96.73 145.72 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -122.15 139.4 53.79 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.6 mp -113.82 135.96 53.39 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -121.88 118.53 29.15 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.74 0.65 . . . . 0.0 109.262 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 51.3 mt -72.56 126.32 29.59 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 79.9 p -119.24 128.59 54.33 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.98 160.31 13.53 Favored Glycine 0 N--CA 1.47 0.929 0 N-CA-C 110.414 -1.075 . . . . 0.0 110.414 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -84.15 145.48 28.37 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 178.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -65.05 137.58 57.79 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.298 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.91 159.57 25.3 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.981 0.419 . . . . 0.0 110.446 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.4 t -71.49 -30.45 65.99 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.559 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -83.62 -11.06 57.77 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 122.156 0.182 . . . . 0.0 111.176 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 64.2 t -108.5 130.06 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 36.1 m -87.19 -41.79 13.47 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.936 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 45.0 t -159.23 160.51 35.41 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.301 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 76.5 mt -132.15 143.57 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.576 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.4 m -130.86 158.1 41.1 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.186 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -142.51 152.47 42.69 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.867 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 45.7 t -151.93 162.82 40.46 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.759 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -143.87 147.38 33.96 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.035 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -72.49 -33.8 67.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.366 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -135.43 -52.38 0.76 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 122.57 0.348 . . . . 0.0 110.251 -179.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.82 28.23 60.19 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 51.5 m-70 -140.96 137.33 32.98 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.6 m -129.66 161.17 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 27.7 m -103.16 138.91 39.35 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 34.3 pt -119.54 147.89 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.484 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 48.6 t -130.4 134.71 61.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.738 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 162.38 -158.47 30.57 Favored Glycine 0 N--CA 1.462 0.413 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 56.4 m -76.11 149.59 37.37 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -62.38 -29.92 70.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.451 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -61.76 -47.96 82.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.47 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.45 -38.45 91.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.631 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 68.1 mtt -65.99 -39.57 90.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.494 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -62.45 -30.74 71.46 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.555 0.216 . . . . 0.0 110.773 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -74.68 -36.98 62.78 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.717 0.294 . . . . 0.0 110.691 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 68.6 mt -89.13 117.5 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -108.24 -21.42 12.78 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.109 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 93.9 p -170.32 159.19 7.04 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.887 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 72.6 mt -109.44 128.04 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.6 m -89.33 131.67 35.3 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.6 t -128.57 90.37 46.69 Favored Pre-proline 0 CA--C 1.542 0.659 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 178.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -81.8 147.84 15.42 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 122.175 1.916 . . . . 0.0 111.297 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.3 p -142.84 136.17 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.077 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -75.62 129.64 37.49 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 35.1 pt -104.69 -11.04 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 O-C-N 123.299 0.374 . . . . 0.0 110.304 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 80.6 p -61.18 -39.3 89.64 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.143 -178.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -86.5 -5.01 59.26 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 122.534 0.334 . . . . 0.0 110.402 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 42.6 t -94.65 117.62 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 58.0 p -134.56 2.05 3.17 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.025 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -147.38 156.52 42.97 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.992 0.425 . . . . 0.0 110.253 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -63.73 136.99 57.89 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.006 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.1 t -166.82 177.49 6.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.163 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 44.1 t -144.01 140.37 29.54 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.408 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -139.28 143.3 37.86 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.108 0.48 . . . . 0.0 110.518 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 28.1 m -83.74 132.52 34.84 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.8 mt -119.69 129.85 54.74 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.451 ' CD ' ' HZ1' ' A' ' 72' ' ' LYS . 19.5 pt-20 -97.81 137.19 37.05 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 43.3 mt -113.49 136.69 52.52 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.451 ' HZ1' ' CD ' ' A' ' 70' ' ' GLU . 63.0 mttp -132.82 140.96 48.22 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -135.55 143.48 45.72 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -85.99 135.62 33.58 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.819 0.818 . . . . 0.0 111.907 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.82 -28.25 8.01 Favored Glycine 0 N--CA 1.476 1.345 0 CA-C-N 114.303 -1.317 . . . . 0.0 112.732 178.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.5 m -118.9 163.45 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 34.0 m -109.48 116.22 31.39 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.0 t -93.81 131.66 40.13 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -157.69 141.39 11.33 Favored Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.703 178.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.54 -12.3 11.72 Favored 'Cis proline' 0 N--CA 1.506 2.239 0 CA-C-N 119.814 0.969 . . . . 0.0 110.051 -0.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.2 p 61.99 23.43 13.8 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.637 177.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 39.3 p -131.01 138.72 49.78 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 24.0 m -151.11 149.76 13.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -95.92 133.51 40.02 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.6 p -128.12 133.09 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -107.52 127.37 53.56 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 39.5 mt -111.06 106.51 15.6 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -89.35 129.63 35.85 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 18.6 t -106.55 132.88 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 31.5 m -100.33 121.03 40.84 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 . . . . . 0 N--CA 1.465 0.307 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -179.387 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 57.2 mt . . . . . 0 N--CA 1.469 0.516 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 95.3 p -147.92 151.07 35.22 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.721 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -146.67 165.09 30.61 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.671 0.748 . . . . 0.0 109.6 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 92.6 p -112.04 136.22 51.68 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 114.004 -1.453 . . . . 0.0 109.918 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.4 m -134.33 99.38 13.31 Favored Pre-proline 0 CA--C 1.544 0.749 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -179.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -57.56 148.23 74.31 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 CA-C-N 120.191 1.104 . . . . 0.0 111.591 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 15.9 t -86.14 132.83 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -113.26 123.34 49.94 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.2 mp -96.27 131.71 42.49 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -120.07 107.73 13.41 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 178.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.9 pp -68.46 129.36 39.7 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.27 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.4 p -130.86 141.7 50.33 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 122.984 0.514 . . . . 0.0 109.645 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.85 168.24 16.49 Favored Glycine 0 N--CA 1.474 1.178 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -86.29 134.76 33.73 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -65.4 137.44 57.49 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.91 173.36 1.08 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.501 0.667 . . . . 0.0 111.32 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 35.2 t -84.71 -23.28 29.4 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.116 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -88.46 -13.65 39.84 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.406 HG13 ' O ' ' A' ' 25' ' ' VAL . 7.1 p -102.28 126.02 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-O 121.169 0.509 . . . . 0.0 112.039 -177.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 38.3 t -91.01 -31.01 16.48 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.35 179.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.7 t -159.75 158.13 30.68 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.47 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 85.9 mt -127.88 136.38 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.586 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.9 t -130.54 153.22 49.08 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -147.22 155.62 42.24 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.115 0.483 . . . . 0.0 110.562 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 50.4 m -146.6 160.09 42.61 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.879 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -140.81 143.1 34.63 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.812 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -71.87 -34.02 68.85 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.757 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.401 ' O ' ' ND1' ' A' ' 36' ' ' HIS . 99.6 mtt180 -128.13 -55.95 1.26 Allowed 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 121.194 0.521 . . . . 0.0 110.132 -179.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.23 22.64 58.69 Favored Glycine 0 CA--C 1.523 0.555 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.536 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.401 ' ND1' ' O ' ' A' ' 34' ' ' ARG . 12.8 p-80 -149.93 138.73 20.91 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.481 HG22 ' N ' ' A' ' 38' ' ' THR . 3.3 p -127.89 163.32 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.481 ' N ' HG22 ' A' ' 37' ' ' VAL . 52.0 m -100.22 132.6 45.49 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.905 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.5 pt -114.84 134.4 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 123.363 0.665 . . . . 0.0 109.304 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.6 t -124.47 133.5 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 163.9 -154.47 25.37 Favored Glycine 0 N--CA 1.468 0.826 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.4 m -69.66 145.41 52.42 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 70.6 tp60 -62.96 -34.49 77.61 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.615 0.245 . . . . 0.0 110.367 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -61.55 -41.44 97.37 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.638 0.256 . . . . 0.0 110.791 -179.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.91 -37.9 89.11 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.777 0.322 . . . . 0.0 110.717 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 66.7 mtt -64.77 -39.78 94.17 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.447 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -63.79 -30.78 71.84 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.539 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -73.92 -40.73 62.91 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.776 0.322 . . . . 0.0 110.66 179.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 58.7 mt -84.8 117.63 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -178.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -114.21 -17.67 11.81 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.04 0.536 . . . . 0.0 110.826 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 73.4 p -174.13 132.74 0.41 Allowed 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.941 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 42.4 mm -83.04 124.08 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 32.5 m -91.55 126.26 36.58 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.4 t -133.46 91.35 26.85 Favored Pre-proline 0 N--CA 1.474 0.774 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -82.01 145.13 13.84 Favored 'Trans proline' 0 N--CA 1.5 1.881 0 C-N-CA 121.672 1.581 . . . . 0.0 111.617 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 60.8 t -129.71 129.13 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.021 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -68.58 125.04 25.25 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.7 pt -99.93 -12.83 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-O 120.847 0.356 . . . . 0.0 110.526 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.5 m -60.17 -38.72 84.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.554 -178.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -86.2 -4.1 59.1 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 122.557 0.343 . . . . 0.0 110.335 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 46.9 t -94.22 111.79 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 60.3 p -128.57 2.87 5.55 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.617 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -152.45 163.03 40.34 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.575 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -64.39 136.64 57.31 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.204 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.7 t -166.36 177.95 6.47 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.585 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 99.1 p -149.71 144.25 25.97 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.818 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -143.51 143.36 31.52 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-O 121.228 0.537 . . . . 0.0 110.476 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 51.4 m -81.75 131.85 35.27 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 64.8 mt -117.39 120.42 38.1 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.823 0.449 . . . . 0.0 109.857 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -84.24 133.64 34.57 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 50.8 mt -102.75 133.79 47.21 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 122.598 0.359 . . . . 0.0 110.047 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -136.17 141.06 44.03 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 122.957 0.503 . . . . 0.0 110.215 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -150.98 130.21 12.74 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -86.21 114.32 22.94 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.293 0.568 . . . . 0.0 111.282 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 128.64 -22.05 5.27 Favored Glycine 0 N--CA 1.48 1.589 0 CA-C-N 114.529 -1.214 . . . . 0.0 111.519 178.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.5 m -134.87 160.41 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-O 120.897 0.38 . . . . 0.0 110.271 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 46.4 m -100.82 117.41 34.83 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.405 HG22 ' H ' ' A' ' 78' ' ' VAL . 0.4 OUTLIER -95.99 131.92 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.881 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -155.29 135.45 8.39 Favored Pre-proline 0 CA--C 1.553 1.07 0 CA-C-O 119.071 -0.49 . . . . 0.0 110.537 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -71.25 -7.53 12.81 Favored 'Cis proline' 0 N--CA 1.52 3.032 0 CA-C-N 121.325 1.509 . . . . 0.0 111.091 0.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.3 p 59.94 17.85 6.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.661 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.4 p -132.92 140.69 47.98 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.6 m -147.73 154.82 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -101.05 134.38 44.14 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.9 p -131.6 138.18 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 121.178 0.514 . . . . 0.0 110.29 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -114.89 126.88 55.31 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.999 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 56.1 mt -109.16 109.15 20.04 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -92.98 127.68 38.58 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.9 t -100.94 132.35 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 46.0 m -100.16 122.09 42.45 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-O 120.689 0.28 . . . . 0.0 110.709 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 . . . . . 0 N--CA 1.47 0.527 0 C-N-CA 123.065 0.546 . . . . 0.0 109.914 179.73 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 71.3 mt . . . . . 0 N--CA 1.466 0.366 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.8 t -159.89 153.41 22.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.515 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -144.89 166.29 25.69 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.561 0.696 . . . . 0.0 109.699 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 95.2 p -114.19 134.87 54.61 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 114.216 -1.356 . . . . 0.0 109.692 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.5 m -129.25 94.99 31.85 Favored Pre-proline 0 CA--C 1.547 0.861 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -57.71 146.02 87.21 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 CA-C-N 119.992 1.033 . . . . 0.0 111.567 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.0 t -93.98 133.94 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.325 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -114.02 130.15 56.57 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.3 tp -96.39 130.61 43.48 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -122.45 108.54 13.3 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 120.976 0.417 . . . . 0.0 109.879 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.0 pp -65.25 130.16 42.33 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.741 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.7 m -127.57 135.38 50.23 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.81 165.19 15.66 Favored Glycine 0 N--CA 1.475 1.273 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -85.72 134.18 33.97 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.7 ptmm? -63.29 136.95 58.01 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.617 0.246 . . . . 0.0 110.459 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.0 170.43 4.38 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.348 0.594 . . . . 0.0 111.133 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 34.6 t -81.0 -23.16 38.87 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.292 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -87.35 -11.34 49.67 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.8 p -110.1 129.28 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-O 120.84 0.352 . . . . 0.0 110.821 -178.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 36.2 t -86.47 -37.6 18.13 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.982 0.42 . . . . 0.0 109.986 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 98.7 p -160.78 160.07 30.79 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.397 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 92.8 mt -131.31 139.73 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 60.2 m -125.75 154.61 42.25 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -141.37 152.84 44.7 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.017 0.437 . . . . 0.0 110.302 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 96.6 p -151.52 162.05 41.62 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.204 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.469 ' CD1' ' N ' ' A' ' 35' ' ' GLY . 25.0 p90 -146.39 147.35 31.2 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.181 -179.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -69.99 -35.11 74.15 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.612 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -158.98 89.07 0.92 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.409 0.623 . . . . 0.0 109.97 -179.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.469 ' N ' ' CD1' ' A' ' 32' ' ' PHE . . . -76.78 38.17 1.48 Allowed Glycine 0 N--CA 1.462 0.429 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.755 -178.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 27.5 p80 -144.85 137.97 26.69 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 117.659 0.73 . . . . 0.0 109.432 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.6 m -129.16 162.45 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 26.4 m -102.61 133.22 47.96 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 37.9 pt -119.31 146.19 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 122.972 0.509 . . . . 0.0 110.325 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 50.0 t -129.37 134.85 62.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.949 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 162.66 -156.96 28.84 Favored Glycine 0 N--CA 1.467 0.753 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 50.9 m -74.85 147.94 40.66 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 110.321 -0.251 . . . . 0.0 110.321 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -63.92 -30.61 71.67 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.371 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -60.47 -45.16 94.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.721 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.42 -39.61 85.48 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.664 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 67.9 mtt -65.54 -40.87 93.37 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.287 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -64.14 -31.71 73.0 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.045 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.1 tppt? -71.94 -38.57 69.81 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.16 0.505 . . . . 0.0 110.551 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 72.4 mt -88.21 117.52 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.604 -178.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -99.92 -24.93 14.5 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.36 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.9 m -169.99 -178.82 3.0 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.616 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 85.8 mt -124.34 123.48 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 42.4 m -96.07 128.38 42.92 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.5 t -128.53 90.6 46.07 Favored Pre-proline 0 N--CA 1.473 0.718 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -83.47 144.08 11.28 Favored 'Trans proline' 0 N--CA 1.5 1.896 0 C-N-CA 121.829 1.686 . . . . 0.0 111.571 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.6 p -137.44 135.35 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 CA-C-O 121.067 0.461 . . . . 0.0 110.935 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -67.07 128.87 38.0 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 36.1 pt -101.67 -11.23 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-O 120.985 0.422 . . . . 0.0 110.547 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.8 t -62.22 -40.6 96.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.57 -178.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -83.26 -6.88 59.62 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.757 0.423 . . . . 0.0 110.218 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 43.4 t -92.56 109.77 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 70.6 p -132.08 1.91 3.92 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.755 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -142.39 151.97 42.37 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -64.28 134.23 54.3 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.249 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.402 ' OG1' ' N ' ' A' ' 66' ' ' SER . 5.5 t -167.13 -178.38 4.12 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.013 0.435 . . . . 0.0 110.907 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.402 ' N ' ' OG1' ' A' ' 65' ' ' THR . 99.2 p -138.62 147.44 42.93 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.196 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -136.03 141.56 44.34 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.268 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 63.8 m -97.36 125.54 42.03 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 177.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 66.1 mt -120.72 135.93 55.0 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.802 0.441 . . . . 0.0 110.09 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.9 mp0 -98.86 138.3 36.19 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 24.7 mt -106.12 132.28 52.39 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 116.296 -0.411 . . . . 0.0 109.995 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -129.98 140.86 50.83 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -146.82 130.9 17.3 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -85.11 115.38 22.88 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.32 0.581 . . . . 0.0 111.203 -178.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 125.78 -21.13 6.32 Favored Glycine 0 N--CA 1.48 1.575 0 CA-C-N 114.577 -1.192 . . . . 0.0 111.761 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.3 m -132.49 159.09 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 80.7 m -102.94 110.64 22.64 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.4 t -91.58 128.93 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -155.69 138.77 10.75 Favored Pre-proline 0 CA--C 1.554 1.115 0 CA-C-O 118.893 -0.575 . . . . 0.0 110.363 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -70.4 -11.21 13.1 Favored 'Cis proline' 0 N--CA 1.517 2.909 0 CA-C-N 121.291 1.497 . . . . 0.0 110.781 0.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 60.1 22.54 11.77 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.744 -1.117 . . . . 0.0 112.343 177.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 37.7 p -127.07 140.57 52.19 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.7 m -147.53 142.83 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -93.86 131.26 39.44 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 43.4 t -123.3 121.5 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -99.83 123.62 44.28 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 65.4 mt -108.45 105.92 15.8 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -87.91 130.46 34.91 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 26.6 t -104.16 131.39 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 49.5 m -100.05 120.07 39.27 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 . . . . . 0 N--CA 1.467 0.381 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -179.375 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 56.9 mt . . . . . 0 CA--C 1.52 -0.197 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.6 t -161.3 141.08 10.55 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -149.85 167.12 27.5 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -178.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 39.8 t -124.11 137.99 54.49 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 114.867 -1.061 . . . . 0.0 109.136 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.3 m -122.76 144.57 43.04 Favored Pre-proline 0 N--CA 1.482 1.139 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -73.05 143.18 35.71 Favored 'Trans proline' 0 N--CA 1.5 1.872 0 C-N-CA 121.345 1.363 . . . . 0.0 111.586 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 43.8 t -103.69 134.0 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -125.91 146.86 49.66 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.2 mt -112.2 132.59 54.82 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -114.22 113.97 25.36 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.317 -0.624 . . . . 0.0 109.317 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 49.5 mt -70.33 124.1 23.33 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 76.4 p -119.76 135.31 54.9 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 115.55 163.14 13.72 Favored Glycine 0 N--CA 1.471 1.024 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.4 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 1.0 OUTLIER -85.13 138.91 32.1 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 179.131 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -65.9 132.09 47.81 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.18 177.02 2.42 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.468 0.651 . . . . 0.0 110.786 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 89.9 p -85.23 -19.16 32.09 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.929 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -88.13 -21.53 24.6 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 122.134 0.174 . . . . 0.0 110.737 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.3 p -97.37 126.33 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-O 120.859 0.361 . . . . 0.0 111.008 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.5 t -92.6 -35.92 13.29 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.7 t -161.21 158.03 26.69 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.095 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 82.3 mt -128.73 136.62 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 60.5 m -128.97 153.49 47.5 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -144.62 155.58 43.69 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.188 0.518 . . . . 0.0 110.346 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 87.8 p -150.95 163.5 38.55 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.16 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -146.4 147.59 31.43 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.017 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -71.59 -34.03 69.56 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.533 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -134.13 -52.09 0.83 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 122.892 0.477 . . . . 0.0 110.167 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.31 23.41 62.22 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.44 ' ND1' ' O ' ' A' ' 36' ' ' HIS . 18.0 p80 -147.6 140.11 24.61 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 28.4 m -133.11 165.97 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 46.1 m -99.8 137.92 37.6 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 38.7 pt -119.63 148.46 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.4 t -130.68 134.13 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-O 120.915 0.388 . . . . 0.0 109.97 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 167.2 -163.09 36.86 Favored Glycine 0 N--CA 1.464 0.536 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.2 t -73.41 155.03 39.74 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 110.375 -0.232 . . . . 0.0 110.375 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 70.4 tp60 -63.36 -37.57 87.8 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.549 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -64.04 -39.01 93.15 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 110.435 -0.209 . . . . 0.0 110.435 -179.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.33 -44.4 83.44 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.868 0.365 . . . . 0.0 111.097 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 77.8 mtm -68.23 -39.27 82.36 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.825 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -60.36 -32.76 71.59 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.578 0.228 . . . . 0.0 110.895 -179.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.5 ttpp -70.69 -33.63 71.11 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.729 0.3 . . . . 0.0 110.49 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 71.1 mt -86.44 119.17 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -107.56 -22.11 12.65 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-O 121.228 0.537 . . . . 0.0 110.194 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 95.2 p -171.96 162.33 5.94 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.877 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 36.5 mm -107.07 119.28 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 38.2 m -96.69 127.77 42.99 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 26.0 t -133.5 93.0 22.47 Favored Pre-proline 0 N--CA 1.474 0.775 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -77.29 145.19 23.88 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 121.032 1.155 . . . . 0.0 111.422 -178.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.9 t -132.48 129.56 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.904 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -71.38 127.06 31.31 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.609 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 36.5 pt -99.09 -12.73 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 122.597 0.359 . . . . 0.0 110.92 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 80.6 p -59.04 -38.57 79.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.568 -178.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -86.79 -4.78 59.22 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 122.565 0.346 . . . . 0.0 110.505 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.1 t -93.72 110.85 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 67.8 p -131.5 4.46 4.29 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.414 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.3 tp10 -152.33 158.13 42.3 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.851 0.358 . . . . 0.0 110.105 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -59.79 137.41 58.06 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.329 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.2 t -165.01 166.99 18.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.13 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 42.5 t -141.79 140.84 33.13 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.655 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -148.81 147.38 28.7 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.892 0.853 . . . . 0.0 111.11 -179.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 39.6 m -81.67 136.08 35.51 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 114.278 -1.328 . . . . 0.0 109.328 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.5 mt -110.9 113.06 25.35 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.061 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 50.2 tp10 -75.73 126.29 30.71 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 44.9 mt -104.63 128.07 52.55 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -133.2 141.56 48.14 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -142.31 141.73 32.43 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -85.06 134.84 34.19 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 122.027 0.918 . . . . 0.0 113.137 -177.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.8 -9.5 76.12 Favored Glycine 0 N--CA 1.474 1.185 0 CA-C-N 114.152 -1.385 . . . . 0.0 112.073 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.0 m -133.89 161.74 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 60.6 m -110.41 113.68 26.52 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.6 t -90.3 132.61 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -156.51 139.73 11.0 Favored Pre-proline 0 CA--C 1.554 1.118 0 CA-C-O 119.013 -0.518 . . . . 0.0 110.867 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.5 -12.94 11.83 Favored 'Cis proline' 0 N--CA 1.515 2.738 0 CA-C-N 120.838 1.335 . . . . 0.0 110.887 0.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.7 p 61.55 22.52 12.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.66 177.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.2 p -131.93 139.97 48.87 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.2 m -151.34 154.27 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -98.44 132.8 43.6 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.3 t -127.64 130.32 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -107.47 124.94 50.62 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 55.0 mt -109.34 109.57 20.5 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -179.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -91.02 128.3 36.79 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 23.9 t -102.78 131.8 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 52.1 m -99.13 118.19 35.3 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 96.0 mm-40 . . . . . 0 N--CA 1.464 0.266 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 -179.542 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt . . . . . 0 N--CA 1.493 1.696 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.9 mm 55.76 95.67 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.781 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 39.6 t -61.16 -41.41 96.71 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.228 0.537 . . . . 0.0 110.768 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.44 ' N ' HD12 ' A' ' 4' ' ' LEU . 8.8 mp -66.16 147.62 53.06 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.514 -0.767 . . . . 0.0 109.426 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -128.8 36.84 4.17 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.443 -177.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -134.09 132.22 39.68 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.4 tp -163.63 152.7 14.24 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 90.3 p -145.06 148.26 33.5 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.476 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -144.52 166.34 25.42 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.466 0.651 . . . . 0.0 109.563 -178.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.4 t -113.45 135.99 53.28 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.572 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.5 m -128.86 100.37 21.29 Favored Pre-proline 0 CA--C 1.549 0.904 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -57.01 144.62 89.09 Favored 'Trans proline' 0 N--CA 1.499 1.842 0 C-N-CA 121.095 1.196 . . . . 0.0 111.704 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 23.0 m -88.86 139.56 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.681 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -119.17 116.41 26.25 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.421 ' N ' HD12 ' A' ' 15' ' ' LEU . 10.8 mp -89.98 135.13 33.83 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -122.49 116.66 24.32 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 58.2 mt -66.61 126.06 27.73 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.3 m -127.4 133.96 49.95 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.65 165.06 15.75 Favored Glycine 0 N--CA 1.472 1.043 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -81.32 138.19 35.7 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -68.22 139.49 56.04 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.03 144.09 57.36 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 83.2 p -68.89 -24.08 64.28 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.185 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -91.5 2.89 56.11 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 122.218 0.207 . . . . 0.0 110.99 -179.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 52.8 t -118.91 126.16 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 36.4 t -75.05 -43.32 54.14 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.339 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 37.5 t -163.94 162.11 23.22 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.723 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 80.4 mt -130.4 146.1 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.337 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 40.2 t -132.58 161.83 32.84 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.497 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -146.21 154.67 42.01 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.069 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 50.8 m -144.69 170.89 15.22 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.802 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -146.74 147.69 31.21 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.808 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -74.57 -33.36 62.67 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.067 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 86.7 mtm180 -133.6 -49.77 0.84 Allowed 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.729 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.38 19.27 57.38 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 47.9 m80 -142.25 137.5 30.74 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.49 HG22 ' N ' ' A' ' 38' ' ' THR . 4.1 p -133.4 161.88 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.49 ' N ' HG22 ' A' ' 37' ' ' VAL . 34.1 m -101.53 135.0 43.78 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.335 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 40.5 pt -120.04 149.66 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.8 t -132.79 134.97 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 166.57 -160.3 33.86 Favored Glycine 0 N--CA 1.464 0.531 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.8 m -73.01 151.74 41.63 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 62.1 tp60 -64.96 -34.49 78.54 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.313 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -60.61 -43.81 97.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.736 0.303 . . . . 0.0 110.622 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.72 -40.09 94.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.623 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 67.7 mtt -65.01 -40.67 95.23 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.597 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -65.55 -23.71 66.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.64 0.257 . . . . 0.0 110.53 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -80.61 -34.96 34.68 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.377 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 67.1 mt -91.61 116.35 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -99.1 -24.58 14.84 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.064 0.459 . . . . 0.0 110.221 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 92.9 p -172.36 162.8 5.52 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.044 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 36.7 mm -107.32 120.48 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 33.5 m -85.01 129.93 34.71 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 38.3 t -123.84 90.75 50.37 Favored Pre-proline 0 N--CA 1.471 0.619 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -79.26 146.2 19.62 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 121.485 1.456 . . . . 0.0 111.371 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.7 p -139.57 137.43 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.883 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -79.16 125.29 29.25 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 36.4 pt -103.08 -9.87 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 120.857 0.36 . . . . 0.0 110.294 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 40.3 m -61.81 -39.82 93.09 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.436 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -86.69 -5.0 59.25 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 122.928 0.491 . . . . 0.0 110.679 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 45.4 t -92.43 114.14 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 70.2 p -132.54 -0.13 3.59 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.172 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -144.62 155.7 43.75 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 121.007 0.432 . . . . 0.0 110.435 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -63.9 132.81 51.89 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.04 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.8 t -167.61 -174.9 2.63 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.342 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 96.8 p -151.26 147.25 26.75 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.611 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -140.16 143.93 36.4 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.109 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.8 m -83.13 132.03 35.11 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.168 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 74.8 mt -120.89 129.66 53.58 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 122.907 0.483 . . . . 0.0 109.839 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -96.6 137.68 35.32 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 52.2 mt -110.64 136.93 48.98 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -141.59 147.24 37.34 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -149.89 137.21 19.78 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -86.29 114.6 23.23 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.004 0.431 . . . . 0.0 110.941 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 125.12 -20.56 6.65 Favored Glycine 0 N--CA 1.485 1.937 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.625 178.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 32.8 m -134.13 159.87 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 31.7 m -102.73 111.14 23.32 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.1 t -92.04 129.14 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -156.75 142.0 12.45 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.494 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.92 -10.28 11.73 Favored 'Cis proline' 0 N--CA 1.508 2.33 0 CA-C-N 120.539 1.228 . . . . 0.0 110.58 -0.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.8 p 60.3 23.15 12.6 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.165 177.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 39.7 p -131.93 139.63 48.77 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.5 m -152.36 151.92 11.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -96.19 134.01 39.8 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 44.7 t -126.1 127.08 70.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -104.95 124.38 49.41 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 58.7 mt -108.01 108.68 19.9 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -90.16 129.63 36.41 Favored 'General case' 0 C--O 1.231 0.105 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 38.6 t -104.14 131.36 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 39.9 m -101.18 120.42 40.21 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 91.3 mm-40 -79.85 132.34 36.09 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -70.4 137.14 50.21 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.7 tp -152.05 127.88 10.25 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -67.59 159.79 29.12 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -161.3 -170.91 2.81 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.917 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -64.78 134.66 54.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.03 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -67.98 144.32 55.22 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 66.5 m80 -65.23 125.08 23.9 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -65.0 -42.24 94.68 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.799 0.333 . . . . 0.0 110.119 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 118.115 -0.945 . . . . 0.0 110.732 -179.885 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 22.1 pttp . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 71.9 mt -64.61 143.47 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.637 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.3 t 55.05 89.95 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.163 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.406 ' O ' ' N ' ' A' ' 6' ' ' LYS . 61.3 mt 56.48 103.64 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.409 0.623 . . . . 0.0 110.709 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -65.11 74.54 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.048 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.406 ' N ' ' O ' ' A' ' 4' ' ' LEU . 46.7 mtpt -98.41 137.71 36.71 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 53.4 mt -93.95 -178.93 4.81 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 95.8 p -160.58 150.31 17.59 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.8 mtpt -151.11 164.98 35.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.619 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 35.0 m -114.18 137.1 52.2 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.634 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.3 m -126.68 101.67 26.67 Favored Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 123.588 0.755 . . . . 0.0 109.051 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -57.02 144.53 89.42 Favored 'Trans proline' 0 N--CA 1.499 1.803 0 CA-C-N 120.342 1.158 . . . . 0.0 111.939 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 23.3 t -89.41 130.93 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.1 ttmm -117.33 126.95 53.55 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.6 mt -101.82 127.95 48.4 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -115.23 109.95 18.73 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.9 pp -64.19 129.23 39.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.154 -0.476 . . . . 0.0 109.736 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 31.6 m -126.07 135.66 52.0 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 115.23 162.66 13.68 Favored Glycine 0 N--CA 1.476 1.367 0 N-CA-C 110.581 -1.007 . . . . 0.0 110.581 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.0 p-10 -82.64 142.18 31.92 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -66.7 134.34 52.03 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.68 176.63 0.64 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.23 0.538 . . . . 0.0 111.143 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.8 t -85.75 -23.98 27.08 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.099 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -91.32 -13.14 33.12 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -178.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.5 p -98.56 128.25 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 CA-C-O 120.79 0.328 . . . . 0.0 110.875 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 46.7 t -92.09 -37.31 12.85 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.839 0.352 . . . . 0.0 110.122 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 98.3 p -161.21 159.16 28.46 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.151 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 73.9 mt -133.78 142.53 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 65.0 p -135.01 159.12 42.52 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.288 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -145.7 155.85 43.25 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.083 0.468 . . . . 0.0 110.182 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 47.7 t -147.4 163.46 36.41 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.254 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -146.46 143.76 29.2 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.288 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -69.27 -34.36 74.63 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.984 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -135.91 -51.27 0.72 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.014 0.526 . . . . 0.0 109.96 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.84 24.03 61.99 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.439 ' ND1' ' O ' ' A' ' 36' ' ' HIS . 17.8 p80 -148.69 139.68 23.04 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 28.4 m -131.6 164.51 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 61.4 m -99.71 133.55 43.89 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 37.9 pt -118.82 147.5 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 122.854 0.462 . . . . 0.0 110.25 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.2 t -132.13 135.6 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.399 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 170.97 -163.08 36.09 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 30.8 t -72.33 147.4 46.35 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 70.8 tp60 -58.8 -38.19 78.05 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.603 0.24 . . . . 0.0 111.117 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.445 ' CD ' ' H ' ' A' ' 44' ' ' GLU . 23.6 mp0 -59.84 -48.02 83.37 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.878 0.37 . . . . 0.0 110.793 -179.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.99 -37.9 86.57 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.738 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 21.2 mmt -65.79 -39.54 91.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.006 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -61.1 -31.98 71.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.609 0.242 . . . . 0.0 110.818 -178.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -71.55 -39.08 70.9 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.776 0.322 . . . . 0.0 110.316 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 57.5 mt -85.54 117.53 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -113.46 -19.52 11.65 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.184 0.593 . . . . 0.0 110.578 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 66.5 p -174.1 161.56 3.63 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.694 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 38.1 mm -111.4 117.85 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 48.2 m -105.51 124.44 49.55 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 36.1 t -127.17 113.44 21.62 Favored Pre-proline 0 N--CA 1.482 1.169 0 CA-C-O 118.446 -0.788 . . . . 0.0 109.792 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -76.81 143.62 23.73 Favored 'Trans proline' 0 N--CA 1.497 1.678 0 CA-C-N 121.254 1.484 . . . . 0.0 110.755 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.8 t -129.31 126.79 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -73.67 126.47 30.4 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.69 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 39.1 pt -102.69 -15.74 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 122.82 0.448 . . . . 0.0 110.912 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.8 t -61.39 -40.32 93.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.594 -178.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -83.3 -5.78 59.25 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 122.374 0.27 . . . . 0.0 110.616 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 47.4 t -91.2 108.45 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 70.6 p -129.88 1.51 4.84 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.636 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -141.95 146.79 36.05 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 21.2 p-10 -63.88 137.12 57.89 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.103 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.431 ' OG1' ' N ' ' A' ' 66' ' ' SER . 5.6 t -168.14 -173.43 2.03 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.265 0.555 . . . . 0.0 110.709 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.431 ' N ' ' OG1' ' A' ' 65' ' ' THR . 90.2 p -147.25 143.35 28.07 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.45 179.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -138.45 142.38 39.47 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.0 0.429 . . . . 0.0 110.238 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 44.6 m -82.1 131.89 35.24 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.5 mt -111.75 111.71 22.88 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 122.659 0.384 . . . . 0.0 110.29 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -83.77 126.37 32.85 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 31.8 mt -103.74 134.74 46.55 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 120.792 0.329 . . . . 0.0 110.597 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -134.94 142.06 46.42 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.084 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -145.41 135.27 23.59 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -85.5 117.73 24.58 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.328 0.585 . . . . 0.0 111.848 -178.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.61 -16.02 16.86 Favored Glycine 0 N--CA 1.482 1.704 0 CA-C-N 114.574 -1.194 . . . . 0.0 112.208 178.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 23.3 m -133.04 159.22 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 56.9 m -107.95 117.73 34.9 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.1 p -105.85 133.52 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 122.938 0.495 . . . . 0.0 109.741 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -158.81 143.67 11.69 Favored Pre-proline 0 CA--C 1.552 1.046 0 CA-C-O 119.078 -0.487 . . . . 0.0 110.654 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.413 ' C ' ' H ' ' A' ' 82' ' ' THR . 87.8 Cg_endo -70.2 -12.13 12.96 Favored 'Cis proline' 0 N--CA 1.516 2.815 0 CA-C-N 120.646 1.266 . . . . 0.0 110.998 0.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 67.6 -6.87 0.62 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.839 177.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.413 ' H ' ' C ' ' A' ' 80' ' ' PRO . 59.0 p -100.31 139.51 35.88 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.8 m -147.92 146.14 18.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -95.23 130.89 41.8 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 44.0 t -126.6 126.04 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -100.09 124.64 45.72 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 59.8 mt -110.41 104.16 12.89 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -92.81 128.88 38.83 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.4 p -107.83 137.08 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.627 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 69.9 m -100.24 121.5 41.56 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 95.4 mm-40 -80.18 133.8 36.07 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.41 ' C ' ' H ' ' A' ' 94' ' ' GLU . 60.1 tttm -61.73 139.41 58.32 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.447 ' N ' HD12 ' A' ' 93' ' ' LEU . 9.6 mp -72.91 7.47 2.0 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.877 0.37 . . . . 0.0 110.047 -178.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 96' ' ' HIS . 93.2 mt-10 50.67 -166.36 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.392 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 72.1 m80 51.84 -87.55 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.599 0.237 . . . . 0.0 111.45 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.432 ' N ' ' O ' ' A' ' 94' ' ' GLU . 71.6 m80 -65.04 120.38 12.53 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.522 ' CD2' ' H ' ' A' ' 99' ' ' HIS . 79.3 t60 -69.5 167.22 17.17 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.446 ' N ' ' CG ' ' A' ' 97' ' ' HIS . 85.8 t60 -60.76 -41.83 96.24 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.291 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.522 ' H ' ' CD2' ' A' ' 97' ' ' HIS . 59.4 t-80 53.85 92.14 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.852 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.771 -179.96 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 68.3 mttm . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 40.6 pt -134.33 163.02 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 122.952 0.501 . . . . 0.0 110.571 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.1 m -162.72 -28.71 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.623 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.43 ' O ' ' N ' ' A' ' 6' ' ' LYS . 4.2 tp -67.06 142.29 57.2 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.025 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 53.46 -87.11 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.731 0.301 . . . . 0.0 110.699 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.43 ' N ' ' O ' ' A' ' 4' ' ' LEU . 67.9 mttm -63.63 133.56 53.9 Favored 'General case' 0 C--O 1.231 0.109 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 58.6 mt -110.59 152.76 26.06 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.0 t -151.67 145.68 25.24 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.567 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -149.64 167.51 26.19 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.565 -178.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 30.5 m -109.48 139.06 44.92 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.059 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.5 m -131.84 95.03 23.48 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 123.625 0.77 . . . . 0.0 109.313 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -58.39 146.19 90.95 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 C-N-CA 121.207 1.272 . . . . 0.0 112.144 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.4 p -98.25 142.1 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.242 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -121.27 133.87 55.15 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 78.3 mt -100.06 128.54 46.13 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -113.47 111.89 22.7 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 56.5 mt -70.28 126.13 28.77 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.1 p -129.31 145.38 51.38 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.956 -0.386 . . . . 0.0 109.956 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.02 168.33 16.39 Favored Glycine 0 N--CA 1.474 1.199 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.6 p-10 -84.75 132.58 34.42 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -64.49 135.93 56.55 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.54 176.06 3.12 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.577 0.703 . . . . 0.0 110.991 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 74.6 m -84.31 -20.75 31.57 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.299 -178.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -90.27 -19.83 23.65 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 122.461 0.304 . . . . 0.0 111.037 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.6 p -97.18 128.31 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-O 120.576 0.227 . . . . 0.0 110.469 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.5 t -103.39 -26.99 12.7 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 120.823 0.345 . . . . 0.0 110.188 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 48.1 t -160.81 154.21 21.9 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.907 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 86.0 mt -129.92 135.79 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.9 p -133.59 154.79 50.6 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -148.42 159.16 44.31 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.409 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.1 t -146.35 168.37 21.29 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.008 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -146.41 149.61 34.06 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.952 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -68.12 -33.54 74.69 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.56 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -150.27 -38.96 0.14 Allowed 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.172 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.422 ' O ' ' ND1' ' A' ' 36' ' ' HIS . . . 55.95 25.86 46.69 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 178.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.422 ' ND1' ' O ' ' A' ' 35' ' ' GLY . 15.3 m-70 -138.0 137.32 37.78 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 31.4 m -129.88 160.93 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 35.5 m -102.88 133.78 47.4 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 38.1 pt -117.8 146.44 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 122.758 0.423 . . . . 0.0 110.326 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.7 t -132.86 134.51 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.786 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 168.5 -159.44 32.6 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 95.0 p -72.63 151.62 42.2 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.647 0.26 . . . . 0.0 110.301 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.8 tm0? -63.35 -36.9 85.22 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.763 0.316 . . . . 0.0 110.237 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.477 ' CD ' ' H ' ' A' ' 44' ' ' GLU . 24.9 mp0 -60.55 -53.71 54.24 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.137 -178.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.51 -40.21 96.01 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.909 0.385 . . . . 0.0 110.88 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 88.3 mtp -66.85 -39.61 87.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.702 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -61.79 -34.31 75.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.478 0.18 . . . . 0.0 111.395 -178.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -68.95 -35.26 76.56 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.749 0.309 . . . . 0.0 110.383 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 63.6 mt -85.67 120.1 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -119.42 -16.67 8.92 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 122.968 0.507 . . . . 0.0 110.404 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 68.9 p -172.29 167.5 5.78 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.45 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 81.6 mt -126.73 128.04 70.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.9 t -104.68 132.4 50.97 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 179.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 38.7 t -133.23 90.63 29.83 Favored Pre-proline 0 N--CA 1.473 0.696 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -58.12 142.24 96.92 Favored 'Trans proline' 0 N--CA 1.501 1.955 0 C-N-CA 121.663 1.575 . . . . 0.0 112.026 178.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 60.3 t -128.67 128.7 68.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -77.53 123.18 26.25 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 38.0 pt -99.63 -10.99 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 122.705 0.402 . . . . 0.0 110.697 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 39.4 t -61.66 -40.13 93.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.461 -178.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -85.23 -5.5 59.32 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 122.748 0.419 . . . . 0.0 110.394 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 46.4 t -91.94 106.99 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 71.5 p -131.03 2.66 4.33 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.703 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -147.2 146.07 29.71 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.936 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -52.33 135.21 33.24 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.453 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.417 ' OG1' ' N ' ' A' ' 66' ' ' SER . 7.0 t -167.95 -173.95 2.24 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.095 0.474 . . . . 0.0 110.863 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.417 ' N ' ' OG1' ' A' ' 65' ' ' THR . 61.8 p -150.92 148.73 28.78 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.101 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -143.54 144.15 31.83 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.225 0.536 . . . . 0.0 111.076 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 t -85.85 132.5 34.09 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.509 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 70.7 mt -115.97 120.63 39.79 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.806 0.443 . . . . 0.0 110.592 -179.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -84.87 133.06 34.32 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.265 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.1 mt -113.61 115.29 27.68 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -134.09 151.43 51.39 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -148.43 143.72 26.95 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -85.23 117.4 24.16 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.355 0.598 . . . . 0.0 111.343 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 118.24 -18.33 11.23 Favored Glycine 0 N--CA 1.481 1.658 0 CA-C-N 114.714 -1.13 . . . . 0.0 112.046 178.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.2 m -133.31 160.96 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 56.5 m -103.55 111.66 24.22 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.1 t -91.12 128.6 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -149.81 143.45 16.72 Favored Pre-proline 0 CA--C 1.553 1.085 0 CA-C-O 119.062 -0.494 . . . . 0.0 110.075 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -72.86 -1.23 11.74 Favored 'Cis proline' 0 N--CA 1.511 2.507 0 CA-C-N 120.906 1.359 . . . . 0.0 110.364 0.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.4 t 56.03 22.08 5.58 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.357 -1.292 . . . . 0.0 111.771 178.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 34.9 p -138.0 139.57 39.72 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.4 m -148.79 154.75 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -103.38 132.61 49.5 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 43.0 t -128.93 125.69 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.023 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -102.21 125.71 48.98 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 65.4 mt -107.54 111.2 23.35 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -95.5 126.57 40.88 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.6 m -96.52 137.6 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 44.1 m -100.61 116.41 32.46 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 95.3 mm-40 -80.99 129.63 34.63 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.4 ptmm? -54.86 138.43 42.91 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.868 0.366 . . . . 0.0 110.995 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 37.8 mt -95.07 -5.49 44.2 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.838 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -170.05 149.89 3.67 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.891 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -71.16 130.56 41.78 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.247 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -169.14 89.67 0.21 Allowed 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 48.9 p-80 -65.17 145.33 56.4 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.069 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -161.0 139.03 9.55 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 45.3 p-80 -160.31 161.26 33.24 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.107 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 42.9 p-80 . . . . . 0 C--O 1.221 -0.447 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.581 179.965 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.0 mttt . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 21.4 mm -72.77 132.14 33.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.2 m -158.78 -63.68 0.08 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.207 0.527 . . . . 0.0 109.757 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.6 tp 59.17 -134.45 0.9 Allowed 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.211 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -65.01 152.59 43.01 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -65.11 138.95 58.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.629 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 54.7 mt -113.94 151.42 32.31 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.7 t -160.35 143.26 13.4 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.593 ' NZ ' HE22 ' A' ' 43' ' ' GLN . 64.0 mttp -149.75 166.62 28.87 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -178.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.0 m -121.75 137.83 54.6 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.898 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.7 m -123.38 143.88 42.44 Favored Pre-proline 0 N--CA 1.486 1.362 0 C-N-CA 122.691 0.396 . . . . 0.0 110.022 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -74.37 142.24 29.72 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 121.429 1.419 . . . . 0.0 111.6 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.9 t -103.52 134.61 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -127.77 148.02 50.43 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 51.8 mt -112.37 137.88 49.91 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.466 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -119.32 110.27 16.79 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.433 ' N ' HD12 ' A' ' 17' ' ' LEU . 9.4 mp -70.52 130.87 43.01 Favored 'General case' 0 C--N 1.334 -0.085 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.8 p -130.03 143.11 50.62 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.7 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.62 170.0 16.48 Favored Glycine 0 N--CA 1.475 1.265 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.8 p-10 -87.06 132.92 33.67 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -65.93 133.65 51.31 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.51 145.47 54.91 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.05 0.452 . . . . 0.0 110.629 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 61.0 m -63.68 -18.33 63.88 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.982 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -84.76 -20.87 30.37 Favored 'General case' 0 C--N 1.343 0.314 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.8 t -107.24 127.48 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-O 121.093 0.473 . . . . 0.0 110.276 -178.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 47.5 t -87.18 -40.7 14.35 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.34 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 47.1 t -155.47 161.31 40.98 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.499 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 82.6 mt -131.4 142.6 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.782 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.3 m -130.41 154.17 47.98 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.283 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -144.68 156.34 44.04 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.134 0.492 . . . . 0.0 110.096 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 45.4 m -148.09 166.52 27.57 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.154 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -146.1 142.49 28.58 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.959 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 33' ' ' ASP . 21.3 p-10 -73.35 -34.23 65.5 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.645 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -126.43 -56.79 1.4 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.111 0.564 . . . . 0.0 110.483 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 59.9 18.64 47.67 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -144.82 136.69 25.75 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.1 m -132.99 163.28 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 44.0 m -102.51 137.37 40.84 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 34.9 pt -117.41 150.44 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.2 p -130.27 134.69 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 123.332 0.395 . . . . 0.0 110.379 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 166.86 -160.75 34.49 Favored Glycine 0 C--N 1.328 0.113 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 44.6 t -77.43 157.04 30.73 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.593 HE22 ' NZ ' ' A' ' 9' ' ' LYS . 9.3 tp-100 -62.81 -35.36 79.64 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -61.75 -44.35 97.07 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.662 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.09 -39.91 95.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.816 0.341 . . . . 0.0 110.754 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 68.6 mtt -66.22 -38.64 88.42 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.418 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -61.08 -31.81 71.48 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.754 -0.203 . . . . 0.0 110.948 -179.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -73.64 -40.37 63.81 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.792 0.329 . . . . 0.0 110.511 179.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 67.0 mt -81.2 116.66 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -112.34 -23.35 10.4 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.248 0.619 . . . . 0.0 109.604 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 98.0 p -170.78 161.67 7.37 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.525 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 77.7 mt -112.53 121.43 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 33.6 m -99.08 130.72 45.42 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.4 t -134.26 93.0 20.07 Favored Pre-proline 0 N--CA 1.475 0.825 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -77.33 145.52 24.06 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 121.118 1.212 . . . . 0.0 111.31 -178.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.1 t -132.21 130.2 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-O 121.113 0.482 . . . . 0.0 110.235 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.9 p-10 -70.43 126.45 29.67 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.921 179.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 34.8 pt -100.02 -13.03 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 120.791 0.329 . . . . 0.0 110.661 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 44.7 m -59.39 -39.12 82.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.332 -178.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -84.65 -6.92 59.39 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 122.744 0.418 . . . . 0.0 110.39 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 42.6 t -93.54 114.48 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 65.4 p -133.48 4.92 3.7 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.158 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -152.66 161.74 42.17 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.846 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -62.36 138.7 58.49 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.953 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.2 t -166.03 170.46 13.55 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.293 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 46.7 m -148.11 140.69 24.5 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.761 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 54.5 pttt -146.63 145.08 29.93 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.488 0.661 . . . . 0.0 110.926 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 33.2 m -81.55 136.76 35.59 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.084 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 70.3 mt -115.89 125.96 53.3 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 122.79 0.436 . . . . 0.0 110.19 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.514 ' CD ' ' HZ3' ' A' ' 72' ' ' LYS . 16.1 pt-20 -92.42 132.16 37.0 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 30.8 mt -107.67 129.77 54.98 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.514 ' HZ3' ' CD ' ' A' ' 70' ' ' GLU . 63.3 mttp -131.15 141.44 50.09 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -139.49 142.14 37.33 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -86.02 133.03 33.93 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 122.21 1.005 . . . . 0.0 112.362 -178.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.05 -15.03 63.83 Favored Glycine 0 N--CA 1.472 1.049 0 CA-C-N 113.564 -1.653 . . . . 0.0 112.149 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 11.1 m -131.55 164.36 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 16.2 m -112.28 112.79 24.62 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.0 t -89.53 132.4 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -155.44 144.38 14.92 Favored Pre-proline 0 CA--C 1.557 1.238 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.858 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.46 -10.79 13.05 Favored 'Cis proline' 0 N--CA 1.514 2.732 0 CA-C-N 120.579 1.242 . . . . 0.0 110.639 0.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 10.4 p 58.21 23.68 10.56 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 114.652 -1.158 . . . . 0.0 112.129 177.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 34.6 p -132.88 139.38 47.38 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.6 m -152.89 154.97 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -94.75 134.74 37.03 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 44.8 t -127.85 130.62 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -111.24 124.23 51.8 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 53.0 mt -108.43 108.86 19.99 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -91.63 128.46 37.47 Favored 'General case' 0 C--O 1.231 0.111 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 43.3 t -102.97 132.61 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 61.8 m -100.31 117.87 35.4 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -78.72 131.51 36.62 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -63.12 138.04 58.42 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.428 ' N ' HD22 ' A' ' 93' ' ' LEU . 4.1 mm? -68.91 130.51 42.98 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -86.58 -171.27 3.46 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.752 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 27.2 p80 -62.95 142.48 58.32 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.319 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -61.45 -47.04 87.52 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.441 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -168.6 156.37 7.93 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.437 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 72.5 m80 -70.2 144.96 51.76 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.956 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 79.2 t60 -161.19 4.55 0.06 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.783 0.325 . . . . 0.0 110.277 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 118.004 -0.998 . . . . 0.0 111.173 179.858 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 63.5 tttm . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 39.6 pt -66.97 -25.07 33.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.621 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.2 m -61.69 144.79 54.04 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.105 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 54.7 tp -65.53 147.64 53.07 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -162.36 42.13 0.13 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.159 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -57.39 155.03 9.77 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.81 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 34.5 tp -131.64 144.88 51.36 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 35.9 m -161.3 140.61 10.24 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.63 ' NZ ' HE22 ' A' ' 43' ' ' GLN . 98.5 mttt -149.25 165.84 30.69 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -178.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 92.5 p -117.16 138.08 51.91 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.903 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.5 m -126.56 143.42 46.23 Favored Pre-proline 0 N--CA 1.482 1.162 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.92 142.4 28.05 Favored 'Trans proline' 0 N--CA 1.501 1.914 0 C-N-CA 121.604 1.536 . . . . 0.0 111.931 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.9 p -95.29 134.51 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.5 mptm? -108.73 133.55 52.65 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.5 tp -104.9 130.42 53.06 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -124.36 111.77 16.17 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.9 pp -69.6 131.11 44.13 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.3 p -125.44 134.95 51.91 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.64 163.88 14.55 Favored Glycine 0 N--CA 1.477 1.417 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.2 p-10 -78.95 136.8 37.35 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -66.81 138.11 57.11 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.42 141.43 58.36 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.206 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.0 t -68.03 -20.87 65.03 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.642 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -94.25 4.71 53.51 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 122.237 0.215 . . . . 0.0 110.914 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 68.6 t -118.42 126.2 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.3 t -73.71 -45.76 50.25 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.069 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 45.6 t -161.1 165.44 29.61 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.175 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 80.1 mt -131.77 144.96 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 99.8 p -135.78 163.37 30.36 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.467 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -144.2 160.13 41.48 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.498 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 61.7 p -148.58 162.87 38.81 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.884 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -146.3 143.9 29.46 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.974 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -72.72 -35.09 67.5 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.682 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -126.61 -54.71 1.43 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 122.95 0.5 . . . . 0.0 110.571 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 62.11 24.23 64.88 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.455 ' ND1' ' O ' ' A' ' 36' ' ' HIS . 15.7 p80 -151.95 138.91 19.04 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 28.9 m -131.29 162.27 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 49.3 m -100.87 134.37 43.95 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 20.4 pt -114.34 145.08 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 49.1 t -127.5 133.54 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 170.47 -162.2 35.28 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.5 m -75.32 160.14 30.66 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.63 HE22 ' NZ ' ' A' ' 9' ' ' LYS . 60.7 tp60 -63.97 -40.14 95.72 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.576 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -65.1 -36.58 84.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.829 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.08 -41.64 90.45 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.783 0.325 . . . . 0.0 111.038 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 68.3 mtt -68.81 -35.96 77.64 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.728 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -60.57 -32.96 72.02 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.519 0.2 . . . . 0.0 110.911 -178.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -73.61 -38.28 65.14 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.839 0.352 . . . . 0.0 110.354 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 68.7 mt -86.27 117.37 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -114.89 -16.7 11.68 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 122.919 0.488 . . . . 0.0 110.108 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 73.4 p -171.49 169.12 6.26 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.809 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 87.9 mt -122.67 124.0 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 33.6 m -89.38 132.15 35.1 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 43.1 t -131.19 91.7 34.96 Favored Pre-proline 0 N--CA 1.476 0.844 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -80.77 140.74 13.14 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 121.597 1.531 . . . . 0.0 111.364 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 49.1 t -131.9 130.87 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.918 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -74.83 124.75 27.42 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 37.6 pt -102.01 -11.86 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 122.795 0.438 . . . . 0.0 110.639 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.7 m -60.53 -38.72 85.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.39 -178.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -86.75 -2.74 58.79 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 45.1 t -97.33 120.72 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.2 t -135.87 6.3 3.15 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.293 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -155.3 171.95 19.0 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.422 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.7 p-10 -65.81 126.45 28.52 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.464 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.0 p -145.58 165.78 27.67 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.899 0.38 . . . . 0.0 110.043 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 90.2 p -150.65 129.36 12.34 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.524 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -140.08 145.97 38.34 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.23 0.538 . . . . 0.0 110.888 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 37.8 m -81.68 134.69 35.49 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.596 178.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.0 mt -118.22 126.24 51.77 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.866 0.467 . . . . 0.0 109.87 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -94.16 135.61 35.35 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.9 mt -106.96 134.84 49.5 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.887 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -134.21 143.77 48.04 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -143.59 137.7 28.55 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -85.77 121.23 28.14 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.256 0.551 . . . . 0.0 112.027 -178.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.71 -13.76 38.56 Favored Glycine 0 N--CA 1.48 1.628 0 CA-C-N 114.571 -1.195 . . . . 0.0 112.305 178.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 18.9 m -133.83 161.43 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 46.7 m -110.77 120.55 42.78 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.6 p -109.52 135.46 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -158.82 144.6 12.21 Favored Pre-proline 0 CA--C 1.551 1.005 0 CA-C-O 119.307 -0.378 . . . . 0.0 110.576 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.407 ' C ' ' H ' ' A' ' 82' ' ' THR . 79.9 Cg_endo -70.57 -12.56 13.82 Favored 'Cis proline' 0 N--CA 1.512 2.571 0 CA-C-N 120.247 1.124 . . . . 0.0 110.82 0.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 p 66.99 -3.51 0.94 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.17 177.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.407 ' H ' ' C ' ' A' ' 80' ' ' PRO . 57.4 p -98.71 140.01 33.56 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.2 m -149.5 144.65 17.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -94.59 132.6 39.12 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 47.4 t -126.35 128.56 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -110.31 123.38 49.71 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 58.3 mt -105.63 120.54 41.93 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm -104.09 126.49 51.25 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 42.4 t -103.77 133.81 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.263 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 70.6 p -96.63 124.04 40.5 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 93.9 mm-40 -93.79 127.73 39.67 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 -179.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -144.42 137.13 26.8 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.546 ' N ' HD23 ' A' ' 93' ' ' LEU . 1.1 pt? -168.17 169.42 10.99 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.79 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -172.14 159.29 4.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.723 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 66.9 m80 52.84 -178.03 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.983 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 51.57 83.87 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.969 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -167.72 83.3 0.2 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.171 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 69.2 m80 -68.75 144.85 54.24 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.888 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 30.1 p80 -63.3 138.87 58.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.296 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 62.9 m80 . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 118.005 -0.998 . . . . 0.0 111.212 179.861 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 68.1 mttm . . . . . 0 N--CA 1.491 1.625 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 37.2 pt -68.84 -16.47 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.332 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.1 t -56.31 -31.01 63.28 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.892 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 39.4 tp 60.16 145.44 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.106 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -70.3 148.33 48.62 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -68.84 143.04 54.68 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.509 HD12 ' OE1' ' A' ' 43' ' ' GLN . 3.8 mm? -83.98 150.55 25.57 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 91.1 p -160.52 133.77 6.69 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.488 ' CE ' HE22 ' A' ' 43' ' ' GLN . 67.6 mttm -147.83 166.81 26.47 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 41.2 t -120.85 136.78 54.83 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.073 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.1 m -122.57 126.25 26.2 Favored Pre-proline 0 CA--C 1.561 1.369 0 CA-C-O 119.034 -0.508 . . . . 0.0 109.772 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -59.29 146.85 93.42 Favored 'Trans proline' 0 N--CA 1.506 2.212 0 CA-C-N 121.664 1.63 . . . . 0.0 111.816 178.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.1 t -96.31 132.31 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -125.2 127.96 47.59 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.0 mp -96.26 135.52 37.97 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -116.82 107.4 14.58 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 57.2 mt -67.32 124.6 23.6 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 28.8 m -117.07 128.72 55.43 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.68 -164.3 12.09 Favored Glycine 0 N--CA 1.473 1.138 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -119.58 147.83 44.03 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 115.005 -0.598 . . . . 0.0 109.817 178.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -68.69 139.68 55.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.078 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.49 151.56 44.03 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.48 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.1 t -63.18 -22.08 66.63 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.194 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -83.67 -21.78 32.32 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.7 t -105.02 126.64 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 121.071 0.463 . . . . 0.0 109.964 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.9 m -88.12 -32.48 18.66 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.149 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 94.1 p -155.82 159.65 39.57 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.202 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 81.7 mt -127.52 134.49 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.523 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.6 m -126.1 150.45 48.2 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -139.31 152.25 47.08 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.04 0.448 . . . . 0.0 109.936 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 93.1 p -150.5 152.18 33.81 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.69 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -147.41 147.87 30.71 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.061 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -69.55 -36.09 76.02 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.738 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -139.67 129.38 24.56 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -117.44 27.96 7.39 Favored Glycine 0 N--CA 1.474 1.194 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 40.7 p-80 -145.63 139.41 26.6 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 29.4 m -131.2 161.28 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 49.9 m -103.79 134.29 47.36 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 38.1 pt -116.86 146.38 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 123.12 0.568 . . . . 0.0 109.664 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 52.1 t -132.69 134.21 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 165.49 -158.98 32.05 Favored Glycine 0 N--CA 1.466 0.667 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.4 t -67.4 149.23 50.55 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.509 ' OE1' HD12 ' A' ' 7' ' ' LEU . 71.3 tp60 -64.86 -38.35 90.68 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.379 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -62.01 -39.1 91.13 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.807 0.337 . . . . 0.0 110.6 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.36 -39.55 92.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.675 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 68.6 mtt -66.41 -40.56 89.65 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.579 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -64.3 -24.93 67.83 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.595 0.236 . . . . 0.0 110.547 -179.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -76.26 -37.71 57.22 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 69.7 mt -83.11 117.41 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -99.94 -26.51 13.97 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.328 0.585 . . . . 0.0 109.875 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 96.8 p -171.05 164.11 7.44 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.087 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 41.4 mm -106.26 118.84 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.658 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.4 t -87.85 134.18 33.75 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 38.6 t -132.39 89.0 37.88 Favored Pre-proline 0 N--CA 1.473 0.683 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -81.64 146.41 15.06 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 121.485 1.457 . . . . 0.0 111.54 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.6 p -139.69 136.49 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.857 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -76.47 126.21 30.58 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 20.8 pt -109.71 -2.94 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 122.706 0.402 . . . . 0.0 110.39 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 91.3 p -80.66 -15.07 57.5 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.58 -178.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -102.75 -11.35 18.42 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.126 0.571 . . . . 0.0 110.778 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.9 m -101.34 131.2 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 68.7 p -137.19 11.71 3.04 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.635 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -147.6 145.95 29.2 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.764 -178.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -56.82 136.18 55.56 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.519 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.409 ' OG1' ' N ' ' A' ' 66' ' ' SER . 5.1 t -167.31 -177.28 3.58 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.555 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.409 ' N ' ' OG1' ' A' ' 65' ' ' THR . 47.3 t -149.55 145.99 27.11 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.058 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -148.02 143.53 27.3 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.362 0.601 . . . . 0.0 110.967 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 35.0 m -82.03 135.82 35.3 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.818 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 89.3 mt -119.8 129.58 54.51 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.075 0.55 . . . . 0.0 110.25 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -94.68 134.9 36.76 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 47.4 mt -108.24 133.95 51.77 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.034 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -139.14 147.1 41.46 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -147.62 139.91 24.44 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.408 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.3 mp0 -86.72 117.43 25.47 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.454 0.645 . . . . 0.0 112.037 -178.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 116.44 -16.71 14.48 Favored Glycine 0 N--CA 1.48 1.597 0 CA-C-N 114.221 -1.354 . . . . 0.0 111.74 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.1 m -134.73 160.33 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 50.5 m -105.63 112.51 25.62 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.4 t -89.73 132.05 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -156.13 140.43 11.75 Favored Pre-proline 0 CA--C 1.552 1.035 0 CA-C-O 119.07 -0.49 . . . . 0.0 110.882 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -70.16 -10.66 12.4 Favored 'Cis proline' 0 N--CA 1.513 2.671 0 CA-C-N 120.788 1.317 . . . . 0.0 111.042 0.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.0 p 58.22 19.36 6.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.704 -1.135 . . . . 0.0 112.029 177.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.1 p -130.16 140.29 50.78 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.5 m -151.46 154.17 8.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -101.96 132.8 47.57 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.3 p -128.85 132.04 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 121.164 0.506 . . . . 0.0 109.935 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -106.28 125.98 51.67 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.871 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 57.6 mt -109.38 108.99 19.73 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -92.95 128.87 38.97 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 33.7 m -91.49 137.42 21.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.226 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 26.3 m -104.11 109.72 21.63 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -76.08 129.25 36.53 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 110.559 -0.163 . . . . 0.0 110.559 -178.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -61.13 104.83 0.42 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.058 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 59.7 mt -75.21 140.12 43.06 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 52.42 89.33 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.526 0.203 . . . . 0.0 110.93 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -68.96 111.14 4.8 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.189 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -67.75 95.66 0.52 Allowed 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 120.805 0.336 . . . . 0.0 110.266 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -168.92 115.24 0.61 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.711 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 43.4 p-80 -169.86 -21.29 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 -166.41 136.6 3.29 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.294 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 118.097 -0.954 . . . . 0.0 110.256 179.751 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 63.6 tttm . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.668 HD13 ' H ' ' A' ' 2' ' ' ILE . 0.1 OUTLIER -139.96 172.17 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.207 -0.452 . . . . 0.0 109.874 -179.77 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 96.2 p -168.92 162.72 11.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.053 178.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 70.1 mt -68.59 148.73 50.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.714 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 71.4 mtp85 -63.06 -84.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.257 -179.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.0 mtmm -83.07 142.67 31.12 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 50.9 mt -113.89 155.05 26.47 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.3 t -153.46 156.56 38.39 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.932 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.8 tptt -155.5 164.19 39.01 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.746 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 87.8 p -127.9 137.42 52.3 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.186 -0.915 . . . . 0.0 108.668 179.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.1 m -131.19 144.52 53.82 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.595 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -74.39 144.43 32.61 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 121.864 1.709 . . . . 0.0 111.505 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.5 m -96.73 145.72 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -122.15 139.4 53.79 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.6 mp -113.82 135.96 53.39 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -121.88 118.53 29.15 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.74 0.65 . . . . 0.0 109.262 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 51.3 mt -72.56 126.32 29.59 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 79.9 p -119.24 128.59 54.33 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.98 160.31 13.53 Favored Glycine 0 N--CA 1.47 0.929 0 N-CA-C 110.414 -1.075 . . . . 0.0 110.414 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -84.15 145.48 28.37 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 178.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -65.05 137.58 57.79 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.298 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.91 159.57 25.3 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.981 0.419 . . . . 0.0 110.446 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.4 t -71.49 -30.45 65.99 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.559 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -83.62 -11.06 57.77 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 122.156 0.182 . . . . 0.0 111.176 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 64.2 t -108.5 130.06 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 36.1 m -87.19 -41.79 13.47 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.936 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 45.0 t -159.23 160.51 35.41 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.301 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 76.5 mt -132.15 143.57 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.576 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.4 m -130.86 158.1 41.1 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.186 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -142.51 152.47 42.69 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.867 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 45.7 t -151.93 162.82 40.46 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.759 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -143.87 147.38 33.96 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.035 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -72.49 -33.8 67.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.366 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -135.43 -52.38 0.76 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 122.57 0.348 . . . . 0.0 110.251 -179.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.82 28.23 60.19 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 51.5 m-70 -140.96 137.33 32.98 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.6 m -129.66 161.17 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 27.7 m -103.16 138.91 39.35 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 34.3 pt -119.54 147.89 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.484 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 48.6 t -130.4 134.71 61.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.738 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 162.38 -158.47 30.57 Favored Glycine 0 N--CA 1.462 0.413 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 56.4 m -76.11 149.59 37.37 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -62.38 -29.92 70.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.451 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -61.76 -47.96 82.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.47 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.45 -38.45 91.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.631 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 68.1 mtt -65.99 -39.57 90.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.494 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -62.45 -30.74 71.46 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.555 0.216 . . . . 0.0 110.773 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -74.68 -36.98 62.78 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.717 0.294 . . . . 0.0 110.691 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 68.6 mt -89.13 117.5 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -108.24 -21.42 12.78 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.109 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 93.9 p -170.32 159.19 7.04 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.887 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 72.6 mt -109.44 128.04 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.6 m -89.33 131.67 35.3 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.6 t -128.57 90.37 46.69 Favored Pre-proline 0 CA--C 1.542 0.659 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 178.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -81.8 147.84 15.42 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 122.175 1.916 . . . . 0.0 111.297 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.3 p -142.84 136.17 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.077 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -75.62 129.64 37.49 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 35.1 pt -104.69 -11.04 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 O-C-N 123.299 0.374 . . . . 0.0 110.304 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 80.6 p -61.18 -39.3 89.64 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.143 -178.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -86.5 -5.01 59.26 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 122.534 0.334 . . . . 0.0 110.402 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 42.6 t -94.65 117.62 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 58.0 p -134.56 2.05 3.17 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.025 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -147.38 156.52 42.97 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.992 0.425 . . . . 0.0 110.253 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -63.73 136.99 57.89 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.006 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.1 t -166.82 177.49 6.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.163 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 44.1 t -144.01 140.37 29.54 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.408 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -139.28 143.3 37.86 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.108 0.48 . . . . 0.0 110.518 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 28.1 m -83.74 132.52 34.84 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.8 mt -119.69 129.85 54.74 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.451 ' CD ' ' HZ1' ' A' ' 72' ' ' LYS . 19.5 pt-20 -97.81 137.19 37.05 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 43.3 mt -113.49 136.69 52.52 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.451 ' HZ1' ' CD ' ' A' ' 70' ' ' GLU . 63.0 mttp -132.82 140.96 48.22 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -135.55 143.48 45.72 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -85.99 135.62 33.58 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.819 0.818 . . . . 0.0 111.907 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.82 -28.25 8.01 Favored Glycine 0 N--CA 1.476 1.345 0 CA-C-N 114.303 -1.317 . . . . 0.0 112.732 178.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.5 m -118.9 163.45 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 34.0 m -109.48 116.22 31.39 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.0 t -93.81 131.66 40.13 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -157.69 141.39 11.33 Favored Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.703 178.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.54 -12.3 11.72 Favored 'Cis proline' 0 N--CA 1.506 2.239 0 CA-C-N 119.814 0.969 . . . . 0.0 110.051 -0.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.2 p 61.99 23.43 13.8 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.637 177.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 39.3 p -131.01 138.72 49.78 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 24.0 m -151.11 149.76 13.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -95.92 133.51 40.02 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.6 p -128.12 133.09 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -107.52 127.37 53.56 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 39.5 mt -111.06 106.51 15.6 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -89.35 129.63 35.85 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 18.6 t -106.55 132.88 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 31.5 m -100.33 121.03 40.84 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -86.7 133.64 33.66 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -67.66 137.55 55.66 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.454 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 6.7 tp -166.03 65.42 0.11 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.067 0.46 . . . . 0.0 110.702 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.454 ' CD ' ' H ' ' A' ' 93' ' ' LEU . 44.6 mp0 -140.62 153.24 45.97 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.3 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 69.1 m80 -65.44 160.14 22.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.771 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 31.7 p-80 -169.04 81.27 0.13 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.994 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -70.56 157.49 37.81 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -162.01 159.76 26.78 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.132 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -67.46 146.55 53.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.862 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 59.9 t-80 . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.012 179.987 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 68.2 mttm . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 38.6 mm -63.65 -43.64 98.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.207 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.1 m -58.96 -42.18 89.29 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.933 0.397 . . . . 0.0 111.05 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 64.7 mt -70.51 146.96 49.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.825 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 54.22 77.68 0.19 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.947 0.403 . . . . 0.0 110.906 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -64.68 136.27 56.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.775 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 57.2 mt -112.88 147.37 37.16 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 95.3 p -147.92 151.07 35.22 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.721 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -146.67 165.09 30.61 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.671 0.748 . . . . 0.0 109.6 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 92.6 p -112.04 136.22 51.68 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 114.004 -1.453 . . . . 0.0 109.918 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.4 m -134.33 99.38 13.31 Favored Pre-proline 0 CA--C 1.544 0.749 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -179.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -57.56 148.23 74.31 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 CA-C-N 120.191 1.104 . . . . 0.0 111.591 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 15.9 t -86.14 132.83 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -113.26 123.34 49.94 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.2 mp -96.27 131.71 42.49 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -120.07 107.73 13.41 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 178.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.9 pp -68.46 129.36 39.7 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.27 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.4 p -130.86 141.7 50.33 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 122.984 0.514 . . . . 0.0 109.645 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.85 168.24 16.49 Favored Glycine 0 N--CA 1.474 1.178 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -86.29 134.76 33.73 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -65.4 137.44 57.49 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.91 173.36 1.08 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.501 0.667 . . . . 0.0 111.32 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 35.2 t -84.71 -23.28 29.4 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.116 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -88.46 -13.65 39.84 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.406 HG13 ' O ' ' A' ' 25' ' ' VAL . 7.1 p -102.28 126.02 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-O 121.169 0.509 . . . . 0.0 112.039 -177.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 38.3 t -91.01 -31.01 16.48 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.35 179.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.7 t -159.75 158.13 30.68 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.47 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 85.9 mt -127.88 136.38 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.586 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.9 t -130.54 153.22 49.08 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -147.22 155.62 42.24 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.115 0.483 . . . . 0.0 110.562 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 50.4 m -146.6 160.09 42.61 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.879 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -140.81 143.1 34.63 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.812 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -71.87 -34.02 68.85 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.757 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.401 ' O ' ' ND1' ' A' ' 36' ' ' HIS . 99.6 mtt180 -128.13 -55.95 1.26 Allowed 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 121.194 0.521 . . . . 0.0 110.132 -179.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.23 22.64 58.69 Favored Glycine 0 CA--C 1.523 0.555 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.536 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.401 ' ND1' ' O ' ' A' ' 34' ' ' ARG . 12.8 p-80 -149.93 138.73 20.91 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.481 HG22 ' N ' ' A' ' 38' ' ' THR . 3.3 p -127.89 163.32 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.481 ' N ' HG22 ' A' ' 37' ' ' VAL . 52.0 m -100.22 132.6 45.49 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.905 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.5 pt -114.84 134.4 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 123.363 0.665 . . . . 0.0 109.304 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.6 t -124.47 133.5 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 163.9 -154.47 25.37 Favored Glycine 0 N--CA 1.468 0.826 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.4 m -69.66 145.41 52.42 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 70.6 tp60 -62.96 -34.49 77.61 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.615 0.245 . . . . 0.0 110.367 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -61.55 -41.44 97.37 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.638 0.256 . . . . 0.0 110.791 -179.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.91 -37.9 89.11 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.777 0.322 . . . . 0.0 110.717 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 66.7 mtt -64.77 -39.78 94.17 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.447 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -63.79 -30.78 71.84 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.539 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -73.92 -40.73 62.91 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.776 0.322 . . . . 0.0 110.66 179.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 58.7 mt -84.8 117.63 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -178.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -114.21 -17.67 11.81 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.04 0.536 . . . . 0.0 110.826 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 73.4 p -174.13 132.74 0.41 Allowed 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.941 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 42.4 mm -83.04 124.08 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 32.5 m -91.55 126.26 36.58 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.4 t -133.46 91.35 26.85 Favored Pre-proline 0 N--CA 1.474 0.774 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -82.01 145.13 13.84 Favored 'Trans proline' 0 N--CA 1.5 1.881 0 C-N-CA 121.672 1.581 . . . . 0.0 111.617 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 60.8 t -129.71 129.13 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.021 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -68.58 125.04 25.25 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.7 pt -99.93 -12.83 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-O 120.847 0.356 . . . . 0.0 110.526 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.5 m -60.17 -38.72 84.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.554 -178.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -86.2 -4.1 59.1 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 122.557 0.343 . . . . 0.0 110.335 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 46.9 t -94.22 111.79 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 60.3 p -128.57 2.87 5.55 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.617 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -152.45 163.03 40.34 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.575 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -64.39 136.64 57.31 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.204 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.7 t -166.36 177.95 6.47 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.585 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 99.1 p -149.71 144.25 25.97 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.818 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -143.51 143.36 31.52 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-O 121.228 0.537 . . . . 0.0 110.476 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 51.4 m -81.75 131.85 35.27 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 64.8 mt -117.39 120.42 38.1 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.823 0.449 . . . . 0.0 109.857 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -84.24 133.64 34.57 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 50.8 mt -102.75 133.79 47.21 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 122.598 0.359 . . . . 0.0 110.047 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -136.17 141.06 44.03 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 122.957 0.503 . . . . 0.0 110.215 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -150.98 130.21 12.74 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -86.21 114.32 22.94 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.293 0.568 . . . . 0.0 111.282 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 128.64 -22.05 5.27 Favored Glycine 0 N--CA 1.48 1.589 0 CA-C-N 114.529 -1.214 . . . . 0.0 111.519 178.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.5 m -134.87 160.41 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-O 120.897 0.38 . . . . 0.0 110.271 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 46.4 m -100.82 117.41 34.83 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.405 HG22 ' H ' ' A' ' 78' ' ' VAL . 0.4 OUTLIER -95.99 131.92 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.881 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -155.29 135.45 8.39 Favored Pre-proline 0 CA--C 1.553 1.07 0 CA-C-O 119.071 -0.49 . . . . 0.0 110.537 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -71.25 -7.53 12.81 Favored 'Cis proline' 0 N--CA 1.52 3.032 0 CA-C-N 121.325 1.509 . . . . 0.0 111.091 0.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.3 p 59.94 17.85 6.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.661 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.4 p -132.92 140.69 47.98 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.6 m -147.73 154.82 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -101.05 134.38 44.14 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.9 p -131.6 138.18 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 121.178 0.514 . . . . 0.0 110.29 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -114.89 126.88 55.31 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.999 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 56.1 mt -109.16 109.15 20.04 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -92.98 127.68 38.58 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.9 t -100.94 132.35 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 46.0 m -100.16 122.09 42.45 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-O 120.689 0.28 . . . . 0.0 110.709 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -101.54 127.78 48.09 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.065 0.546 . . . . 0.0 109.914 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -127.29 99.16 5.54 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 177.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.431 ' N ' HD12 ' A' ' 93' ' ' LEU . 9.8 mp -73.62 95.11 2.26 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -61.88 -31.9 72.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.047 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 60.5 t-80 53.03 79.83 0.11 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.928 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 47.6 p-80 -62.2 126.17 26.41 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.417 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -169.44 119.89 0.68 Allowed 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.4 ' CD2' ' H ' ' A' ' 98' ' ' HIS . 17.2 p80 -68.09 118.21 10.94 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -69.32 130.31 42.23 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 . . . . . 0 C--O 1.221 -0.437 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.551 -179.88 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 63.0 mttp . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 37.2 pt -64.06 168.28 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.202 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.9 m -157.63 161.62 38.66 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.577 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.488 HD23 ' N ' ' A' ' 5' ' ' ARG . 1.8 tt -147.98 118.86 7.6 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.488 ' N ' HD23 ' A' ' 4' ' ' LEU . 48.5 ptt85 -169.23 157.52 7.67 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.948 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -136.69 144.45 43.94 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 71.3 mt -97.69 177.02 5.62 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.8 t -159.89 153.41 22.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.515 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -144.89 166.29 25.69 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.561 0.696 . . . . 0.0 109.699 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 95.2 p -114.19 134.87 54.61 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 114.216 -1.356 . . . . 0.0 109.692 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.5 m -129.25 94.99 31.85 Favored Pre-proline 0 CA--C 1.547 0.861 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -57.71 146.02 87.21 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 CA-C-N 119.992 1.033 . . . . 0.0 111.567 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.0 t -93.98 133.94 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.325 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -114.02 130.15 56.57 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.3 tp -96.39 130.61 43.48 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -122.45 108.54 13.3 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 120.976 0.417 . . . . 0.0 109.879 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.0 pp -65.25 130.16 42.33 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.741 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.7 m -127.57 135.38 50.23 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.81 165.19 15.66 Favored Glycine 0 N--CA 1.475 1.273 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -85.72 134.18 33.97 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.7 ptmm? -63.29 136.95 58.01 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.617 0.246 . . . . 0.0 110.459 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.0 170.43 4.38 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.348 0.594 . . . . 0.0 111.133 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 34.6 t -81.0 -23.16 38.87 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.292 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -87.35 -11.34 49.67 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.8 p -110.1 129.28 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-O 120.84 0.352 . . . . 0.0 110.821 -178.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 36.2 t -86.47 -37.6 18.13 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.982 0.42 . . . . 0.0 109.986 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 98.7 p -160.78 160.07 30.79 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.397 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 92.8 mt -131.31 139.73 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 60.2 m -125.75 154.61 42.25 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -141.37 152.84 44.7 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.017 0.437 . . . . 0.0 110.302 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 96.6 p -151.52 162.05 41.62 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.204 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.469 ' CD1' ' N ' ' A' ' 35' ' ' GLY . 25.0 p90 -146.39 147.35 31.2 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.181 -179.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -69.99 -35.11 74.15 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.612 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -158.98 89.07 0.92 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.409 0.623 . . . . 0.0 109.97 -179.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.469 ' N ' ' CD1' ' A' ' 32' ' ' PHE . . . -76.78 38.17 1.48 Allowed Glycine 0 N--CA 1.462 0.429 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.755 -178.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 27.5 p80 -144.85 137.97 26.69 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 117.659 0.73 . . . . 0.0 109.432 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.6 m -129.16 162.45 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 26.4 m -102.61 133.22 47.96 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 37.9 pt -119.31 146.19 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 122.972 0.509 . . . . 0.0 110.325 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 50.0 t -129.37 134.85 62.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.949 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 162.66 -156.96 28.84 Favored Glycine 0 N--CA 1.467 0.753 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 50.9 m -74.85 147.94 40.66 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 110.321 -0.251 . . . . 0.0 110.321 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -63.92 -30.61 71.67 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.371 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -60.47 -45.16 94.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.721 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.42 -39.61 85.48 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.664 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 67.9 mtt -65.54 -40.87 93.37 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.287 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -64.14 -31.71 73.0 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.045 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.1 tppt? -71.94 -38.57 69.81 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.16 0.505 . . . . 0.0 110.551 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 72.4 mt -88.21 117.52 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.604 -178.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -99.92 -24.93 14.5 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.36 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.9 m -169.99 -178.82 3.0 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.616 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 85.8 mt -124.34 123.48 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 42.4 m -96.07 128.38 42.92 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.5 t -128.53 90.6 46.07 Favored Pre-proline 0 N--CA 1.473 0.718 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -83.47 144.08 11.28 Favored 'Trans proline' 0 N--CA 1.5 1.896 0 C-N-CA 121.829 1.686 . . . . 0.0 111.571 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.6 p -137.44 135.35 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 CA-C-O 121.067 0.461 . . . . 0.0 110.935 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -67.07 128.87 38.0 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 36.1 pt -101.67 -11.23 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-O 120.985 0.422 . . . . 0.0 110.547 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.8 t -62.22 -40.6 96.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.57 -178.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -83.26 -6.88 59.62 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.757 0.423 . . . . 0.0 110.218 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 43.4 t -92.56 109.77 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 70.6 p -132.08 1.91 3.92 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.755 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -142.39 151.97 42.37 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -64.28 134.23 54.3 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.249 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.402 ' OG1' ' N ' ' A' ' 66' ' ' SER . 5.5 t -167.13 -178.38 4.12 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.013 0.435 . . . . 0.0 110.907 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.402 ' N ' ' OG1' ' A' ' 65' ' ' THR . 99.2 p -138.62 147.44 42.93 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.196 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -136.03 141.56 44.34 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.268 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 63.8 m -97.36 125.54 42.03 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 177.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 66.1 mt -120.72 135.93 55.0 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.802 0.441 . . . . 0.0 110.09 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.9 mp0 -98.86 138.3 36.19 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 24.7 mt -106.12 132.28 52.39 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 116.296 -0.411 . . . . 0.0 109.995 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -129.98 140.86 50.83 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -146.82 130.9 17.3 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -85.11 115.38 22.88 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.32 0.581 . . . . 0.0 111.203 -178.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 125.78 -21.13 6.32 Favored Glycine 0 N--CA 1.48 1.575 0 CA-C-N 114.577 -1.192 . . . . 0.0 111.761 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.3 m -132.49 159.09 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 80.7 m -102.94 110.64 22.64 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.4 t -91.58 128.93 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -155.69 138.77 10.75 Favored Pre-proline 0 CA--C 1.554 1.115 0 CA-C-O 118.893 -0.575 . . . . 0.0 110.363 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -70.4 -11.21 13.1 Favored 'Cis proline' 0 N--CA 1.517 2.909 0 CA-C-N 121.291 1.497 . . . . 0.0 110.781 0.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 60.1 22.54 11.77 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.744 -1.117 . . . . 0.0 112.343 177.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 37.7 p -127.07 140.57 52.19 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.7 m -147.53 142.83 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -93.86 131.26 39.44 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 43.4 t -123.3 121.5 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -99.83 123.62 44.28 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 65.4 mt -108.45 105.92 15.8 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -87.91 130.46 34.91 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 26.6 t -104.16 131.39 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 49.5 m -100.05 120.07 39.27 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 -82.46 132.2 35.21 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -54.54 142.85 26.22 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.645 0.26 . . . . 0.0 110.799 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.431 ' N ' HD22 ' A' ' 93' ' ' LEU . 3.8 mm? -72.62 147.34 45.9 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -71.14 4.23 2.92 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.137 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.501 ' N ' ' HD1' ' A' ' 95' ' ' HIS . 0.0 OUTLIER -59.67 141.93 54.05 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.678 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -67.16 127.97 34.63 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.284 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -167.26 149.63 6.05 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -168.62 88.41 0.21 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.881 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 68.5 m80 53.54 -174.96 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.992 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 32.2 p-80 . . . . . 0 C--O 1.221 -0.441 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.56 179.937 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.0 mttt . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 33.7 pt -66.14 -24.63 34.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.234 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.6 p 61.59 148.82 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.241 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.4 tt -71.63 145.72 48.78 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.901 0.381 . . . . 0.0 110.141 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 47.1 ptt85 -170.0 145.21 2.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.429 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -92.83 149.4 21.3 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 56.9 mt -89.74 164.82 14.52 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.6 t -161.3 141.08 10.55 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -149.85 167.12 27.5 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -178.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 39.8 t -124.11 137.99 54.49 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 114.867 -1.061 . . . . 0.0 109.136 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.3 m -122.76 144.57 43.04 Favored Pre-proline 0 N--CA 1.482 1.139 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -73.05 143.18 35.71 Favored 'Trans proline' 0 N--CA 1.5 1.872 0 C-N-CA 121.345 1.363 . . . . 0.0 111.586 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 43.8 t -103.69 134.0 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -125.91 146.86 49.66 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.2 mt -112.2 132.59 54.82 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -114.22 113.97 25.36 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.317 -0.624 . . . . 0.0 109.317 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 49.5 mt -70.33 124.1 23.33 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 76.4 p -119.76 135.31 54.9 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 115.55 163.14 13.72 Favored Glycine 0 N--CA 1.471 1.024 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.4 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 1.0 OUTLIER -85.13 138.91 32.1 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 179.131 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -65.9 132.09 47.81 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.18 177.02 2.42 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.468 0.651 . . . . 0.0 110.786 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 89.9 p -85.23 -19.16 32.09 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.929 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -88.13 -21.53 24.6 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 122.134 0.174 . . . . 0.0 110.737 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.3 p -97.37 126.33 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-O 120.859 0.361 . . . . 0.0 111.008 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.5 t -92.6 -35.92 13.29 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.7 t -161.21 158.03 26.69 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.095 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 82.3 mt -128.73 136.62 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 60.5 m -128.97 153.49 47.5 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -144.62 155.58 43.69 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.188 0.518 . . . . 0.0 110.346 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 87.8 p -150.95 163.5 38.55 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.16 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -146.4 147.59 31.43 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.017 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -71.59 -34.03 69.56 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.533 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -134.13 -52.09 0.83 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 122.892 0.477 . . . . 0.0 110.167 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.31 23.41 62.22 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.44 ' ND1' ' O ' ' A' ' 36' ' ' HIS . 18.0 p80 -147.6 140.11 24.61 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 28.4 m -133.11 165.97 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 46.1 m -99.8 137.92 37.6 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 38.7 pt -119.63 148.46 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.4 t -130.68 134.13 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-O 120.915 0.388 . . . . 0.0 109.97 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 167.2 -163.09 36.86 Favored Glycine 0 N--CA 1.464 0.536 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.2 t -73.41 155.03 39.74 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 110.375 -0.232 . . . . 0.0 110.375 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 70.4 tp60 -63.36 -37.57 87.8 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.549 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -64.04 -39.01 93.15 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 110.435 -0.209 . . . . 0.0 110.435 -179.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.33 -44.4 83.44 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.868 0.365 . . . . 0.0 111.097 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 77.8 mtm -68.23 -39.27 82.36 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.825 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -60.36 -32.76 71.59 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.578 0.228 . . . . 0.0 110.895 -179.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.5 ttpp -70.69 -33.63 71.11 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.729 0.3 . . . . 0.0 110.49 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 71.1 mt -86.44 119.17 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -107.56 -22.11 12.65 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-O 121.228 0.537 . . . . 0.0 110.194 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 95.2 p -171.96 162.33 5.94 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.877 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 36.5 mm -107.07 119.28 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 38.2 m -96.69 127.77 42.99 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 26.0 t -133.5 93.0 22.47 Favored Pre-proline 0 N--CA 1.474 0.775 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -77.29 145.19 23.88 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 121.032 1.155 . . . . 0.0 111.422 -178.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.9 t -132.48 129.56 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.904 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -71.38 127.06 31.31 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.609 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 36.5 pt -99.09 -12.73 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 122.597 0.359 . . . . 0.0 110.92 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 80.6 p -59.04 -38.57 79.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.568 -178.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -86.79 -4.78 59.22 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 122.565 0.346 . . . . 0.0 110.505 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.1 t -93.72 110.85 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 67.8 p -131.5 4.46 4.29 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.414 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.3 tp10 -152.33 158.13 42.3 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.851 0.358 . . . . 0.0 110.105 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -59.79 137.41 58.06 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.329 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.2 t -165.01 166.99 18.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.13 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 42.5 t -141.79 140.84 33.13 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.655 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -148.81 147.38 28.7 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.892 0.853 . . . . 0.0 111.11 -179.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 39.6 m -81.67 136.08 35.51 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 114.278 -1.328 . . . . 0.0 109.328 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.5 mt -110.9 113.06 25.35 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.061 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 50.2 tp10 -75.73 126.29 30.71 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 44.9 mt -104.63 128.07 52.55 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -133.2 141.56 48.14 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -142.31 141.73 32.43 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -85.06 134.84 34.19 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 122.027 0.918 . . . . 0.0 113.137 -177.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.8 -9.5 76.12 Favored Glycine 0 N--CA 1.474 1.185 0 CA-C-N 114.152 -1.385 . . . . 0.0 112.073 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.0 m -133.89 161.74 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 60.6 m -110.41 113.68 26.52 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.6 t -90.3 132.61 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -156.51 139.73 11.0 Favored Pre-proline 0 CA--C 1.554 1.118 0 CA-C-O 119.013 -0.518 . . . . 0.0 110.867 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.5 -12.94 11.83 Favored 'Cis proline' 0 N--CA 1.515 2.738 0 CA-C-N 120.838 1.335 . . . . 0.0 110.887 0.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.7 p 61.55 22.52 12.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.66 177.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.2 p -131.93 139.97 48.87 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.2 m -151.34 154.27 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -98.44 132.8 43.6 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.3 t -127.64 130.32 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -107.47 124.94 50.62 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 55.0 mt -109.34 109.57 20.5 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -179.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -91.02 128.3 36.79 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 23.9 t -102.78 131.8 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 52.1 m -99.13 118.19 35.3 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 96.0 mm-40 -74.79 135.29 41.69 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -89.85 139.85 30.18 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -153.16 47.97 0.7 Allowed 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.311 0.577 . . . . 0.0 109.975 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -150.32 162.93 39.56 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.581 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -152.83 148.72 27.52 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.844 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -74.69 7.0 3.33 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.304 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 21.1 m170 56.92 106.12 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.642 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 15.5 p80 -56.71 -41.39 77.34 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.823 0.344 . . . . 0.0 110.688 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 -61.74 111.69 1.96 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.344 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 . . . . . 0 C--O 1.22 -0.471 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.413 179.947 . . . . . . . . 0 0 . 1 stop_ save_